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QUILL ON SCALPEL
This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

Undergraduate Education in Surgery: a Challenge
The days are gone when a Blimey Austin,
a Botterell or a Gallie taught the whole
undergraduate course in surgery. Increas
ing specialization has killed the concept
of the “ general” surgeon, who had an
overview of all aspects of surgical disease
and could teach these to the undergradu
ate medical student. Paralleling this
specialization has been the development
of postgraduate residency training pro
grams. They have changed the focus of
teaching in university departments of sur
gery from the undergraduate to the post
graduate level, with a consequent de
emphasis of undergraduate teaching. The
fact that teaching medical students often
interferes with operating schedules, office
hours or laboratory commitments, which
postgraduate teaching seldom does, is a
strong disincentive for this type of edu
cation.
The challenge that faces departments
of surgery across the country is how to
get “ surgeon-teachers” back into the
undergraduate education process. If this
does not occur, surgeons will confirm
themselves in the eyes of those from other

The Canadian journal of
Surgery
Le journal canadien de
chirurgie
( 613) 731-9331

The Canadian Journal o f Surgery is pub
lished by the Canadian Medical Association
and sponsored by the Royal College o f Phy
sicians and Surgeons o f Canada. The estab
lish m e n t o f e d ito ria l p o lic y is the
responsibility of the Royal College. The
objectives of the Journal, endorsed by the
Council of the College, are: (1) to contribute
to the effective continuing education of
Canadian surgical specialists, using innova
tive techniques when feasible and (2) to pro
vide Canadian surgeons with an effective
vehicle for the dissemination of their obser
vations in the area o f clinical research.

Published every 2 months by the Canadian
Medical Association, PO Box 8650, Ottawa,
Ont. K1G 0G8. Printed by Harpell’s Press

disciplines as being interested only in the
technical aspects of surgical care; the
opportunities to mould young minds and
later to attract high-quality individuals
into surgery will thus be lost. We must
also recognize that the primary function
of a university medical school is to teach
undergraduate students and the tendency
for the postgraduate tail to wag the
undergraduate dog must be resisted. The
advent of systems teaching and the
revamping of undergraduate medical cur
ricula have all provided opportunities for
surgeons to delegate undergraduate edu
cation to others, with the effect that the
level of visibility of the department of sur
gery, in the educational sense, is now
extremely low in many centres.
How can the department of surgery
respond to this challenge? Initially, it is
the ultimate responsibility of each depart
ment chairman to guarantee to the dean
of his school that the department will
place equal emphasis on undergraduate
education, postgraduate education and
research when determining its goals and
objectives. If the department chairman
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Instructions to Contributors

devalues undergraduate education, the
staff will certainly not see it as a priority.
Having made the commitment, the chair
man must then follow through by recog
nizing the importance and quality of the
undergraduate education performed by
individuals in his department. While this
may take the form of financial reward,
promotion to a higher academic level,
nomination for a prize for teaching excel
lence or increased administrative respon
sibility and authority, probably the
greatest contribution a department chair
man can make is to provide an organiza
tional structure that facilitates the whole
process of undergraduate teaching. In a
recent survey conducted by the Associa
tion of Surgical Education, less than half
o f the North American departments of
surgery were found to have an under
graduate education office or a secretary
assigned primarily to that end. Just over
half had a departmental committee
responsible for undergraduate surgical
education, but two thirds had access to
a centralized medical education office for
consultation regarding undergraduate

Editorial Advisory Board
Conseil consultatif de redaction

S.A. Awad, Halifax, NS
R.J. Blanchard, Winnipeg, Man.
M.M. Cohen, Toronto, Ont.
P.J.E. Cruse, Calgary, Alta.
J.B. Freeman, Ottawa, Ont.
W.J. Keon, Ottawa, Ont.
M.
J. Rheault, Montreal, PQ
N.
M. Sheiner, Montreal, PQ
C. Sorbie, Kingston, Ont.
H.T.G. Williams, Edmonton, Alta.
P.P. Morgan (ex officio)

The Canadian Medical Association
L’Association medicale canadienne
President / president

T.A. McPherson, MD, PhD, FRACP
Secretary General
Secretaire general

B.E. Freamo
Director o f Publications
Directeur des publications

David Woods
Director o f Advertising Sales
Directeur de la publicite

N. Hutton (416) 598-9870
Detailed instructions to contributors, in En
glish and French, appear on page 95 of the
January 1985 issue.

Coeditors
Corddacteurs

L.D. MacLEAN, Montreal, PQ
C.B. MUELLER, Hamilton, Ont.
Associate Editor
Redactrice associee

G. PANCIROV

Montreal Sales M anager
Chef du service des ventes a M ontreal

The Royal College of Physicians
and Surgeons of Canada
Le College royal des medecins et
chirurgiens du Canada
President / president

J.G. Couture, MD, FRCSC
Executive Director
Directeur general

J.H. Darragh, MD, FRCPC

VOLUME 28, NO. 2, M A R C H 1985 / THE CANADIAN JOURNAL OF SURGERY

R. Stapleton (514) 620-8877
Production M anager
Chef du service de la production

K.A. Freamo
PAAB

CCPP
Note: All prescription drug advertisements
in the Journal have been precleared
by the Pharmaceutical Advertising
Advisory Board.

teaching. Only 15% had a professional
educator on staff. The issue of teaching
incentives was also the subject of a panel
discussion at the 1984 meeting of the
Association of American Medical Col
leges. It was clear at that discussion that
departments of surgery in the United
States were not considered as major par
ticipants in the undergraduate teaching
process. Some of our Canadian medical
schools may be similarly perceived, so it
is essential that further erosion of the sur
geon’s role in undergraduate teaching
must be resisted at all costs and this incor
rect perception be changed.
The most effective way to do this is by
improving the organization of the depart
ment of surgery as it relates to under

graduate education. A departmental
officer for undergraduate education
should be established with a secretary for
the director of undergraduate education.
The director should be a senior, full-time
surgeon, preferrably with additional post
graduate training in education, who is as
committed to undergraduate education as
some of his peers are to research. The
appointment of a professional educator,
who should be cross-appointed to the
appropriate university or faculty educa
tional body, will also add to the profes
sionalism that must accompany excellence
in education. Such an individual will be
able to help with the evaluation of
teachers, the outcomes of undergraduate
education and course assessment. These

moves will undoubtedly raise the level of
visibility of the department of surgery at
a crucial time when it is on the decline.
If we do not get surgeons back into the
undergraduate educational process, we
may at worst forfeit our right to be part
of a university and at best will deny stu
dents the opportunity to be exposed to the
excellence in teaching and problem solv
ing that many surgeons now demonstrate.
Departments of surgery — go to it!
J.L. P rovan, mb, ms, frcs, frcsc, FACS
Director of Undergraduate Education,
Department of Surgery,
University of Toronto,
Toronto, Ont.
M4Y 1J3

The Benefits of War — to Surgery
Ares, the Greek god of war, still wields
his influence over mankind. It may be
said with cynicism that Ares has benefited
only the manufacturers of arms and the
discipline of surgery. In this issue (pages
183 to 186), Dr. Campbell Derby gives
due credit to the military surgeon, who
treats friend and foe and uses the expe
rience to benefit all.
In war, men die because of wounds or
disease, or both. In the Iliad, Homer
described 147 wounded soldiers whose
death rate was 77%; that is, 3 dead for
every 1 who survived. This high mortal
ity remained remarkably constant until
the beginning of the 20th century; as
Derby points out, in the latest wars five
survived for every six wounded. But dis
ease was an even bigger threat and, until
World War II, more soldiers died of dis
ease than of wounds.
Gunpowder was introduced into war
fare in the 1300s, and wounds result
ing from its use were considered poi
soned, requiring cauterization with boil
ing oil or the red-hot iron. In 1536,
Ambroise Pare accidentally rediscovered
the gentle management of wounds when
he ran out of boiling oil. As significant
an observation was that of John Hunter,
in the Belle Isle campaign in the 1700s,
who noted the advantages of delayed
closure of war wounds. He found that the
body can cope with an open wound but
not with an abscess. Delayed primary
closure has had to be rediscovered with
every successive war — including the
Falklands campaign.
Napoleon’s remarkable surgeon, Larrey, developed “ flying ambulantes” to
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evacuate the wounded from battlefields.
Until his time, wounded were left to the
care of fellow wounded and had to make
their own way to the rear. Larrey also
practised emergency operation in the
field, and at the Battle of Borodino per
formed 200 amputations in 24 hours. He
earned the gratitude of the soldiers and
his emperor.
Forty years later, in the Crimean War,
cold, filth and disease took its dreadful
toll. This war taught the world the value
of nursing care, through the influence and
organizational talents of Florence Night
ingale. Ironically, she never accepted the
germ theory of disease. Two men, Dr.
Sutherland in public health and a Mr.
Rawlinson who was a civil engineer,
ensured working drains and clean water
in the Barracks Hospital of Scutari. This
reduced the mortality in 1 month from
40% to 2% — and Miss Nightingale
received the credit!
In two conflicts at the beginning of this
century — the Boer War in South Africa
and the Russo-Japanese War — penetra
ting abdominal injuries were treated con
servatively (by order), until Vera
Gedroitz, a Russian princess turned sur
geon, used Larrey’s principles of urgent
operation in an ambulance train.
In World War I, wound infection and
gangrene in the trenches dominated the
picture. Alexis Carrel and Henry Dakin
developed hypochlorite wound irrigation,
but then a young surgeon-bacteriologist,
Alexander Fleming, also studied the
problem and boldly stated that antisep
tics did more harm than good. In 1929,
he noted the effect of an accidental

growth of Penicillium on a culture of
Staphylococcus aureus. At the beginning
of World War II, Florey and Chain
searched for an anti-infective agent and
in literature research came across Flem
ing’s article, developed penicillin and
introduced antibiotics — one of the
greatest boons to mankind.
The first blood bank in war was made
possible by the energy and organization
of the Montreal surgeon Norman Bethune,
during the Spanish Civil War. This
achievement led to the extensive use of
blood in World War II and greatly
increased the scope of postwar surgery.
And so, through the lessons of war, we
have learned to treat contaminated
wounds gently with debridement and
delayed closure. Hygiene, vaccine and
antibiotics have become effective
weapons against Apollo’s arrows of pes
tilence. Blood transfusion, intravenous
fluid resuscitation and rapid evacuation
have effected an unbelievable change in
the outlook of the wounded. Dr. Derby’s
article is a timely reminder of the debt we
owe the military surgeon — and his
patients.
P eter C ruse, mb, frcsc , frcs(edin ),
facs

Member,
Editorial Board
Professor and Head,
Department of Surgery,
Foothills Hospital,
Calgary, Alta.
T2N 2T9
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Surgical Management of Hydatid Disease of the Liver
Hydatid disease of the liver is increasingly
prevalent in North America, particularly
in cities with an immigrant population
from the Mediterranean area. It is there
fore important that the practising surgeon
be aware of presenting signs and symp
toms and the modern treatment of this
disease. Akinoglu and coauthors in this
issue (pages 171 to 174) report a large
experience with hydatid disease in Tur
key. They describe clearly the methods of
presentation and, in particular, the fre
quency with which biliary communication
with cyst cavities and superimposed infec
tion are seen. They indicate that
ultrasonography and Casoni skin testing
in their experience have provided satisfac
tory diagnosis. In North America, the
availability of other serologic tests such
as the indirect hemagglutination test
(IHA) is more specific than the Casoni
test. Our own experience1 also suggests
that computerized tomography, where
available, is superior to ultrasonography
in providing noninvasive imaging of
hydatid cysts. The treatment of the dis
ease remains primarily surgical; it in
volves evacuation of the cyst, elimina
tion of the parasite and management of
the remaining cavity. Some authors have
advocated hepatic resection for most
cysts,2 but we agree with Akinoglu and
colleagues that this is an unnecessarily
aggressive approach, and reports in the
literature indicate a higher morbidity and

mortality than with more conservative
methods.
Conservative management involves
evacuation of the cyst, protection of the
peritoneal cavity, elimination of the para
site and management of the residual
cavity. The cyst must be evacuated care
fully with particular attention to protect
ing the peritoneal cavity from spillage of
cyst contents. We have used a plastic
drape sutured to the cyst wall for this pur
pose, but other equally efficacious
methods have been described. The endocyst, daughter cysts and all fluid must be
removed carefully and completely.
Many compounds have been used as
scolicidal agents, including formalin,
hypertonic saline, Hibitane and alcohol.
Akinoglu and associates describe one
patient who died from the systemic effects
of formalin. This complication has been
previously reported and emphasizes that
formalin should never be used as a scoli
cidal agent.
The management of the cyst cavity is
still controversial. Whether capitonnage
as used by Akinoglu has any advantages
over simple cyst closure or partial exci
sion of cyst wall, is uncertain. We have
achieved similar results without either
capitonnage or omentoplasty. The ques
tion of whether to use drainage tubes is,
however, important. Our experience sug
gests that in patients who have neither
communication of the cyst cavity with the

biliary tract nor infection of the cyst
cavity, partial excision of the cyst wall or
closure of the cyst cavity without drains
is the treatment of choice. Where infec
tion in the cyst or biliary communication
exists, drainage tubes are indicated.
Although there are some reports of suc
cess with medical treatment of hydatid
disease using mebendazole,3 there is
insufficient evidence to use this drug as
primary treatment. We reserve its use for
patients in whom spillage has occurred
and for those not amenable to surgical
treatment.
B. L a n g er , m d , frcsc
J.C. L anger , md
Department of Surgery,
Toronto General Hospital,
University of Toronto,
101 College St.,
Toronto, Ont.
M5G 1L7
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SESAP IV Question
151. A 56-year-old woman has a smooth, tense, 8-cm mass in the left adnexal area. The right adnexal area, uterus, and
cervix are normal on pelvic examination. All of the following steps are appropriate for evaluating this problem EXCEPT
(A)
(B)
(C)
(D)
(E)

laparoscopy
uterine endometrial sampling
barium enema
intravenous pyelography
Pap smear from squamocolumnar junction of the cervix

For the incomplete statement above select the one answer that is best of the five given. For the critique of Item 151 see
page 146.
(Reproduced by permission from SESAP IV Syllabus; Surgical Education and Self-Assessment Program No. 4. For enrol
ment in the Surgical Education and Self-Assessment Program No. 4, please apply to the American College of Surgeons,
55 East Erie St., Chicago, IL 60611.)
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SURGEONS’ UPDATE

What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Dr. Joseph L. Shugar,
CJS Senior Associate Editor,
Dies

Almost every surgeon who has con
tributed to this journal within the last few
years has also corresponded or spoken
with Dr. Joseph L. Shugar; most readers
are familiar with his editorials, con
tributed regularly since 1979 when he
joined the staff. All who knew him will
understand the sadness we feel at the
announcement that Dr. Shugar died on
Dec. 21, 1984 during a coronary bypass
operation at the Ottawa Civic Hospital.
He is described by words like quiet,
kind, straightforward and unassuming. A
creative man, with hands that engaged in

surgery, writing, sculpting, woodwork
ing, orchid growing and photography,
Dr. Shugar will be much missed.
Born in 1919 in Montreal, the youngest
of four children, his undergraduate
studies at McGill led to a medical degree
in 1943. He and Anne were married
shortly afterwards, during his rotating
internship at the Royal Victoria, Alexan
dra and Montreal Neurological hospitals.
He spent the next 3 years in military serv
ice, with more than a year in Europe. Dis
charged in April 1946, he took up
residency training in general surgery in
Montreal, to focus later on orthopedics
at the Massachusetts General, the Boston
Children’s and Peter Bent Brigham hospi
tals in Boston. He returned to Montreal
to become a faculty member at his alma
mater where he continued teaching until
he left the province. For much of the time
he was also Chief of Orthopedic Surgery
at the Jewish General Hospital.
Seven years ago, Dr. and Mrs. Shugar
moved to Ottawa with plans to find more
time for hobbies and family. Dr. Shugar
became Deputy Chief of Surgery at the
Grace General Hospital and within 2
years had accepted a position as Assistant
Professor in the Department of Surgery,
University of Ottawa. He also agreed to
work as Senior Associate Editor of the
Canadian Journal o f Surgery.

Joseph L. Shugar, M D, FRCSC

Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery,
PO Box 8650, Ottawa, Ont. K1G 0G8.

— For prescribing information see page 142

Throughout, he participated actively in
his professional associations: as an
examiner for the Royal College of Phy
sicians and Surgeons of Canada and as
a consultant in orthopedics for CARE
(Medico) Tunisia.
A prize-winning photographer in his
youth, he never stopped working to cap
ture beauty. He became a master of
woodworking and studied with Hans
Schleeh, Toronto, to develop skills as a
sculptor of stone and metals.
When he moved to Ottawa, he took up
yet another form of art — orchid grow
ing; only a week before he died he was
awarded second prize in a local orchid
exhibit.

A close friend commented, “ Joe pos
sessed a fundamental honesty, interwoven
with personal and professional integrity.
He was patient; he was kind; he was a
most devoted family man. He was a mar
vellous friend, an excellent teacher, a
healer, an interpreter of the medical arts
and a leader in his work. His objectivity
was always tempered by humanity and
humour. If things were bad he could con
vincingly explain how they were likely to
get better. And if they weren’t going to
get better . . . well, he had a way of
softening the blow. He could communi
cate his inner peace to others and that
peace was with him to the end.”
Dr. Shugar is survived by his wife
Anne, three children — Richard, Donna
and Bill — and four grandchildren.
Surgeons Receive Order of Canada

Drs. Lloyd D. MacLean and Wilbert J.
Keon became officers of the Order of
Canada on Dec. 17, 1984. Chosen from
a group of 400 nominees from across the
country, the two surgeons will attend
investiture ceremonies in April.
The Order of Canada, established dur
ing the centennial celebrations in 1967, is
the centrepiece of honours available to
Canadians. The motto “ They desire a
better country” echoes the emphasis on
the recipients’ efforts to improve their
community and nation. There are three
levels in the Order: companions, officers
and members, and the constitution limits
the numbers awarded. There can be only
150 living companions at any one time,
and each year 46 officers and 92 members
can be appointed.
The Governor General, who is the
Chancellor and Principal Companion for
the Order, approves the appointments
and presides over investiture. The honour
is never awarded posthumously, although
some people have died before the inves
titure and their families accepted the
award.
Individuals submit nominations and
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about a year is usually needed for tes
timony and follow-up. An advisory coun
cil reviews the files on nominees and
recommends appointments to the Gover
nor General. The council is chaired by the
Chief Justice of Canada, with other per
manent members being the Clerk of the
Privy Council, the Under Secretary of
State, the Chairman of Canada Council,
President of the Royal Society of Canada
and the President of the Association of
Universities and Colleges of Canada. To
ensure representation from across Can
ada, the Governor General can appoint
two other council members for 1-year
terms.
Dr. MacLean, Surgeon-in-Chief of the
Royal Victoria Hospital, Montreal, and
Coeditor of this journal, was cited in the
government announcement of the awards
as having “ international recognition for
his work in the field of surgery, especially
in kidney transplants. A scientist as well,
he has been responsible for the present
emphasis on basic research within depart
ments of surgery in Canadian hospitals.”
He was born in Calgary, attended local
elementary and high schools and received
his MD from the University of Alberta
in 1949. After a rotating internship and
a straight surgical internship, Dr.
MacLean undertook residency training in
general surgery at the University of Min
nesota where he remained for the next 6
years, holding positions as instructor,
assistant and associate professor. In 1962,
he accepted his current position at the
Royal Victoria and joined McGill’s
Department of Surgery, which he chaired
in alternating 5-year terms from 1968 to
the present. A fellow of the Royal Col
lege of Physicians and Surgeons of
Canada and the Royal Society of Canada,

Llovd D. MacLean, MD, FACS, FRCSC
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he has amassed awards and visiting
professorships throughout the world.
Besides his role on this journal, he is
a consultant to the World Journal o f Sur
gery and the Annals o f Surgery. He edited
volumes 15 and 16 of “ Advances in Sur
gery” and in 1974 participated in the film
production “ Surgery for Obesity” . He is
an author of almost 300 scientific articles
and book chapters.
The other surgeon honoured, Wilbert
Keon, gained recognition for “ his skills
as a cardiac surgeon, teacher and medi
cal administrator” and his role in estab
lishing the Heart Institute within the
University of Ottawa and the Ottawa
Civic Hospital. He is also noted for his
research into cardiovascular diseases,
including emergency interventions during
myocardial infarction and investigations
into atrial muscle mechanics, defining
optimal preservation of the myocardium.
Dr. Keon performed Ottawa’s first heart
transplant at the Heart Institute in the
spring of 1984. The government press
release on the awards refers to the insti
tute as “ a world class facility at which he
is director and head of a renowned team
of surgeons” .
Keon was born just outside Ottawa
in Sheenboro, PQ, and, with the excep
tion of the time in training, has spent his
life in the area. He received his medical
degree from the University of Ottawa. He
completed residencies in general surgery
at the Montreal General Hospital and
went on to the Toronto General Hospi
tal and the Hospital for Sick Children for
training in cardiovascular surgery. After
becoming a fellow of the Royal College
of Physicians and Surgeons in both dis
ciplines, he took up a research and clini
cal associateship at Peter Bent Brigham

Wilbert J. Keon, MD, FACC, FRCSC
(photo by Karsh)

Hospital and Harvard Medical Center for
a year.
A member of the editorial board of this
journal and of Ontario Medicine and
Associate Editor of the new Canadian
Journal o f Cardiology, he has authored
more than 50 articles, about 15 book
chapters and is currently coordinating the
production of a surgical handbook for
fourth year clinical clerks; he has collabo
rated in six films.
Two others in the field of medicine, F.
Clarke Fraser, a professor of clinical
genetics, Memorial University of New
foundland, and Charles-Eugene Marin,
psychiatrist (and mayor), Ste-Anne-desMonts, PQ, were also appointed to the
Order.

New Laboratory at Memorial
Focuses on Carcinoembryonic
Antigen
Scientists in the Department of Surgery
at Newfoundland’s Memorial University
are attempting to direct chemotherapy
toward cancerous cells and, thus, to pro
tect healthy cells from the damage caused
by the potent drugs used in treatment.
The group, headed by Dr. C.H .J.
Ford, is working in a newly established
oncology research laboratory funded by
several grants, including one for $150 000
from the Terry Fox Special Cancer
Research Fund.
To date, the investigation has focused
on monoclonal antibodies to pilot the
drugs to the offending cells. The re
searchers chose carcinoembryonic antigen
(CEA) as the target (although not all
cancers express the antigen nor is it
expressed only by cancerous tissues)
because this antigen if often present in
carcinomas of the stomach, lung, breast
and ovary.
The group has characterized several
antibodies and selected a few for further
testing in vivo. Cancer cells with and
without CEA are being grown as xeno
grafts on immunoincompetent nude mice
for tests of the efficacy of antibodies in
their role as the drug delivery system.
Other thrusts of the research are to
identify the chromosomes responsible for
producing CEA — a goal the group hopes
to achieve by fusing rodent cells with lines
that express CEA and then to see what
elements in the hybrids correlate with
human chromosome content.
The Newfoundland studies are part of
an international effort to test the antibod
ies, with scientists at the Surgical Immu
nology Unit, University of Birmingham,
UK, assessing potential uses in diagnosis,
and scientists at the National Cancer
Institute in the United States evaluating
the therapeutic effects of different com
binations of drugs and antibodies.
A my C houinard
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CORRESPONDENCE

Contributions to the Correspondence section are welcomed.
They should be typewritten and double spaced.

Radiotherapy Versus Resection
for Palliation of Carcinoma of
the Esophagus
To the editors.—In a recent issue (Can J
Surg 1984; 27: 491-5), Stoller and Brumwell examined palliation after operation
and after radiotherapy for cancer of the
esophagus. Using a grading system
designed to assess the subjective responses
of each patient, the authors concluded
that there was no difference in palliation
between radiotherapy and surgical resec
tion plus bypass. They recommended
radiotherapy as the best primary treat
ment for squamous cell esophageal car
cinoma.
Unfortunately, the data they presented
did not support this contention. In the 53
patients treated by radiotherapy, 89% of
the evaluations (87/98) scored in the
excellent or good range. Yet 45% (24/53)
of the patients required a secondary
procedure to maintain their palliation.
Thus, the grading system identified very
few patients (only 11 evaluations) who ran
into problems sufficient to require a
secondary procedure to maintain their
palliation. In the 29 patients treated by
surgical resection, 80% (36/45) of the
evaluations revealed excellent or good
palliation. In contrast, 28% (8/29) of the
surgically treated patients required secon
dary intervention, suggesting that most of
these patients were identified by the grad
ing system. Unfortunately, the authors
did not give the number of patients avail
able for examination in any given time
period and appear to have a highly
selected population for their grading
project. The grading system did not iden
tify patients who had difficulty swallow
ing after radiotherapy and conclusions
based upon the grading system are there
fore without merit.
Several years ago we reported the inci
dence of postradiation esophageal stric
ture in 152 patients with esophageal
cancer, treated at the Princess Margaret
Hospital in T oronto.1 In the follow-up
period, a clinically apparent malignant
stricture of the esophagus developed in
108

49% (75/152), while only 33% (50/152)
had no evidence of stricture. When
autopsy data were combined with the clin
ical data, it was noted that 80% of
patients with carcinoma of the esophagus
treated by radiation to a dose of at least
4000 rad had recurrent disease in the
esophagus, and in 80% of these, the
recurrence was symptomatic. Thus, 63%
of the 152 patients with esophageal car
cinoma had symptomatic recurrence
when radiotherapy was the primary treat
ment. We carefully excluded from the
study patients with advanced disease who
were treated with low doses of radiation.
In contrast, only 8 of 30 (27%) of the sur
gically treated patients in our study had
clinical or autopsy evidence of stricture
or obstruction of the esophagus postoperatively. It is interesting that in the report
by Stoller and Brumwell the incidence of
clinically identified poor palliation is simi
lar: 45% in the radiotherapy group and
28% in the surgically treated group.
From the data we presented previously,
it could be concluded that patients with
carcinoma of the esophagus treated sur
gically received the best palliation. The
results of Stoller and Brumwell support
this. Furthermore, when examining the
results of Stoller and Brumwell, we can
conclude that although patients with
cancer of the esophagus may not do well
in general, their ability to come in for
follow-up was an indication that 86% of
the time (123/143 evaluations) they were
in good or excellent condition. Patients
who did not come in for a follow-up were
probably doing poorly or were deceased,
and therefore were not evaluated.
Moreover, at 2 years, only 4 (8%) of 53
patients treated by radiotherapy were
even available for evaluation, whereas 6
(21%) of 29 patients treated surgically
were still available for follow-up. As both
the objective palliation and survival
reported by Stoller and Brumwell appears
better in the surgical group, it is hard to
understand how the authors have sug
gested that radiotherapy is the better
primary treatment for symptomatic squa
mous and undifferentiated carcinoma of
the esophagus.

In his editorial (Can J Surg 1984; 27:
417), Goldberg concluded that there is a
need for a prospective, randomized study
to compare the differences between sur
gery and radiotherapy. While we await
such an effort, patients with esophageal
carcinoma continue to require therapy
directed primarily at palliation. The
objective data reported in the highly
selected series from the Cancer Control
Agency of British Columbia (Stoller and
Brumwell) and from the Princess Mar
garet Hospital (Beatty and associates)
suggest that surgical resection and bypass
should be undertaken for the treatment
of esophageal cancer. Seventy-five per
cent of patients will be palliated this way.
When distant metastatic disease is iden
tified or the patient’s condition prohibits
a laparotomy, with or without thoracot
omy for esophagectomy, an alternative,
namely radiotherapy, is required. In
almost 50% of these irradiated patients
it can be anticipated that other palliative
maneuvers, such as rigid tube placement,
will be required to establish or maintain
palliation. Obviously, we all hope for
more effective treatment modalities than
current surgery or radiotherapy, modali
ties that can withstand careful, critical
scientific evaluation.
J. D avid Beatty , md , facs, frcsc
Department of General Oncologic Surgery,
City of Hope National Medical Center,
Duarte, Calif.
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To the editors.— Thank you for the
opportunity to consider Dr. Beatty’s
letter.
After discounting our data (Can J Surg
1984; 27: 491-5) as being without merit,
Beatty claims our findings as evidence
that surgical resection is better than radio
therapy for primary treatment of eso
phageal cancer! In the paper he quotes as
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While almost every patient with eso
phageal cancer treated by radiation in Bri
tish Columbia is seen and followed up Thrombosis of the Ulnar Artery
until death at the Cancer Control Agency,
To the editors.—The report by Lee and
we have no knowledge of the total pool
from which the referred surgical patients Evans of a case of vibration-induced
originated. This was enunciated in our white finger disease (Can J Surg 1984; 27:
paper and certainly we agree that the sur 513-4) warrants further scrutiny. They
gical series may not be representative. report the case of a 22-year-old man in
Patterns of practice in North America whom pain and swelling of the middle
make this kind of clinical control extre finger associated with signs of digital
ischemia developed after use of an air
mely difficult.
Dr. Beatty cannot conclude that the gun. Allen’s test and arteriography con
firmed occlusion of the ulnar artery.
scoring system did not identify patients
Thrombosis of the ulnar artery occurs
having problems or that those who did
not come in for follow-up study were typically in manual labourers. It causes
pain and swelling, usually in the palm,
doing poorly or were deceased. We did
not attempt to study these points. This and may cause ischemic symptoms in the
would have required patients being seen digits.1-3 I believe the vibration-induced
once or more per month — a frequency white finger disease reported by Lee and
only acceptable if one can send a visitor Evans was actually a case of ulnar artery
thrombosis. It is important to recognize
out on rounds to the patients’ homes.
Thus, a patient who scored A may have ulnar artery thrombosis as the primary
been asked to return in 3 months. After underlying condition, since some patients
1 month, he may have been swallowing may require reconstruction of their super
poorly, been referred by his family phy ficial palmar arch if the ischemic symp
sician to a suitable specialist, treated and toms do not respond to the prevention
been back at grade A or B by the time he of repetitive trauma, stellate ganglion
came in for his next follow-up visit at the block or the administration of reserpine
clinic. At an anecdotal level we did intra-arterially.4 For this reason, I sug
encounter instances in which the score gest a more appropriate title for this
assigned identified deterioration. We are interesting case report would have been
“ Ulnar artery thrombosis caused by a
aware that this is an item we must try to
include in our future studies. Regardless vibrating tool” .
of intermittent fluctuations, we believe we
have shown that patients can be kept at R obin R. R ichards , m d , frcsc
A or B grades by judicious interventions
even if 45% do get recurrent dysphagia Lecturer in Orthopedic Surgery,
at one time or another. This is also true St. Michael’s Hospital,
University of Toronto,
for surgically treated patients but is Toronto, Ont.
negated by the initial mortality and mor
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bidity they suffer from the operation.
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posttraumatic digital ischemia. Surgery 1970;
“ suggest” in regard to our advocacy of
68: 1122-8
radiotherapy. We did this because we 2. COSTIGAN DG, RILEY JM JR, COY FE JR: Thrombofibrosis of the ulnar artery in the palm. J Bone Joint
recognize that our data are not conclu
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sive. However, we believe, with others,2,3 3. KLEINERT HE, VOLIANITIS G J: Thrombosis o f the
palmar arterial arch and its tributaries: etiology and newer
that adoption of the idea of evaluating by
concepts in treatment. J Trauma 1965; 5: 447-57
numbers a concept as vague as “ pallia 4. URBANIAK JR, KOMAN LA: Ulnar artery thrombosis: a
rationale for m anagem ent. In STRICKLAND JW ,
tion” is overdue and has put anecdotal
STEICHEN JB (eds): Difficult Problems in Hand Surgery,
reports out of contention.
Mosby, St. Louis, 1982: 253-63
J ulius L. Stoller , mb , frcs , frcsc
Laurel Medical Centre,
316 - 888 West 8th Avenue,
Vancouver, BC
V5Z 3Y1

1944. As pointed out in our article, the
exact etiology of this condition has not
been clearly defined. Dr. Richards has
rightly pointed out that some of these
cases result from ulnar artery thrombosis.
We recently re-evaluated our patient’s
condition. When Allen’s test was per
formed, he had excellent cross-filling
between both the ulnar and radial arter
ies. All his digital arteries were found to
be patent on Doppler examination, and
the arterial pressures in the digital arter
ies of the middle fingers of both hands
were found to be equal. The evidence
suggests that our patient did not have
ulnar artery thrombosis but more likely
spasm of the palmar vasculature.
E.H . L e e , m d , frcsc
Senior Lecturer,
University Department of
Orthopedic Surgery,
Singapore General Hospital,
Singapore 0316
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REVIEW ARTICLE

Carlos Del Cam po ,

md , frcsc

Pulmonary Embolectomy: a Review
Massive pulmonary embolism continues
to be a major cause of death in spite of
improved medical therapy. Only a small
number of patients with pulmonary
embolism refractory to medical treatment
are referred for pulmonary embolectomy.
A literature review of patients with mas
sive pulmonary embolism treated by pul
monary embolectomy showed that the
operation was highly successful in those
who were unlikely to survive with other
modes of therapy. Specific indications
and management are outlined on the
basis of these cumulative data.
L'embolie pulmonaire massive demeure
une cause majeure de deces en depit des
ameliorations de son traitement medical.
Seul un petit nombre de patients souffrant d'embolies pulmonaires resistantes
au traitement medical doivent etre soumis d une embolectomie pulmonaire. La
revue de la litterature relative au traite
ment par embolectomie des patients
souffrant d'embolie pulmonaire massive
revele que cette operation est souvent
couronnee de succes chez ceux dont la
survie serait douteuse par tout autre
mode de therapie. A partir des donnees
cumulatives, on decrit les indications
specifiques et la marche a suivre dans de
tels cas.

Pulmonary embolectomy remains a con
troversial operation. Statements such as
“ there are no indications for the
operation” 1 to “ prophylactic open
embolectomy can be justified” 2 exem
plify the extremes of opinion, and neither
one is applicable to all clinical cases.

From the Division o f Cardiovascular and
Thoracic Surgery, Halifax Infirmary and
Dalhousie University, Halifax, NS
Accepted fo r publication Nov. 16, 1984
Reprint requests to: Dr. C. Del Campo,
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Halifax, NS B3J 1B6

New therapeutic modalities, based on
better understanding of the pathophysiol
ogy o f the disease, have led to a substan
tial improvement in the prevention o f
deep venous thrombosis and pulmonary
embolism. Furthermore, better therapeu
tic regimens for the symptomatic patient
with pulmonary embolism, that is, sys
temic heparinization, inotropic support
and, recently, locally administered strep
tokinase, have reduced even further the
number of patients who in the past would
have been considered for pulmonary
embolectomy. In spite o f these advances,
approximately 200 000 deaths in the
United States each year are associated wih
pulmonary embolism.3 In 150 000 o f
these it is the major cause of death4 and
it is the only cause of death in 50 000 o f
them.5 Since most patients with massive
pulmonary embolism, if not treated
promptly, die shortly after the event,
patients suitable for treatment would be
those located in acute-care general hospi
tals when the embolism occurs. In these
hospitals 15% o f patient deaths are due
to pulmonary embolism,6'7 and it is the
only cause o f death in 3% o f them.4
Since these figures include patients who
died in spite o f optimal medical treat
ment, the question is whether an
appreciable number o f them should have
been offered a pulmonary embolectomy.
The purpose of this paper is to answer
this question by analysing the indications,
techniques and results o f the operation
and to draw conclusions on its applica
bility, based on a review o f the literature.

Collection of Data
The literature was reviewed, including
series and isolated reports of pulmonary
embolectomy. Only cases of massive pul
monary embolism were considered. This
was defined as the sudden occurrence o f
an embolus producing severe cardiovas
cular decompensation, manifested by
severe hypotension, oliguria and hypoxia
refractory to aggressive medical treat
ment. To avoid duplication o f data, iso

lated cases that were found in later
cumulative series were excluded. Patients
who underwent pulmonary embolectomy
were divided into two groups — those in
whom cardiopulmonary bypass was used,
and the others. Each group was then sub
divided into series o f cases and case
reports, because usually isolated case
reports included only successful cases that
cannot be considered in an accurate anal
ysis o f survival. On the other hand, the
total numbers o f successful cases are
important in showing whether the reports
o f an operation are anecdotal or not.
Overall figures were calculated separately.
The circumstances under which pulm o
nary embolectomy was performed, use of
partial cardiopulmonary bypass before
pulmonary embolectom y, pulmonary
angiography and venous interruption
were recorded whenever available. Cases
o f transvenous pulmonary embolectomy
were analysed separately and not included
in the cumulative data. Only patients who
left the hospital alive were considered as
having survived the operation.

Findings
O f 651 pulmonary embolectomies per
formed in patients with massive pulm o
nary embolism, the operation was per
formed with extracorporeal circulation in
537 patients (82%), and in 26% o f these,
partial cardiopulmonary bypass was
started before sternotomy (femoral vein
to femoral artery bypass) to maintain the
circulation until the embolus could be
removed. The remaining 114 patients
were operated upon without cardiopul
monary bypass. Survival was superior in
patients who had cardiopulm onary
bypass (59.3% versus 47.7% , p = 0.05)
(Tables I8'21 and n 2,i 1. 16, 19,22-48) In this
group 170 patients underwent pulmonary
angiography before operation. This infor
mation was not available in most series
when cardiopulmonary bypass was not
used; angiography appears not to have
been done in most instances. Usually the
embolus occupied from 50% to almost
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100% of the lumen of the pulmonary
artery. Most patients had bilateral
emboli. There was no important differ
ence in the size of clot between the two
groups. Concomitant venous interruption
procedures (i.e., inferior vena caval pli
cation or ligation) were carried out much
more frequently in patients who had
cardiopulmonary bypass. There were 379
long-term survivors.

who had cardiopulmonary bypass. The some form of venous interruption to pre
accuracy of diagnosis was also greater. As vent recurrence (Table II). This is the cur
a result, fewer patients with myocardial rently accepted practice.
infarction rather than pulmonary embo
Since the unfavourable initial results of
lism underwent the procedure. When pul the Trendelenburg procedure,58 the mor
monary embolectomy is performed with tality of pulmonary embolectomy has
this erroneous diagnosis, the mortality is been markedly reduced, being reported
100%.“ Thus, pulmonary angiography retrospectively as low as 10%.28 A ran
or a conclusive lung scan are mandatory domized trial is not feasible1 due to the
before any surgical procedure is carried critical condition of patients who fail to
out.
respond to medical treatment and the
Discussion
Reports of pulmonary hemorrhagic small number of cases in each centre.
This collective review shows that pul
Most patients with large pulmonary infarction following revascularization of
emboli who can tolerate a 50% occlusion ischemic lungs have been only anecdo monary embolectomy is a feasible proce
of their pulmonary artery will survive tal,52,53 but this complication should be dure and is associated with an accepta
with aggressive medical therapy.49 kept in mind after pulmonary embolec ble survival rate. Operative mortality will
continue to be high due to the precarious
Nevertheless, some continue to deteri tomy is performed.
Other reports, not included in this condition of the patient, but operation
orate rapidly in spite of optimal
anticoagulation and respiratory and review, have shown that pulmonary may be the only chance for survival.
The ideal candidate for pulmonary
inotropic support. If within 1 hour of embolectomy performed in a hyperbaric
initiating therapy the blood pressure chamber with inflow occlusion and embolectomy is the patient with a diag
remains below 90 mm Hg, the urinary unilateral pulmonary embolectomy are nosis of pulmonary embolism proven
output is less than 20 mL and the arterial also successful.54,55 This could be an within 1 hour of the event who fails to
oxygen tension is below 60 mm Hg,50 alternative in centres where cardiopulmo respond to other modes of treatment, “ a
nary bypass is not available.
difficult group to define and a challenge
alternative treatment should be sought.
Prophylactic removal of a pulmonary to clinical judgement” .59 Based on the
Such patients represent 2% to 6% of all
those suffering pulmonary embolism.51 embolus has been advocated to prevent data presented here, pulmonary embolec
Therefore, between 1000 and 3000 pulmonary insufficiency or to provide tomy should be offered to such patients.
patients a year should be considered for cardiopulmonary reserve should a second A coordinated approach between differ
pulmonary embolectomy. With the cur embolism occur2 or to prevent later ent specialities and awareness by the sur
rent operative survival rate, between 500 onset of pulmonary hypertension.29 gical team are essential to improve sur
These eventualities, however, do not vival. Pulmonary embolectomy is feasible
and 1500 could be expected to survive.
Some authors1 have stated that if the occur.1 Provided the pulmonary embo in the absence of cardiopulmonary bypass
patient survives long enough to reach the lism does not recur, the clinical course of facilities and gives acceptable results
operating room, pulmonary embolectomy most patients is one of gradual resolution (Table I). Pulmonary embolism still
would have been unnecessary. This may of the embolus with reestablishment of remains a widespread lethal disease. In
be true if the patient has been stabilized flow in the pulmonary arteries.56 This many cases it occurs in the absence of
and is operated on after 24 hours but not has been shown in the experimental associated terminal illness.
for the patient requiring operation due to animal and in humans.57 Thus, pulmo
Transvenous Pulmonary Embolectomy
continuing rapid deterioration.10 This nary embolectomy should not be per
formed
prophylactically.
In
a
small
group
Transvenous catheter embolectomy of
was the case in the series studied since all
pulmonary embolectomies performed of patients the embolus does not resolve the pulmonary artery was first described
and the condition becomes chronic. Satis by Greenfield and colleagues in 1971.60
under other conditions were excluded.
The present review shows better sur factory results have been obtained with The catheter is inserted through the
vival for patients operated upon with embolectomy in these circumstances.56
femoral or jugular vein by venotomy and
Most surgeons operating on patients
guided under fluoroscopy into the pulmo
cardiopulmonary bypass. These are obvi
nary artery. The embolus is then removed
ously the most recent series and thus bet with cardiopulmonary bypass elected
ter techniques and better medical support
may have been a factor. On the other
hand, femorofemoral cannulation under
Table 1—Pulmonary Embolectomy Without Cardiopulmonary Bypass
local anesthesia before sternotomy made
No. of
Pulmonary
Venous
Survivors,
it possible for some patients to undergo
Published reports
patients
angiography*
interruption
no. (%)
the procedure who otherwise might not
Series8"16
109
6
10
52
(47.7)
have survived long enough to be operated
Case reports17' 21
5
1
3
4
upon.
Totals
114
7
13
5 6 (4 9 .1 )
Cardiac arrest occurs on induction of
*No
available
information
in
most
series.
anesthesia as a result of peripheral
vasodilatation in the presence of a fixed
cardiac output; it is usually fatal.29
Femorofemoral bypass under local
anesthesia before induction helps to over
Tabje II—Pulmonary Embolectomy With Cardiopulmonary Bypass
come this problem because it relieves the
No. of
Pulmonary
CPB before
Venous
Survivors,
strain on the right side of the heart, oxy
Published reports
patients
angiography
operation
interruption
no. (%)
genates the blood, maintains the circula
Series2'111619'22- 37
526
165
134
219
312 (59.3)
tion and allows the flow to increase to
Case reports38"48
11
5
6
8
11
compensate for the vasodilatation.
Totals
537
170
140
227
323 (60.1)
Although preoperative pulmonary an
giography was not reported in all cases,
CPB = cardiopulmonary bypass.
it was reported much more often in those
112
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by means of a suction cup. Several
retrievals may be necessary if the embo
lus fragments. To date, Greenfield’s
group have reported 25 patients with a
56% overall survival.61
This method cannot be applied when
closed chest massage is required or if
cardiac output cannot be restored,
because it precludes the use of
fluoroscopy. Thus, patients who undergo
this procedure are selected and obviously
in better condition than those who
undergo pulmonary embolectomy either
with closed chest massage or than those
needing partial cardiopulmonary bypass
before embolectomy. On this basis, sur
vival rates with these two techniques can
not be compared. At present, the trans
venous technique is not available in most
hospitals; nevertheless, Greenfield’s
results are encouraging even if the num
ber of patients so treated is small. In
hospitals where cardiopulmonary bypass
facilities exist and the equipment and
expertise for transvenous catheter
embolectomy are available, both tech
niques could be combined in the future,
particularly in those patients who require
partial cardiopulmonary bypass before
embolectomy due to severe cardiogenic
shock, but for whom cardiac massage is
not necessary. Further trials and a larger
number of patients are needed before
conclusions can be drawn.
Streptokinase Thrombolysis

Better results have been reported
recently with direct infusion of strep
tokinase into the pulmonary artery.62
Thirty patients with major pulmonary
emboli were studied; 26 (87%) survived.
Only 5 (17%) patients were in shock
before the procedure. This technique, like
transvenous pulmonary embolectomy,
cannot be applied when circulatory
assistance is required (i.e., closed chest
massage, cardiopulmonary bypass) and
therefore shares its limitations and indi
cations.
Pulmonary embolectomy should be a
continuation of treatment for patients
with pulmonary embolism who fail to
respond to medical therapy. It is a com
bined, well-coordinated medical-surgical
effort that ultimately will determine
patient survival.
I thank Mrs. Jean Bone and Miss Patti Snarr
for their secretarial assistance in the prepara
tion of this manuscript.
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Ovarian Cancer
The behaviour of epithelial cancer of the
ovary differs from that of other epithelial
tumours that the general surgeon nor
mally contends with for the following
reasons: first, it often responds well to
incomplete surgery as it is frequently
sensitive to chemotherapy and, second,
its method of spread is unique. Proper
treatment of this lesion must take these
characteristics into account. Immediate
therapy is excision of the tumour mass
and its principal metastases. This nor
mally includes removing the uterus and
its adnexae plus the omentum. Only
when the remaining tumour masses are
small will postoperative chemotherapy be
effective. Moreover, the chemotherapy
can only be given rationally if the extent
of dissemination of the disease is care
fully defined. The spread of this malig
nant tumour is most often by way of
free-floating cells in the peritoneal cavity.
The tumour cells subsequently deposit in
"watersheds" throughout the peritoneal
cavity and accumulate on the undersur
face of the diaphragm and in the omen
tum. Staging, which describes this
process and its variations, is therefore of
great importance and is described in this
paper in detail.
L'evolution du cancer epithelial de
I'ovaire differe de cede des autres
tumeurs epitheliales pour les raisons suivantes: premierement, il repond souvent
bien a une chirurgie incomplete car cette
tumeur est frequemment sensible a la
chimiotherapie; et deuxiemement, son
mode de dissemination est unique. Le
traitement approprie de cette tumeur doit
tenir compte de ces caracteristiques. Le
traitement immediat consiste a exciser la
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masse tumorale et ses principales metas
tases. Ceci comprend habituellement I'ablation de I'uterus et de ses annexes
ainsi que de I'epiploon. La chimiotherapie
postoperatoire n'est efficace que quand
la masse tumorale residuelle est petite.
Qui plus est, la chimiotherapie ne peut
etre administree correctement que si
I'etendue de dissemination de la maladie
est connue. Cette tumeur se propage le
plus souvent par voie de cellules flottant
dans la cavite peritoneale. Ces cellules
se deposent par la suite dans des
"points morts" de la cavite peritoneale
et s'accumulent sous la surface du
diaphragme et de I'epiploon. Le diagnos
tic du stade de la maladie qui prend en
consideration ce processus et ses varia
tions, est done de premiere importance.
On le decrit en detail dans cet article.

All general surgeons who operate on
women must be concerned with the treat
ment of cancer of the ovary, for these
patients are often first seen and treated
by them. The therapy that gynecologic
oncologists recommend is comprehensi
ble only when the unique behaviour of
epithelial cancer of the ovary is under
stood. Based on this understanding, the
presentation of the patient, the staging of
the disease and the surgical therapy fol
low logically. Although all three aspects
will be dealt with in this article, I shall
emphasize the staging procedure, for
several important reasons. First, if stag
ing is not done well, there is danger that
the subsequent treatment may be inap
propriate. Second, it is this aspect of the
initial operation that is most often sub
ject to valid criticism. The ovary is the site
of many unusual tumours, but I shall dis
cuss only epithelial tumours. They form
the majority of all ovarian neoplasms and
are therefore those most frequently
encountered by the surgeon. This class of
ovarian tumour is also highly malignant.
Pathogenesis
Cancer of the ovary afflicts middle-

aged, middle-class women. Those who
have had no rest from “ incessant ovula
tion” are at particular risk. Both preg
nancy and the use of oral contraceptives
prevent ovulation. For this reason some
measure of protection from cancer of the
ovary is gained by pregnancy or the use
of oral contraceptives.
The course of the disease is straightfor
ward. The abnormal cells initially leave
the confines of the ovary by invading the
ovarian capsule. As the capsule is dis
rupted, tumour cells are disseminated
freely into the peritoneal cavity. The
direction of the flow is towards the
diaphragm, due to the suction-like action
of the diaphragm and the rolling motion
of the intestines. Movement along this
path is directed by the peritoneal attach
ments of the ascending and descending
colon and the mesenteries of the small
bowel and transverse colon. Because of
these anatomical barriers, pooling of the
tumour-laden fluid occurs. This stagna
tion (with subsequent tumour deposit)
most commonly occurs in the cul de sac,
in the right lower and left upper quad
rants.
The flow is limited by the right
diaphragm. Here the fluid is engulfed by
the lymphatic network that lines the sur
face of the diaphragm. These lymphatics
also traverse the diaphragm and reach its
pleural surface. They then enter the
retrosternal nodes and finally drain into
the thoracic duct.
The lymphatics on the surface of the
diaphragm soon become blocked with
tumour cells. This obstruction upsets the
drainage pattern of the peritoneal cavity
and results in ascites.1 Lymphatic drain
age is now directed to the omentum. As
a result, the omentum becomes loaded
with tumour cells. The drainage of the
peritoneal cavity is thus further ob
structed and ascites accentuated. There is
another reason for fluid accumulation:
the uninvolved surface of the peritoneum,
as a result of the presence of tumour,
produces fluid at an excessive rate.
Next, the tumour is most likely to
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invade the intestine and its mesentery.
The result is both partial and complete
bowel obstruction. In the former, the
slow passage of the intestinal contents
through the intestine is called ‘carcinoma
tous ileus” . If death follows, in 50% of
the cases the disease will be found to be
limited to the abdomen.
Although intraperitoneal spread is the
most important, there are other means of
dissemination. It has been recognized
recently that lymphatic spread may occur
early in the course of the disease. In 15%
of patients with stage I disease, the
lymphatics draining the ovaries are in
volved.2,3 The lymph vessels draining
the ovary are located retroperitoneally
and accompany the ovarian vessels to the
lower pole of the kidney where they turn
inwards to the aortic lymph nodes located
anterior and lateral to the aorta and the
inferior vena cava. The secondary lym
phatic drainage of the ovary is to the
interiliac nodes.
The stage, although the most important
factor, is not the sole element in determin
ing prognosis. Prognosis also depends on
the histologic grade of the tumour and on
the presence or absence of ascites.4
However, both factors are closely linked
to the stage. Low-stage tumours are
generally of low-grade malignancy.
Ascites is prim arily dependent on
diaphragmatic metastases. A most impor
tant prognostic factor is the disease
remaining after surgical therapy. It
should be noted that the cell type of
epithelial tumours is in itself unimportant
compared with the grade of anaplasia. In
the future, staging will certainly include
the factors of histologic grade, ascites and
residual disease, which will permit a fur
ther refinement of treatment.

Presentation
It is now generally agreed, contrary to
what was earlier believed, that cancer of
the ovary in the early stages is not always
asymptomatic. These patients commonly
have complaints of a mild and nonspecific
digestive upset. Even later, when the dis
ease is widespread, the symptoms do not
necessarily suggest an ovarian origin.
Nausea, loss of appetite and abdominal
distension are often present at this stage
and are more suggestive of a gastrointes
tinal disturbance than a gynecologic one.
The only physical finding of note is a
pelvic mass. This is most often discovered
by chance. There is considerable doubt
that routine physical examination will
result in increased frequency of early
diagnosis of this ovarian cancer.5 The
best hope for early detection would be a
laboratory test to detect the localized and
unpalpable tumour. One of the most
promising of such tests depends on the
purification of ovarian tumour antigen,
which is not yet possible. None the less,
there is reason to be optimistic that such
tests will be available shortly.6
The presence or absence of ovulation
is particularly helpful in differentiating
between benign and malignant ovarian
tumours. Special attention should be paid
to a woman who is not ovulating and who
presents with a pelvic mass. Post
menopausal women, those who are using
oral contraceptives and lactating mothers
with demonstrable ovarian tumours are
at special risk. In such cases, the work
ing diagnoses should include ovarian
cancer until proven otherwise. On the
other hand, if the patient is ovulating and
has an ovarian mass measuring less than
8 cm, the possibility that it is a physio

Table I—Stages of Primary Carcinoma of the Ovary,
International Federation of Gynecology and Obstetrics,
1971 Classification
Stage

Description

I
IA

Growth limited to the ovaries
Growth limited to one ovary; no ascites
1. No tumour on the external surface; capsule intact
2. Tumour present on the external surface or capsule ruptured, or both
Growth limited to both ovaries; no ascites
1. No tumour on the external surface; capsule intact
2. Tumour present on the external surface or capsule(s) ruptured, or both
Tumour either stage IA or IB, but with ascites or positive peritoneal washings
Growth involving one or both ovaries with pelvic extension
Extension or metastases, or both, to the uterus or tubes, or both
Extension to other pelvic tissues
Tumour either stage IIA or IIB, with ascites present or positiveperitoneal washings
Growth involving one or both ovaries with intraperitoneal metastasesoutside the pelvis or
positive retroperitoneal nodes, or both
Tumour limited to the true pelvis with histologically proven malignant extension to small
bowel or omentum
Growth involving one or both ovaries with distant metastases; if pleural effusion is pre
sent, cytologic finding must be positive to allot a case to stage IV
Parenchymal liver metastases equal stage IV
Unexplored cases thought to be ovarian carcinoma

IB

IC
II
IIA
IIB
IIC
III

IV

Special
category

logic cyst or a benign neoplasm is much
more likely; oral contraceptives should be
given to this patient, and she should be
re-examined after 6 weeks. In most cases,
the mass will resolve completely. Fine
judgement is required to avoid either
overly aggressive excision of all ovarian
masses or undue delay in the treatment
of an early ovarian cancer.
Staging
Rational treatment of ovarian cancer
depends on accurate staging (Table I).7
There can be no intelligent planning of
therapy without a detailed knowledge of
the presence or absence of metastases.
The evolution of our present therapy has
depended on our ability to compare
results o f different modes of treatment
from different institutions for given stages
of the disease. The literature on the treat
ment o f ovarian cancer is complicated by
the frequent lack of careful staging. As
an example, removal of the omentum has
been a m ajor part of treatment, giving
seemingly worthwhile results. In fact, the
excision and subsequent histologic exami
nation o f the specimen only serve to
transfer cases from stage I to stage III.
The presence or absence of omental me
tastases therefore is more important to
prognosis than the excision. Prognosis
cannot be determined accurately without
meticulous staging. A final justification
for precise staging is to allow conserva
tive therapy in certain cases. Admittedly,
these are unusual cases, but it is only
when we can be certain that the disease
is limited to one ovary that the con
tralateral ovary and uterus may be con
served. Staging must be carried out
accurately and completely, for if it is not,
a second laparotomy may be undertaken
to the surgeon’s embarrassment and the
patient’s anxiety and displeasure.
All proper staging begins with an ade
quate abdominal incision. It is important
that in a large series of patients with
cancer of the ovary referred to a tertiary
hospital, only 17% had had an adequate
incision.8 It is impossible to persuade the
oncologist that staging was complete if
the incision is other than vertical and does
not extend above the umbilicus. This
entire process is impossible through a
Pfannenstiel incision; its use in these cir
cumstances and many others is to be
deplored. The incision should be made
from 4 cm above to 10 cm below the
umbilicus.
If ascitic fluid is present, it is immedi
ately collected (before being contami
nated with blood) and sent for cytologic
examination. The presence of malignant
cells in the peritoneal cavity is the first evi
dence of dissemination of the tumour. In
the absence of ascites, 36% of one group
had positive cytologic findings.9 There
fore, fluid should be collected for cyto-
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logic examination from four areas of the
peritoneal cavity. A lavage of 50 mL of
normal saline is done at each site. The
first specimen is collected from the area
beneath the right diaphragm. After instil
lation, the saline is aspirated and sent for
cell-block analysis. This procedure is
repeated in right and left peritoneal gut
ters and finally in the pelvis itself.
The abdomen is then explored. At first,
the nature of the pelvic mass is deter
mined. There are sharp limitations to the
diagnosis of ovarian cancer from the
gross specimen. The surface of the ovar
ian tum our may not reflect its contents.
There is an understandable fear of ovar
ian biopsy because of the possible spillage
of malignant contents into the peritoneal
cavity. In doubtful circumstances, the
ovary should be removed intact. It is then
opened in the operating room so that its
contents may be inspected. Frozen section
is carried out. These examinations are
best done by the pathologist.
After the character of the mass is
defined, all peritoneal surfaces are care
fully inspected. If rough areas or adhe
sions are discovered, they are excised and
sent for histologic analysis with careful
notation of the site from which they were
obtained. Such areas are often found to
contain microscopic tumour deposits.
Specimens should also be taken of the pel
vic peritoneum and the peritoneum in
both gutters, even though they may
appear normal. Both liver surfaces are
then palpated, as are the stomach and
pancreas. The large and small intestines
and their mesenteries are inspected. The
lower surface of the right hemidiaphragm
and the omentum merit special care. The
undersurface of the diaphragm is involved
in 15% of apparent stage I and 23% of
apparent stage II disease.2 In order to
explore this surface properly, it is neces
sary to extend the incision. The surface
of the diaphragm is first palpated and
then inspected. The inspection may be
done with a laparoscope, a sigmoidoscope
or a cold-light source. It is unusual to find
an adequate description of the find
ings.2,1°'12 Any suspect nodule is biopsied
with a Kevorkian biopsy forceps or
curette. Even if the diaphragm appears
normal, a small specimen is taken.
Each surface of the omentum is care
fully examined. Even if it is grossly nor
mal, its removal from the transverse colon
is recommended. Although the value of
this excision has not been proven, in addi
tion to providing adequate biopsy mate
rial, it may improve the prognosis.
The retroperitoneal area is next in
spected. In all patients but those with
obvious stage III or IV disease, a biopsy
of any palpated or suspicious node should
be taken. In all other cases, there is much
merit in taking biopsy specimens of the
periaortic nodes at the level of the renal
116

blood vessels. The retroperitoneal space
in normal circumstances is easy to work
in. In order to obtain biopsy material, the
peritoneum is widely opened and fatty tis
sue and nodes from the front and sides
of the inferior vena cava and aorta below
the insertion of the renal blood vessels are
removed. Any suspicious pelvic nodes are
also excised. Finally, if the opposite ovary
is to be spared, a generous biopsy speci
men must be taken from it.
Treatment

The basis of treatment is the removal
of the gross mass of the ovarian tumour
and its principal metastases. This excision
does not have to be complete in order to
be successful. Because of the unique pat
tern of the dissemination of the disease,
it is possible to achieve the surgical ob
jectives by abdominal hysterectomy, bila
teral salpingo-oophorectomy and omentectomy.
There are two benefits of this excision.
The first is immediate, the other long
term. The immediate benefit is the relief
of gastrointestinal symptoms and the dis
appearance of ascites. The long-term
benefit depends on the cancer’s sensitiv
ity to appropriate chemotherapy. The
response to therapy is best, however, if
the residual tumour masses are small.13
The reason for this relation between size
and sensitivity is thought to be connected
both to the patient’s immune status and
to tumour kinetics. The immunologic
resistance the body offers the tumour
appears to be overwhelmed when the
tumour mass is large. This resistance can
be restored with excision of the mass.
Neoplastic growths are resistant to
chemotherapy when in a resting cycle. It
has been shown14 that in the case of
large tumour masses many of the cells are
in the resting phase. Excision appears to
force the remaining tumour into the
proliferative stage, when it becomes sus
ceptible to chemotherapy. All data sup
port the value of this excision. Thus, the
2-year survival of stage III patients may
be increased from 15% to 70% if no gross
tumour remains after the initial surgical
intervention. It is therefore important to
be aggressively optimistic when presented
with patients who have cancer of the
ovary. There are good reasons for this
optimism. In most cases it is possible,
with diligent, time-consuming dissection,
to excise the tumour mass. The tumour
is rarely inoperable. It is inoperable only
when it has covered both peritoneal sur
faces and has left no individual tumour
masses that permit excision.
If the involvement is extensive, the hys
terectomy may be subtotal. The oopho
rectomies are safely accomplished when
the retroperitoneal spaces are opened.
The ureters may then be displayed and the
ovarian vessels safely ligated so that
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preparations containing epinephrine are employed in patients during or
immediately following the administration of chloroform, halothane,
cyclopropane, trichloroethylene or other related agents. In deciding
whether to use these products concurrently in the same patient,
the combined action of both agents upon the myocardium, the concen
tration and volume of vasoconstrictor used, and the time since injec
tion, when applicable, should be taken into account.
The decision to use a local anesthetic containing a vasoconstrictor in
areas with a limited blood supply or in patients with peripheral vascular
disease, will depend on the physician’s appraisal of the relative advan
tages and risks.
Local anesthetics which contain preservatives, i.e. those supplied in mul
tiple dose vials, should not be used for caudal or epidural anesthesia.
Epidural Use: It is advised that a test dose, generally 2-3 mL of 0.5%
bupivacaine (or other amide anesthetic) containing 1:200,000 epine
phrine (10-15 micrograms) be administered to check that the spinal
canal or a blood vessel has not been entered while locating the epidural
needle or catheter.
In the event of spinal injection clinical signs of spinal block would
become evident in a few minutes.
In the event of intravascular injection a transient increase in pulse rate
and possibly momentary increase in systolic blood pressure are
usually detectable with a monitor. The other symptoms and signs of
"epinephrine response" are less dependable. The effects of other medi
cation the patient has received may modify this response.
When reinforcing doses are required the test dose should be used
again to check the catheter location.
Use in Ophthalmic Surgery: When Marcaine 0.75% is used for retrobul
bar block, complete corneal anesthesia usually precedes onset of clini
cally acceptable external ocular muscle akinesia. Therefore, presence
of akinesia rather than anesthesia alone should determine readiness of
the patient for surgery.
Adverse Reactions:
Reactions to bupivacaine are characteristic of those associated with
amide-type local anesthetics. A major cause of adverse reactions to
this group of drugs is excessive plasma levels, which may be due to
over-dosage, inadvertent intravascular injection, or slow metabolic
degradation. Other causes of reactions to these local anesthetics may
be hypersensitivity, idiosyncrasy, or diminished tolerance.
Excessive plasma levels cause systemic reactions involving the central
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nervous system and the cardiovascular system. The central nervous
system effects are characterized by excitation or depression. The first
manifestation may be nervousness, dizziness, blurred vision, or tre
mors, followed by drowsiness, convulsions, unconsciousness, and pos
sibly respiratory arrest. Since excitement may be transient or absent,
the first manifestation may be drowsiness, sometimes merging into
unconsciousness and respiratory arrest.
Other central nervous system effects may be nausea, vomiting, chills,
constriction of the pupils, or tinnitus. The cardiovascular manifesta
tions of excessive plasma levels may include depression of the myocar
dium, blood pressure changes (usually hypotension), and cardiac
arrest. Recent clinical reports and animal studies suggest this may be
more likely to occur with the long acting amide local anesthetics such
as bupivacaine.
Allergic reactions are characterized by cutaneous lesions (e.g. urticaria,
edema) and other manifestations of allergy.
Reactions following epidural or caudal anesthesia may include: high or
total spinal block, urinary retention; fecal incontinence, loss of perineal
sensation and sexual function; persistent analgesia, paresthesia, and
paralysis of the lower extremities; headache and backache; and slow
ing of labor and increased incidence of forceps delivery.
It should be noted that reactions due to systemic absorption may be
slow or rapid in onset. Those of rapid onset include respiratory depres
sion, cardiovascular collapse and cardiac arrest. This type of reaction
necessitates a high degree of preparedness since it can occur with little
warning.
In co-ordinated studies of 3200 procedures carried out by 15 investiga
tors. there were 2 severe systemic reactions. Both patients experienced
convulsions as a result of inadvertent vascular injection.
Fetal bradycardia has been observed with the use of bupivacaine. Most
cases, including a few fatalities, occurred when the paracervical route
was used (see "Warnings").
In some subjects bupivacaine may produce marked peripheral vaso
constriction in unanesthetized areas which may last for several hours.
Treatment of Overdose and Severe Reactions:
Toxic effects of local anesthetics require symptomatic treatment; there
is no specific cure. The physician should be prepared to maintain an
airway and to support ventilation with oxygen and assisted or con
trolled respiration as required. Supportive treatment of the cardiovas
cular system includes intravenous fluids and, when appropriate, vaso
pressors (preferably those that stimulate the myocardium).
Convulsions may be controlled with oxygen and intravenous adminis
tration, in small increments, of a barbiturate or muscle relaxant, as
follows: preferably, an ultra short-acting barbiturate such as thiopental
or thiamylal; if this is not available, a short-acting barbiturate (e.g. seco
barbital or pentobarbital) or a short-acting muscle relaxant (succinylcholine). Intravenous muscle relaxants and barbiturates should only be
administered by those familiar with their use.
Dosage and Administration:
The duration of anesthesia with bupivacaine is such that, for most pro
cedures, a single dose is sufficient. Maximum dosage limit must be indi
vidualized in each case after evaluating the size and physical status of
the patient, as well as the usual rate of systemic absorption from a par
ticular injection site. Most experience to date is with single doses of
bupivacaine up to 225 mg with epinephrine 1:200,000, and 175 mg
without epinephrine; more or less drug may be used depending on indi
vidualization of each case.
At present there is insufficient clinical evidence with multiple dosage or
intermittent dose techniques to permit precise recommendations for
such procedures to be given. However, limited clinical experience in this
area of use indicates that bupivacaine may be repeated in 3 to 6 hours
up to a maximum dose of 400 mg in 24 hours. In most cases the dura
tion of anesthetic effect is prolonged by the addition of epinephrine.
The following doses have generally proved satisfactory for the average
adult. They may require adjustment in relation to age and the physical
condition of the patient.
Local infiltration: up to a maximum dosage of 0.25% solution.
Peripheral nerve block: 5 to 30 mL of 0.50% or 5 to 60 mL of 0.25%
solution.
Sympathetic: 20 to 50 mL of a 0.25% solution.
Epidural: 10 to 20 mL of a 0.25%, 0.50%, or 0.75%t solution.
caudal: 15 to 30 mL of a 0.25% or 0.50% solution.
t0.75% not recommended for obstetric use.
Supplied:
Each 20 mL single dose vial contains: bupivacaine 0.25%, 0.50% or
0. 7 5 . with or without epinephrine 1:200,000. Boxes of 5 vials.
Each 50 mL multiple dose vial contains: bupivacaine 0.25% or 0.50%.
Boxes of 1 vial.
Note: Bupivacaine solutions without epinephrine may be autoclaved.
Product Monograph available on request.
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any ovarian mass can then be removed
easily and safely. When the tumour
involvement o f the omentum is limited,
its removal from the transverse colon is
all that is needed. If, however, the tumour
extends further, the lesser sac should be
opened and the omentum removed from
the greater curvature of the stomach.
Radical and aggressive surgery should not
extend to the excision o f metastatic
lesions on the intestines. No data suggest
that survival is improved when segments
o f the intestine are removed. Since
obstruction is rarely isolated and intesti
nal malfunction is an added complicat
ing factor, the least possible intestinal sur
gery should be done.
Summary
Epithelial cancer o f the ovary often
masquerades as a bowel disturbance. The
first surgeon, often operating in the most
adverse circumstances, has tjie best
chance to effect a cure and ensure proper
postoperative care. To achieve these pur
poses, the natural course o f the disease
must be taken into account. Once this
course is understood, staging is likely to
be complete and special efforts will be
made to ensure that excision is adequate.
With postoperative chemotherapy these
patients can then look to the future with
optimism.
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Mitral Valve Replacement With Hancock Porcine
Bioprostheses: Up to 7-Year Follow-up
From February 1976 to May 1981 at the
University of Ottawa Heart Institute, 137
mitral valves were replaced with the
Hancock porcine bioprosthesis. This
study concerns 111 patients (55 men,
56 women) who had single-valve
replacement. The average age of the
patients was 53.0 years. The
predominant lesion in the 102 patients
who were receiving their first substitute
valve was stenosis in 4 6 % and regurgi
tation in 4 2 % . Preoperatively, 8 2 % were
New York Heart Association (N YHA)
class III or IV. Additional procedures
were performed in 44 patients (3 9 .6 % ).
The 26 patients who had multiple valves
replaced were considered only for dura
bility studies.
Hospital mortality was 8 .9 % for iso
lated replacement and 2 2 % for replace
ment associated with aortocoronary
bypass grafting. At the time of dis
charge, 5 0 % of patients were in atrial
fibrillation, 14% were taking warfarin
and 8 2 % antiplatelet agents. Follow-up
was available for a total of 374 patientyears (average of 5.4 years per patient).
The mean symptomatic improvement
was 1.6 NYHA classes per patient. Actu
arial analysis indicated a survival rate of
7 0 % at 8 years. Of the 18 late deaths,
4 (2 2 % ) were valve-related. The rates of
endocarditis and thromboembolism were
1 .1 % and 5 .8 % patient-year respec
tively. In the 137 prostheses at risk,
intrinsic failure occurred at the rate of
4 .7 % patient-year for a cumulative rate
of 3 5 % at 8 years.
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The authors conclude that the Han
cock porcine bioprosthesis provides good
relief of symptoms in the mitral position
with an acceptable rate of thromboem
bolism even without anticoagulation.
Unfortunately, in this position the
prosthesis has a high late failure rate and
is therefore not recommended.

A I'institut de cardiologie de I'Universite
d'Ottawa, de fevrier 1976 a mai 1981,
137 valvules mitrales ont ete remplacees
par des protheses de Hancock d'origine
porcine. Cette etude porte sur 111
patients (55 hommes, 56 femmes; age
moyen: 53.0 ans) qui ont subi un remplacement monovalvulaire. Chez 102
malades qui en etaient a leur premier
remplacement, les principales lesions
etaient la stenose (4 6 % ) et la regurgita
tion (4 2 % ). En preoperatoire, 8 2 % etaient
dans les classes III et IV de la New York
Heart Association (N YHA). Des interven
tions additionnelles ont du etre pratiquees chez 44 patients (3 9 .6 % ). Vingtsix malades chez qui on remplaca plus
d'une valvule n'ont ete consideres que
pour les etudes de durability.
La mortality hospitaliere fut de 8 .9 %
pour les remplacements isoles et de 2 2 %
pour les remplacements associes a des
pontages aorto-coronariens. Au moment
de recevoir leur conge, 5 0 % des patients
faisaient de la fibrillation auriculaire,
1 4 % prenaient de la warfarine et 8 2 %
des anti-agregants plaquettaires. Des
examens de controle existent pour un
total de 374 patients-annees (soit une
moyenne de 5.4 annees par patient).
L'amelioration symptomatique moyenne
fut de 1.6 classes NYHA par patient.
L'analyse actuarieile indique une survie de
7 0 % a 8 ans. Des 18 deeds tardifs, 4
(2 2 % ) etaient relies d un probleme valvulaire. Les taux d'endocardite et de
thrombo-embolie par patient-annee ont
yte, respectivement, de 1 .1 % et 5 .8 % .
Des 137 protheses a risque, une defaillance intrinseque est survenue au rythme

de 4 .7 % patients-annees pour un taux
cumulatif de 3 5 % apres 8 ans.
Les auteurs concluent que dans le rem
placement de la valvule mitrale la prothese porcine de Hancock offre un bon
soulagement des symptomes avec un
taux acceptable de thrombo-embolie
meme sans anticoagulation. Malheureusement, dans cette indication elle a aussi
un haut taux de defaillance et ne peut
dont etre recommandee.

The Hancock porcine bioprosthesis has
been the most widely used o f all tissue
valves. In the last few years there has been
a growing concern in the surgical field
regarding its long-term behaviour.1'6
Therefore, we reviewed our results with
this valvular substitute, which we have
used only in the mitral position.

Patients and Methods
Patients
From February 1976 to May 1981 at the
University o f Ottawa Heart Institute, 137
glutaraldehyde-stabilized Hancock por
cine heterografts were implanted in the
mitral position. There were 111 single
valve replacements, 21 double-valve
replacements (20 mitral-aortic) and 5
triple-valve replacements. All double- and
triple-valve replacements included the use
of other types o f substitutes. These
patients were not considered, except for
durability studies.
Of the 111 patients who had a single
mitral valve replaced, 55 were men
(mean age 53.6 years) and 56 women
(mean age 52.4 years). Only two men and
two women were younger than 30 years.
Twenty-nine (26%) had undergone a
previous commissurotomy. Nine under
went reoperation for dysfunction o f a
previous prosthesis. O f the 102 patients
receiving their first substitute, 47 (46%)
had predominant stenosis and 43 (42%)
predominant regurgitation; there was no
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definable predominance in 12 (11.8%).
Table I shows the symptom status
preoperatively in 108 of the patients.
Eighty-nine of these (82.4%) were NYHA
class III or IV. There were 44 combined
operative procedures (39.6%), most often
coronary artery bypass grafting (27/111
patients, 24.3%).
Follow-up (Table II)
All surviving patients were registered
with the Valvular Surgery Follow-up
Clinic. They were examined at yearly
intervals, if they were living in our geo
graphic area. They were specifically ques
tioned about complications related to the
prosthesis. Telephone interviews with the
patients and their physicians were con
ducted if the patient lived too far from
Ottawa for a personal visit. Two patients
were lost to follow-up. The other sur
vivors were followed up for from 32 to
92 months (374 patient-years, an average
of 5.4 years per patient). Including
double- and triple-valve replacements,
113 valves have been at risk, 63 for more
than 5 years.
Calculations
Survival and event-free actuarial prob
ability curves were constructed using the
method of Cutler and Ederer as presented
by Grunkemeier and Starr.7 Linearized
rates of complications were calculated as
R = E /T , where R is the rate in percent
patient-year, E is the total number of
events occurring in each group and T is
the total follow-up time accounted for by
all the members of the group as of the
study date, whether or not they had the
event.8

Results

salicylic acid (150 mg and 975 mg daily)
after a 5- to 7-day course of mini
heparinization. Warfarin anticoagulation
has been reserved for high-risk patients
(i.e., those with clots in the left atrium at
surgery or a combination of atrial fibril
lation and giant left atrium). At dis
charge, 14.3% of patients (14/98) were
taking warfarin, and 82.6% (81/98)
dipyridamole and acetylsalicylic acid. Of
the 96 patients with documented predis
charge electrocardiograms, 48 were in
atrial fibrillation. Of these, only seven
(14.6%) were taking anticoagulants.
All episodes of neurologic symptoms,
transient or permanent, focal or not well
defined, and all episodes of acute vascu
lar insufficiency, were considered to be
secondary to thromboembolism. Twentytwo episodes occurred in 18 patients.
There were seven transient ischemic
attacks, nine frank cerebrovascular acci
dents (one fatal) and six peripheral
embolic episodes (one fatal). Twelve of
these 18 patients were in atrial fibrillation
at the time of discharge, 5 in normal sinus
rhythm, and for 1 the type of rhythm was
unknown. At the time of the thromboem
bolic event, 11 patients had been in atrial
fibrillation since surgery, 3 were in nor
mal sinus rhythm, for 6 the rhythm was
unknown, 1 patient had a pacemaker and
one thromboembolic episode was secon
dary to bacterial endocarditis. At the time
of the episode, 11 patients were on
dipyridamole and acetylsalicylic acid, 3
on warfarin with or without dipyrida
mole, 1 on heparin, 5 on no specific ther
apy and for 2 the anticoagulation status
was unknown.
The episodes occurred from 5 days to
64 months after valve replacement
without any significant time predom
inance after the first year. The linearized
incidence was 5.8% patient-year, with an

actuarial probability of being free of
thromboembolism of 73.4 ± 5.1% at 6
years (Fig. 2). There were also four epi
sodes of bleeding for which the patients
required either hospitalization or trans
fusion.

Table 1-Preoperative Status, New York Heart
Association Classification (n = 108*1

FIG. 2—Actuarial probability of throm
boembolic complications, n = number of
patients entering each interval, events = num
ber of complications during same interval, bars
denote mean ± standard error of mean, dot
ted line = less than 25 patients completing
interval.

Endocarditis
There were five episodes of bacterial
endocarditis, one early at 2 months after
operation and four late, from 8 to 64
months. One patient was successfully

YEARS

FIG. 1—Actuarial probability of survival,
n = number of patients entering each inter
val, deaths = number of deaths during same
interval, bars denote mean ± standard error
of mean, dotted line = less than 25 patients
completing interval.

Mortality
The hospital mortality (death within 30
days of operation) was 11.7% (13/111)
overall, 8.9% for isolated mitral valve
replacement and 22.2% for mitral valve
replacement and coronary artery bypass
grafting. Two early deaths may have been
related to the prosthesis as they were
secondary to carotid artery embolism.
There were 18 late deaths, 11 (61%) from
cardiac causes, 2 (11 %) from non-cardiac
causes, 1 from an unknown cause and 4
(22%) related to the valve (2 from
endocarditis and 2 secondary to throm
boembolic complications). The linearized
death rate was 4.8% patient-year, with an
actuarial probability of survival of 69.8
± 4.6% at 6 years (Fig. 1).
Thromboembolic Complications
It has been our policy to place all
patients with porcine bioprostheses on a
combination of dipyridamole and acetyl120

No, of
NYHA class
patients
1
6
II
13
III
47
IV
42
’ Status not recorded for 3 patients.

%
5.5
12.0
43.5
38.9

Table II—Follow-up Details

Single mitral valve replacement
Discharged
Long-term deaths
Reoperation
Lost to follow up
Available for follow-up

No. of
patients
111
98
18
9
2
69

YEARS

FIG. 3—Actuarial probability of endocardi
tis. Format is similar to that in Fig. 2.
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treated medically, two underwent reoper
ation and survived and two died in septic
shock. The linearized rate of endocardi
tis was 1.3% patient-year, with an actu
arial probability of being free of
endocarditis of 92.2% ± 3.5% at 6 years
(Fig. 3).
Reoperation
Of the 113 patients with valves initially
at risk (including double- and triple-valve
replacements), 14 required reoperation at
a mean interval of 51 months. Two
patients had paravalvular leaks, two
endocarditis, eight intrinsic tissue failure
and two had hemodynamic compromise.
The linearized rate of reoperation was
3.3% patient-year, with a probability of
not requiring reoperation of 87% ±
4.4% at 6 years.
Valve Failure
All patients seen at follow-up were
assessed for signs of prosthetic failure.
Failure was defined as the appearance of
a new murmur, reoperation or death
secondary to a new hemodynamic lesion.
Ten patients had their valve removed for
intrinsic tissue failure. Four patients had
new diastolic murmurs and five new pansystolic murmurs. In one patient who died
of thromboembolic complications, the
valve was found to have thrombosed.
There were 20 instances of valve failure,
with 10 occurring after 5 years when the
rate of failure was 14.6% patient-year.

FIG. 4—Actuarial probability o f valve
failure. Format is similar to that in Fig. 2.

The actuarial probability of the valve
being free of failure was 65% ± 7.4%
at 7 years (Fig. 4).
Clinical Status
Table III shows the clinical status of the
69 patients with isolated mitral valve
replacement at the latest follow-up visit.
There was substantial functional improve
ment with an average gain of 1.61 NYHA
classes per patient. Preoperatively, 82%
of patients were in classes III and IV. At
the last follow-up, 96% were in classes I
and II. Only two patients considered
themselves worse than before they under
went valve replacement.
Discussion
The Hancock bioprosthesis, in use for
14 years, has been the most widely
implanted tissue valve. It was by far the
most popular bioprosthesis in the 1970s,
but several reports at the end of that
decade, concerning the increasing rate of
late failure, raised doubts in the minds of
surgeons.2-4,6,9
Our experience seems similar to that of
other centres. With respect to long-term
mortality, most deaths seem to be related
to the basic cardiac condition; only 4 of
the 18 deaths (22%) were related to val
vular complications. The overall late mor
tality of 4.8% patient-year is similar to
the rates reported by others (ranging from
5.5% to 6.9% ).3,10
We have not used anticoagulation rou
tinely and have thus had a low overall rate
of bleeding complications (1.0% patientyear). However, the rate of thromboem
bolic complications is relatively high at
5.8% patient-year for the whole group
with 12 of the 48 patients who were in
atrial fibrillation at the time of discharge
eventually suffering thromboembolism.
As shown by many authors,2,3,11 atrial
fibrillation seems to be an important fac
tor in the etiology of thromboembolism
with the Hancock porcine valve. This may
in part be related to the somewhat res
tricted flow pattern across the prosthesis,
leading to some degree of stagnation in
the immobile fibrillating atrium. In con
trast, in our experience with the Ionescu-

Table Ill-Current Clinical Status, NYHA Class
NYHA class
preoperatively
1
II
III
IV
Totals
No.
%

NYHA class postoperatively

Totals

1

II

III

IV

No.

%

5
4
17
14

1
3
15
7

0
0
2
0

0
0
0
1

6
7
34
22

9
10
49
32

40
58

26
38

2
3

1
1

69

Average gain: 1.61 NYHA classes per patient.
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Shiley valve, which is known for its bet
ter hemodynamic properties,12 none of
the patients with mitral valve replacement
who had thromboembolism were in atrial
fibrillation either at discharge or at the
time of th ro m b o em b o lism .13 The
reported incidences of thromboembolism
may be intrinsic to each type o f substi
tute, as suggested by Ionescu and col
leagues,14,15 and may not be really
prevented by anticoagulation. In our
experience, 3 of the 14 patients taking
warfarin at the time of discharge suffered
from thromboembolism, while only 11 of
the 81 patients on antiplatelet agents had
such a complication. Of course, in our
group warfarin was prescribed to patients
with a higher risk of thromboembolic
complications and was not given rou
tinely.
The major problem with the Hancock
bioprosthesis is the high rate of late
failure. This phenomenon is now well
described.2,3,5,6,9,16 It develops rapidly in
young patients or patients with altered
calcium m etabolism ,1,4,17-19 and some
theories on its etiology have been sug
gested.5,18,20,21 The quoted probability of
the valve being failure-free at 5 years
ranges from 58% to 98%, with linearized
rates of failure of 1.1 % to 7.1 % , this rate
tripling after 5 years.3-5,9,11 Recent
reports have shown a much higher failure
rate when the valve is used in the mitral
position compared with the aortic posi
tion.2,5,6,9 This would be related to a
higher mechanical stress from the left ven
tricular systolic pressure. The rate of
failure in our patients is comparable at
14.6% patient-year after 5 years with only
65% of the valves being failure-free at 7
years.
The Hancock bioprosthesis has a good
initial performance in the mitral position.
This is manifested by a good symptomatic
improvement (1.6 NYHA classes per
patient) and 96% of the patients being in
classes I and II at the latest follow-up.
However, there is a relatively high inci
dence o f thromboembolism with atrial
fibrillation playing an important role. In
our experience as in that of others,22 the
use of warfarin does not seem to reduce
the incidence of thromboembolism and is
still associated with a high rate o f bleed
ing complications. Finally, the rate of
valve failure in the mitral position is dis
tressing and not acceptable.
For these reasons we have discontinued
the use of this substitute and do not
recommend it for m itral valve re
placement.
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TABLE 1
Strong analgesics and structurally related drugs used in the treatment of cancer pain*
IM or SC administration
Non-proprietary
(trade) name
Morphine sulfate
Papaveretum (Pantopon)
Hydromorphone (Dilaudid) hydrochloride
Oxymorphone (Numorphan) hydrochloride
Nalbuphine (Nubain) hydrochloride
Heroin, diamorphine hydrochloride (NA in USA)
Levorphanol (levo-Drom oran) tartrate
Butorphanol (Stadol) tartrate
Pentazocine (Talwin) lactate or hydrochloride
Meperidine pethidine (Demerol) hydrochloride
Methadone (Dolophine) hydrochloride

Dose, mg
equianalgesic to
10 mg of IM morphine1

Duration
compared with
morphine

10
20
1.3
1.1
•12
4-5
2.3
1.5-2.5
60
80
10

Same
Same
Slightly shorter
Slightly shorter
Same
Slightly shorter
Same
Same
Same
Shorter
Same

‘ From Beaver, WT. Management of cancer pain w ith parenteral medication. JAMA 1980; 244:2653-2657.
f ln terms of the area under the analgesic tim e-effect curve.
Product Monograph available upon request
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Preventing Superficial Phlebitis During Infusion of Crystalloid
Solutions in Surgical Patients
Thirty patients who received routine
intravenous therapy <3.3% dextrose and
0.3 % normal saline at a rate of 100
mL/h) were randomized prospectively
into two groups to receive an antiphlebitic mixture of heparin-hydrocortisonesodium bicarbonate or placebo in a
double-blinded fashion for 4 to 7 days.
The code was then broken and the data
were analysed using x2 analysis with
respect to the clinical grade and inci
dence of phlebitis. Phlebitis developed in
2 of 14 study and 10 of 16 control
patients. All study patients tolerated
their intravenous lines longer and needed
less restarting. The antiphlebitic mixture
effectively prevented superficial infusion
phlebitis in patients receiving dextrosesaline solutions.
Trente patients soumis a un traitement
intraveineux de routine (dextrose a 3.3%
et chlorure de sodium a 0.3 % au rythme
de 100 mL/h) ont ete repartis au hasard
de facons prospective a deux groupes
qui ont recu a double-insu soit un
melange anticoagulant compose d'heparine, d'hydrocortisone et de bicarbonate
de sodium, soit du placebo, pendant 4 a
7 jours. Apres quoi, le code d'attribution
du hasard a ete ouvert et les donnees
relatives au stade Clinique et & la fre
quence des phlebites ont ete analysees
au moyen du test du x2- Des phlebites
sont survenues chez 2 des 14 patients
experimentaux et chez 10 des 16
temoins. Tous les sujets du groupe expe
rimental ont pu tolerer leur ligne d'admi-
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nistration intraveineuse et ont necessity
moins de remises en route. Le melange
anticoagulant a protege de facon efficace
contre la phlebite superficielle de perfusion
des patients qui recevaient des solutions
de dextrose et de chlorure de sodium.

Superficial phlebitis secondary to the
intravenous administration of fluids
affects 25% to 70% of all hospitalized
patients.1 Phlebitis is more prevalent on
surgical wards where each patient oper
ated upon receives crystalloid solutions
for 24 hours or longer. Phlebitis results
in patient discomfort because of pain and
swelling. Restarting augments this dis
comfort, increases nursing time and cost,
and delays the proper timing of impor
tant medications because they cannot be
administered until a new vein is cannulated. To reduce the incidence of phlebi
tis and accelerate restarting, many hospi
tals have resorted to specialty teams. With
such teams the incidence of phlebitis is
decreased, indicating that the technique
used for insertion is one important fac
tor in its cause.2’3 Unfortunately, these
teams are costly in economic terms.
The cause of phlebitis is not related to
the technique of insertion alone. Other
factors include the pH of the solution
infused, osmolarity, medications infused
into the vein, vein diameter and the type
of catheter used. Each variable has been
studied before, but to date no study has
attempted to control all of these impor
tant variables.4-8 For example, studies
dealing with the prevention of phlebitis
are unreliable if the medications infused
into the line are uncontrolled. This is par
ticularly important for surgical patients
since, during anesthesia, many drugs
known to irritate the intima of veins are
administered.
Patients and Methods

Thirty patients from one surgical floor
of the Ottawa General Hospital were
entered into the study after informed con
sent was obtained. The protocol was
approved by the Human Experimental
Procedures Committee. All patients were
scheduled to receive 3.33% dextrose in
0.3% saline (“ Vi-'A”), as part of their

regular intravenous therapy, at a rate of
100 mL/h by constant infusion pump.
Additional fluids, medications or electro
lytes were given through separate intra
venous lines when required.
Using a table of random numbers, the
pharmacist assigned patients to receive
either a placebo or the following anti
phlebitic mixture (APM) in each litre of
dextrose-saline solution: heparin 1000IU,
hydrocortisone 5 mg and sodium bicar
bonate 2.5 mmol.
Teflon catheters, 20 gauge, were used.
All insertions were carried out by two of
the authors using identical technique,
according to a protocol similar to that
used for subclavian catheters during total
parenteral nutrition. Under sterile condi
tions, the skin was cleaned with acetone
and scrubbed with povidone-iodine solu
tion. Following catheter insertion,
povidone-iodine ointment was applied
and the area covered with a semipermeable membrane.9 Arm boards and gauze
wraps were used when indicated to pro
tect intravenous lines located in precari
ous positions. Signs indicating that the
patient was part of a study were attached
to the bed and the intravenous site to pre
vent administration of other medications
through the cannula and, when patients
went to the operating room, we spoke to
the anesthetist-in-charge to make sure
that this problem did not occur. Addi
tional bags of fluid accompanied the
patient to ensure a constant flow during
operation and in the recovery room.
The intravenous sites were monitored
for phlebitis four times daily by the same
two persons. Educational seminars were
given to nursing staff before and during
the 12-month study to ensure prompt
reporting of infiltrated or phlebitic lines.
In this way, we were able to distinguish
between mechanical infiltration and phle
bitis. Phlebitis was graded as follows:
grade 1 — pain, no erythema; grade 2—
pain with erythema or edema, or both;
grade 3 — grade 2 plus palpable venous
cord; grade 4 — grade 3 plus induration;
grade 5 — frank thrombosis, alone or
with induration.
For practical and ethical reasons we
discontinued the intravenous therapy
whenever a phlebitis of grade 2 or greater
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occurred. The intravenous infusion was
restarted at another site. If a second epi
sode of phlebitis occurred, the numerical
gradings were added to the previous
grade.
All catheters were removed by the same
two authors. Those in patients with phle
bitis (total of 24) were sent immediately
for semiquantitative cultures of the tip,
using the technique of Maki.2 The
presence or absence of a fibrin clot was
noted.
The project continued until we had
obtained 30 complete 4- to 7-day studies
at which time the code was broken and
the data were analysed in consultation
with the Department of Statistics.
Results

When the code was broken, the patient
composition was found to consist of 14
patients who had received the antiphlebitic mixture and 16 controls who had
not.
In 2 (14%) of the 14 study patients,
grade 2 phlebitis developed; in 1 of these
the phlebitis did not occur until after 120
hours of infusion. On the other hand,
phlebitis developed in 10 (62.5%) of the
16 controls (p < 0.02). Of the 10, 1 had
grade 1 phlebitis, 2 had grade 2, 6 had
grade 3 and 1 had grade 4 phlebitis. The
intravenous infusion had to be stopped
due to phlebitis in four of the control
patients, and had to be restarted 32 times
compared with 18 times for the patients
who received antiphlebitic mixture. The
total duration of infusion was shorter
(due to early onset of phlebitis) in the
former group (48 hours versus 87 hours).
Of the 50 catheters used, the tips of 24
were cultured; only 1 contained bacteria
(less than 15 colonies of diphtheroid
bacilli). None of the catheters had fibrin
clots.
Discussion

The antiphlebitic mixture we used per
mitted the infusion of dextrose-saline
solutions for 4 to 7 days with very few
restarts and a remarkably low frequency
of phlebitis. This is an important advan
tage on a busy general surgical unit where
phlebitis causes patient discomfort, delays
delivery of medications and may lead to
unnecessary and expensive tests to rule
out other causes of fever. Such an anti
phlebitic mixture might also obviate the
need for intravenous teams since frequent
restarting is not necessary. This would
account for a substantial reduction in
cost.
Another consideration is the delivery of
nutrients intravenously. Not all hospitals
have nutrition support services and the
insertion and care of subclavian catheters
may become difficult if not impossible.
Such hospitals use various methods of

peripheral parenteral nutrition. This is
reasonably efficacious, but the hyper
osmolar amino acid-dextrose solutions
produce phlebitis even more frequent
ly.10 Studies dealing with the prevention
of phlebitis during peripheral parenteral
nutrition are currently under way in our
institution. The preliminary data are
remarkably similar to those reported here,
indicating that the mixture prevents phle
bitis under these conditions as well.
Five factors have been directly cor
related with the high incidence of post
infusion phlebitis in hospitalized
patients:1’2’11 the formation of clots
around the catheter tip in 24 hours due
to trauma from catheter insertion; the
irritative properties of drugs; the low pH
of most commonly used intravenous
fluids; particulate matter from the
intravenous bottle or other materials; and
finally infection secondary to poor tech
nique or contamination from the skin
around the catheter insertion site. It has
been recommended that the intravenous
site be changed every 24 to 36 hours,2
but phlebitis is not eliminated by this
procedure which is impractical and pain
ful, particularly when therapy is needed
for more than 5 days.
It is essential to differentiate infiltra
tion from phlebitis. A dislodged catheter
results in the infusion of fluids into
perivenous tissues. This produces an
inflammatory response simulating phle
bitis. It is important to eliminate factors
that may promote phlebitis such as the
type of intravenous catheter, insertion
technique and drugs given through the
catheter during and after operation. A
large, poorly inserted plastic catheter
through which medications are infused
into a small vein results in phlebitis 90%
of the time.3 Ours was the first study to
control all of the variables involved in the
development of phlebitis and to combine
three different compounds known to have
antiphlebitic effects in an effort to reduce
the incidence of phlebitis.
Heparin is thought to prevent phlebi
tis by effecting ionic changes in the vein
wall, thereby setting up a protective
hydrostatic barrier.8 Others believe that
heparin prevents the deposition of fibrin
which acts as a nidus for the accumula
tion of bacteria, particulate matter or
drug by-products. Fibrin accumulates on
most catheters within 24 hours, including
those inserted into large veins such as the
subclavian.2 This is corroborated by the
observation that local high concentrations
of heparin, added to the intravenous infusate, reduce the incidence of phlebitis
from 50% to 10%.5’8 Low-dose heparin
given systemically reduces the incidence
of phlebitis from 50% to 25%, presuma
bly also by preventing the formation of
fibrin clots.8 However, some authors
have been unable to demonstrate a

favourable effect of heparin.3-12 Further
more, those studies that did demonstrate
salutary effects were either uncontrolled
or used other compounds, such as buffers
or steroids, as well.6,13 As previously
noted, in our series no fibrin clots were
found in any of the 24 catheter tips exa
mined, suggesting either that heparin was
not necessary in the antiphlebitic mixture
or that it acted in some other manner. The
homeopathic doses of heparin that were
used did not produce any complications
of note — only a single episode of
hematemesis has been reported to date.5
The anti-inflammatory effects of
steroids were assessed by Isaacs and
associates.6 They infused an amino aciddextrose-electrolyte mixture with an
osmolarity of 900 mOsm/L for an aver
age of 114 hours before phlebitis neces
sitated a change. However, they did not
regulate the pH and control subjects were
not studied. Others have studied the com
bined effects of heparin and cortisone.
Although other factors were uncontrolled
and infusion rates varied greatly, a reduc
tion in phlebitis for 72 to 104 hours was
observed.4’6,7
Hence, despite arguments for the
beneficial effects of each of the antiphle
bitic materials referred to, no previous
study has combined heparin, steroid and
buffers while at the same time using
blinded control and study subjects and
eliminating other causative variables.
We thank J. Garber, RN, for technical
assistance and the surgical nursing staff of the
seventh floor of the Ottawa General Hospital.
We are also grateful to Ms. Catherine Oxley
from the Infection Control Service who per
formed the catheter cultures.
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Transabdominal Total Fundoplication Gastroplasty to
Control Reflux: a Preliminary Report
Transthoracic total fundoplication gas
troplasty has been reported as having a
low mortality and a 1 .1 % recurrence
rate and to produce excellent results in
9 3 .1 % of patients, moderate results in
3 .7 % and poor results in only 2 .8 % of
patients. In approximately 7 .0 % inter
costal neuritis is a serious residual
problem. The transabdominal total fun
doplication gastroplasty uses the identi
cal repair technique but avoids the chestwall pain. Previous esophageal or gastric
surgery and major esophageal shortening
are contraindications to an abdominal
approach.
The authors report their results with
50 patients who underwent transabdomi
nal total fundoplication gastroplasty and
were followed up for 6 to 20 months.
There was no mortality or major mor
bidity. Clinical follow-up was complete,
9 4 % of patients were assessed by roent
genography and 7 2 % by manometry.
None had anatomic recurrence, 46
(9 2 % ) were asymptomatic and 4 (8 % )
had minor residual gastric symptoms of
fullness or occasional epigastric pain. All
were much improved and none had
wound pain.
Long-term follow-up of transabdominal
total fundoplication gastroplasty is
necessary; however, since the technique
of repair is identical to the thoracic
approach, the results should be similar.

On reconnaft a la gastroplastie transthoracique par plicature totale du fundus,
une mortalite peu elevee et un taux de
recidive de 1 .1 % seulement. Elle donne
des resultats dans 9 3 .1 % des patients.
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moyens dans 3 .7 % et mediocres dans
2 .8 % . Une nevrite :itercostale demeure
un problbme residue! serieux chez envi
ron 7 .0 % des patients. La gastroplastie
transabdominale par plicature totale du
fundus fait appel a une technique de
reflection identique sans causer de douleur de la paroi-thoracique. L'abord abdo
minal est contre-indique chez les patients
que ont deja subi une chirurgie oesophagienne ou gastrique, ou un raccourcissement important de I'oesophage.
Les auteurs decrivent les resultats
obtenus chez 50 patients qui ont subi
une gastroplastie transabdominale par
plicature totale du fundus. La surveil
lance des suites therapeutique s'etale sur
6 a 20 mois.
II n'y a eu ni mortalite ni morbidity
importante. Tous les patients ont subi
des examens cliniques de controle, 9 4 %
ont ete evalue par radiographie et 7 2 %
par manometrie. II n'y a eu aucune reci
dive anatomique, 46 (9 2 % ) sont devenus asymptomatiques et les 4 autres
(8 % ) n'avaient plus que de symptomes
gastriques mineurs: plenitude et douleur
epigastrique occasionnelle. Tous furent
considerablement ameliorer; aucun n'a
souffert de douleur au niveau de la cica
trice.
II est maintenant necessaire de faire
une surveillance a long terme de la gas
troplastie transabdominale par plicature
totale du fundus. Cependant, comme la
technique operatoire est la meme que
pour l'abord thoracique, les resultats
devraient etre similaires.

achieved in 93.1%, moderately good
results in 3.7% and poor results in 2.8%.
The most serious disadvantage of the
transthoracic approach is that it causes
chest-wall discomfort. Although in most
patients this becomes a minor irritant, in
approximately 7% it is persistent and in
a few patients intercostal neurectomy and
wound revision are necessary. Transab
dominal TFG was developed to eliminate
this problem. The technique of hernia
repair is identical to that used transthoracically.
This is a preliminary report of the early
results achieved with transabdominal
TFG.

Patients and Methods
Fifty consecutive patients have been
evaluated and treated surgically by trans
abdominal TFG. There were 35 women
and the average age was 45.9 years (rang
ing from 18 to 67 years). The patients
were studied by history, radiology,
manometry with pH and with acid per
fusion (Bernstein test) and esophagogastroduodenoscopy.
A detailed history was obtained using
a prepared format. This included a his
tory of reflux, a diagrammatic display of
pain distribution and an evaluation of
past medical and surgical treatment.
Follow-up roentgenography was con
ducted by the same radiologists as
preoperatively and included water-siphon
tests for reflux.
Manometrie data were recorded using
a Honeywell U.V. vesicorder (Honeywell
Ltd., Toronto, Ont.). Constant water
Gastroplasty was first described by Collis infusion at a rate per minute of 6.8
in 19611 for the management of the scar- mL/tube was obtained using a directshortened esophagus. Since then the oper drive syringe pump and three fused poly
ative technique has changed and a vari ethylene catheters. A Beckman probe
ety of operations have been described, (Beckman Instruments Inc., Toronto,
including the Belsey gastroplasty,2 the Ont.) and pH monitor were used to
uncut Belsey gastroplasty,3 the uncut record pH change or reflux, using the
total fundoplication (Nissen) gastroplas common cavity test of abdominal com
ty4 and the total fundoplication gas pression.
troplasty (TFG).5
Esophagogastroduodenoscopy was
In a personal series6 of transthoracic conducted under local anesthesia.
TFGs with a 5-year follow-up, the mor
Following investigation, all patients
tality was 0% and the anatomic recur underwent transabdominal TFG. A mid
rence rate 1.1%. Excellent results were line upper abdominal incision is used. The
/ THE CANADIAN JOURNAL OF SURGERY
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sternum is elevated using a Goligher
retractor. The left lobe of liver is mobi
lized by dividing the triangular ligament.
The lesser sac is entered and the hepatic
branch o f vagus preserved. The greater
curvature is mobilized by dividing the
proximal four short gastric vessels. When
exposure is difficult the vessels are
clipped. The esophagogastric junction is
now fully mobilized by dividing the
phrenoesophageal ligament. Care is taken
to preserve the vagi and the peritoneal
coverings of the crurae.
The esophagogastric fat pad is
removed. Posterior crural sutures of no.
1 silk are placed, taking care to make deep
bites into muscle and to incorporate
peritoneum. Three to four sutures are
usually placed and tied later (Fig. 1).
A no. 60 French Maloney bougie is
now passed into the stomach; great care
is taken to place a right-angled DeBakey
vascular clamp snugly along the bougie.
Clamp placem ent incorporates the
phrenoesophageal ligament. A second
clamp is placed on the fundus for
hemostasis and to prevent spillage of gas
tric content. The 5-cm gastroplasty tube
is now cut leaving a 4-mm cuff of
stomach for suture closure.
The tube and gastric fundus are closed
with continuous locked 00 chromic cat
gut suture and, following clamp removal,
with a continuous 000 silk inverting
suture.
Posterior sutures are tied for loose
crural approximation. The new fundus of
the stomach is passed in a clockwise
fashion posterior to the esophagus and
the tip of fundus protrudes for 2 cm on
the hepatic surface of the esophagus and
tube. Positioning of the fundus is most
important as it must be sutured to guaran
tee only 1 cm of completion fundoplication.
The fundus of stomach is now sutured
to the left lateral aspect of the distal 1.5
cm of esophagus and 5 cm gastroplasty
tube using five mattress double-eye
sutures o f 00 silk (Fig. 2). These sutures
incorporate and support the gastroplasty
suture line. An intra-abdominal segment
of 6.5 cm is created.
The fundus is now approximated an
teriorly with three mattress sutures of 00
silk for a distance of 1 cm (Fig. 3). In
patients with an adynamic esophagus, the
completion fundoplication is reduced to
0.25 cm to 0.5 cm. One suture is placed
from the esophagus to the medial aspect
of the fundoplication to prevent slipping
and another suture is placed from the
fundus to the diaphragm to add to the sta
bility. The abdomen is closed in a routine
fashion.

40.3%. The percentage of disordered
motor activity in the lower esophagus fell
from 38.2 preoperatively to 28 postoperatively, a decrease of 26.7%.
The clinical result was staged as fol
lows: stage I — asymptomatic, stage II
— minor residual symptoms and stage III
— major residual symptoms.
At present, in early follow-up, 46
patients (92%) are asymptomatic and 4

Postoperative Follow-up
Follow-up ranged from 6 to 20 months
(mean 12.1 months). There was no oper
ative mortality or major morbidity. The
anticipated complications of this proce
dure were splenectomy, gastric fistula and
wound infection. In the 50 patients
reported here, none of these complica
tions occurred. (Since this study was com
pleted, a total of 150 transabdominal
TFGs have been done. Splenectomy was
required in one and there were no gastric
fistulas.) Clinical follow-up was complete
and radiologic studies were done in 47
(94%) and manometry in 36 (72%).
Radiologically there was no evidence of
anatomic recurrence or reflux.
Manometrically the tone of the high
pressure zone rose from a preoperative
level of 13.4 cm H20 to a postoperative
level of 18.8 cm H20 , an increase of

FIG. 2—Fundus is sutured to distal 1.5 cm
of esophagus and 5 cm of gastroplasty tube
with five mattress sutures of 00 silk.

FIG. 3—Completed total fundoplication
gastroplasty has 6.5 cm intra-abdominal
esophagus which is responsible for operative
stability. Completion fundoplication, tailored
to 1 cm length, effectively controls reflux and
avoids overcompetence.

T a b le 1— P r e o p e r a t iv e S y m p t o m s a n d
S ig n s ( 5 0 P a t ie n t s * )
No. of
S y m p t o m / s ig n

The preoperative symptoms and signs
noted in our 50 patients (Table I) were all

p a t ie n t s

H e a r tb u r n

50

R e f lu x

39

E r u c t a t io n

37

H ic c o u g h
W a te rb ra s h
N au sea

4
9
25

V o m it in g

6

M o t o r d y s p h a g ia
C r ic o p h a r y n g e a l

18

G a s tro e s o p h a g e a l

25

S t r ic t u r e
T o t a l d y s p h a g ia
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severe and unresponsive to medical
management. The most diagnostic symp
toms were reflux and dysphagia; 92% of
patients had at least one of these. Radiologically 34 had a hiatal hernia, 7 had
reflux only and in 9 the findings were
reported as normal.
Manometrically the mean tone of the
high pressure zone was 13.4 cm HzO
(normal 15 to 20 cm H20 ) and the mean
percentage of lower esophageal disor
dered motor activity in each examination
was 38.2. Acid-perfusion studies (Bern
stein test7) gave positive results in 31 and
negative in 16; in 3 patients the test was
not done.
Endoscopically no duodenal abnormal
ities were seen. Two patients had moder
ate gastritis and one had a superficial gas
tric ulcer. All had an incompetent
gastroesophageal junction, including nine
who had gastroesophageal mucosal pro
lapse. Twenty-one had localized eso
phageal ulceration and 8 had a stricture.

FIG. 1—Gastroplasty tube, 5 cm long, is cut
over no. 60 French Maloney bougie. Left gas
tric artery is preserved. Both vagi and hepatic
branch of vagus nerve are preserved.

8
33

' M e a n w e ig h t 6 6 . 4 kg ( ra n g in g fr o m 4 3 . 6 to
1 2 2 .7

kg ).
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(8%) have minor residual gastric symp
toms of fullness or occasional epigastric
pain when they are guilty of dietary
indiscretion, but all are much improved.
Dysphagia is the most serious disadvan
tage of a total fundoplication procedure.
Two patients who had persistent minor
dysphagia 3 to 5 months after surgery had
one dilatation with a no. 60 French
Maloney bougie and both are now asymp
tomatic.
Two of the eight patients who had a
stricture preoperatively have required one
dilatation postoperatively and are now
swallowing normally. This is a lower inci
dence of stricture than would be antici
pated; however, these patients were
selected for a transabdominal approach
because they had no major associated
ulceration.
None of the 50 patients have residual
wound pain and none have ventral her
niation.
Discussion
Total fundoplication gastroplasty
(TFG) reduced the incidence of anatomic
recurrence of a hiatal hernia to 1.1 % and
produced satisfactory results in 96.8% of
patients after a 5-year follow-up. These
results have improved further with tech
nical modifications to the operation that
have much reduced the incidence of dys
phagia. As with all thoracic operations,
the incidence of post-thoracotomy pain
is 7% and for this reason, without alter
ing the design of the operation, it has been
adapted for a transabdominal approach.
In the early stages the abdominal
approach was restricted to thin patients
without clinical evidence of esophageal
shortening and without previous gastric
or esophageal surgery. At this stage these
are the only contraindications. Initially,
gastroplasty was used only in patients
with an esophagus shortened from refluxinduced panmural fibrosis. This remains
the only absolute indication; however, the
low incidence of anatomic recurrence is
a substantial benefit and for a surgeon
experienced in gastroplasty, long-term
results will be improved.
The standard transabdominal Belsey or
Nissen procedures need esophageal length
to create stability. Approximately 4 cm
of esophagus is reduced below the
diaphragm to allow adequate fundoplica
tion. With TFG, only 1.5 cm of esopha
gus is reduced below the diaphragm. This
reduced abdominal length of esophagus
minimizes tension on the esophagus and
allows effective, stable reflux control in
patients with minor degrees of esophageal
shortening.
The technique of TFG has been deve
loped to produce a high degree of ana
tomic stability and simultaneously to con
trol reflux effectively. Stability is
produced by having a 5-cm gastroplasty

tube and 1.5 cm of distal esophagus main
tained below the diaphragm, instead of
the 4 cm required by the Belsey,8 Hill9 or
standard Nissen procedures.10 Thus,
with TFG, minor degrees of esophageal
shortening are accommodated. It is
important to recognize that the esopha
gus shortens by at least 2 cm when the
relaxants wear off following anesthesia.
This shortening is a causative factor in
early anatomic recurrence.11
A further factor producing stability is
the presence of the left gastric artery at
the base of the gastroplasty tube. This is
essential for vascularization of the tube
and also provides natural support to pre
vent anatomic recurrence.
In TFG, the completion wrap is
reduced to 1 cm maximal length. The
intra-abdominal segment is sutured
separately to the fundus and indepen
dently adds strength to the anatomic cor
rection. With this separate suturing tech
nique, stability and reflux control are
independent and can be tailored to fit the
patient’s problem. In the presence of
severe shortening, the high pressure zone
can be left in the chest. In patients who
have an adynamic esophagus, a previous
esophageal myotomy or very severe reflux
motor damage, the total completion fun
doplication length can be reduced to 0.25
to 0.5 cm.
A lthough the results we rep o rt
represent our early experience with trans
abdominal TFG, they do show that the
operative technique is safe. Since the
long-term results of transthoracic TFG
are well established, we anticipate that
our early good results will be maintained.
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Congenital Cervical Salivary Fistula
A study of 35 lesions diagnosed as bran
chial cleft sinuses or fistulas identified a
homogeneous subgroup characterized by
ectopic salivary tissue, draining serous or
mucoid fluid through a short sinus tract
to the base of the neck anteriorly.
These lesions should more properly be
called congenital cervical salivary
fistulas, since they may not arise from
the branchial apparatus but rather from
the embryonic placodal duct.
Une etude de 35 lesions auxquelles le
diagnostic de sinus ou fistule branchiale
a ete attribue a permis a I'auteur d'isoler
un sous-groupe caracterise par une
masse microscopique de tissu salivaire
ectopique drainant un liquide sereux ou
muqueux par un court trajet fistuleux a
la base du cou.
L'auteur croit que le terme le plus
approprie pour designer cette lesion
serait celui de fistule salivaire cervicale
congenitale et que son origine n'est pas
de I'appareil branchial mais plutot du
canal placodal embryonnaire.

in surgical texts. Histologic examination
will show a squamous or columnar, cili
ated epithelium with abundant underly
ing lymphoid tissue. Mucous glands are
said to be rare.1 Inflammatory cells and
variable destruction of the wall are seen
if the lesion has been infected (Fig. 1).
Incomplete tracts (sinuses) are said to
be less common than complete fistulas.2
At the Children’s Hospital of Eastern
Ontario, we recently encountered a child
whose fistula did not fit this traditional
concept. This led us, after a study of our
patient material and of the literature, to
revise our thinking about second-cleft
fistulas.

Case Report
A 1-year-old girl presented with a tiny, con
genital sinus opening in the midline, just above
the sternal notch. The opening drained a clear,
watery fluid, rather than the mucoid material
usually associated with second-cleft branchial
fistulas.

Probing with a fine ureteric catheter at oper
ation showed only a very short sinus tract, and
surgical exploration revealed only a short flim
sy canal that petered out in the soft tissues of
the neck. The histologic examination demon
strated ectopic salivary tissue. We gave the le
sion the descriptive name of “ congenital cer
vical salivary fistula” .

A number of authors3-7 have described
similar lesions although the standard
reference texts give them only one line or
no mention at all. The following facts
emerge from their reports:
• Salivary tissue is found in a number
of aberrant locations. The most frequent
is the low anterior part of the neck, usual
ly in association with a congenital sinus
tract. These sinuses cluster in an area
about the width of the manubrium sterni
and at the most 2 to 3 cm above it. They
may be found in the midline, along the
anterior border of the sternomastoid, or
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Literature Review

The presence of a congenital sinus open
ing along the anterior border of the ster
nocleidomastoid is generally interpreted
as being the external manifestation of a
second-cleft branchial fistula. The sur
geon operating on such a lesion expects
to find a tract of substantial size extend
ing to the lateral pharyngeal wall, along
a predictable course that is well described

Reprint requests to: Dr. Pierre Soucy,
Children’s Hospital o f Eastern Ontario,
401 Smyth Rd., Ottawa, Ont. K1H 8L1
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FIG. 1—Cross-section of branchial fistula. Respiratory type epithelium has been partially
destroyed by infection. There is abundant lymphoid tissue and no glands in wall (hematoxylin
and eosin, reduced by 31% from x 40).
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overlying the sternal origin of the mus
cle. These aberrant salivary fistulas ap
pear to be rare.
• Palpable masses of salivary tissue
have been found close to the sinus open
ing; in one instance a sialogram was
obtained on injection of the tract with
contrast material.
• The drainage is usually mucoid rather
than serous; our case is an exception, and
the histologic features are those of a
mixed (seromucous) salivary gland.
Drainage may be increased with any
stimulus to salivation.

intralobular ducts that in some instances
were in continuity with the main sinus
tract (Fig. 2). Clinically, these eight chil
dren all presented with a low anterior cer
vical sinus present since birth, draining
clear mucoid or serous fluid. The longest
tract extended to the level of the bifurca
tion of the carotid artery. Most were only
1 to 2 cm long.
It is evident that the clinical and
histopathologic features of these eight
patients are similar or identical to those
of other cases reported as cervical salivary
fistulas, and that the lesion is much com
moner than was previously thought.

Patient Material

We then reviewed the findings in 35
branchial sinuses and fistulas that we had
operated on. The lesions fell into three
distinct categories. In six cases the tract
was lined by a stratified, squamous, ker
atinizing epithelium, and in four of these
the course of the tract was that of a firstcleft branchial fistula. Two tracts had
courses that did not correspond to con
ventional descriptions.
In 12 cases there was a complete
second-cleft fistula to the pharynx, and
in all the histologic findings were as
expected. Two fistulas had a few seromu
cous glands in the wall and one had a
more substantial cluster of seromucous
tissue that was labelled as ectopic salivary
gland.
The third category consisted of 17
sinuses, an unexpectedly high proportion
of the total. Four sinuses had only a few
seromucous glands in their walls but
another eight were composed of substan
tial masses of salivary tissue with an orga
noid pattern, arranged in lobules with

FIG. 2—Ectopic salivary tissue and ducts.
Serous units stain more deeply (hematoxylin
and eosin, reduced by 50% from x 40).

Discussion

Is this a distinct lesion that is not of
branchial origin, or is it simply a histo
logic variant of the branchial sinus?
Most authors support the theory of heteroplasia, that is, anomalous differenti
ation to salivary tissue of cells within the
wall of a branchial sinus.
In favour of this theory is the fact that
the sinus opening is generally in the same
location as a typical branchial sinus, the
tract usually follows the same course
upwards and, as we noted, the main sinus
tract may be lined by ciliated epithelium,
which is not a feature of normal salivary
gland ducts. In addition we have
documented one case of a complete
fistula to the pharynx containing ectopic
salivary glands.
Against the theory of heteroplasia and
in favour of the theory that the lesion is
an entity distinct from branchial sinuses
is the fact that on a number of occasions
the sinus opening was not at the anterior
border of the sternomastoid, and dipped
downwards rather than led upwards. The
frequency of this process and its singular
predilection for low neck sinuses is also
surprising.
Himalstein,8,9 based on the studies of
Fraser10 and G arrett,11 proposed an
intriguing theory to explain the occur
rence of low cervical sinuses. In the
human embryo, in the area just dorsal to
the arch field, contiguous with but not a
part of the branchial apparatus, ectoder
mal thickenings form in relation to the
underlying ganglia of the 7th, 9th and
10th cranial nerves. These are called
epibranchial placodes.
As the ganglia sink in deeper, the pla
codes become invaginated as ducts that
follow the ganglia. The area bearing the
opening of these ducts is closely related
to the embryonic cervical sinus of His, the
persistence of which has been said to
account for second-cleft branchial
anomalies, and it corresponds to the
inferior apex of the anterior triangle of
the neck in the mature fetus.
Himalstein has suggested that the
placodal duct of the 10th ganglion is a

logical source of blind low cervical sinuses
composed of ectodermal derivatives such
as salivary tissue.
Why the ectoderm lining of this placo
dal duct would have a particular propen
sity for differentiation into salivary tis
sue, though, remains unexplained.
Summary

We propose that there is a distinct
entity that is best called congenital cervi
cal salivary sinus or fistula. It mimics
branchial sinus, but can be distinguished
from it by its presence very low in the
neck, its inconstant relation to the
anterior border of the sternomastoid mus
cle and its drainage occasionally of ser
ous rather than mucoid material.
A fistulogram shows a short tract and
may in fact have the appearance of a
sialogram. At operation the tract is short
and flimsy and may not extend upwards.
The sinus tract drains a microscopic or
grossly visible mass of salivary gland tis
sue, usually with a mixed, seromucous
pattern.
This lesion may not arise from hetero
plasia within a branchial sinus, as is com
monly proposed, but may represent per
sistence of the placodal duct with
differentiation of its cells into salivary
tissue.
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Correction
In the paper “ Winnipeg Orthopaedic
Society, a Short History” , which appeared
in the January 1985 issue, the sentence on
page 93 (left-hand column) “ Others served
as chairman of the local arrangements com
mittee for the Association’s annual meet
ing: Dr. W.B. MacKinnon — 1962, Dr.
D.R. Bigelow — 1973, Dr. R. Macoomb
— 1964.” should read “ Others served as
chairman o f the local arrangements com
mittee for the Association’s annual meet
ing: Dr. W.B. MacKinnon — 1962, Dr.
D.R. Bigelow — 1973, Dr. R. Macoomb
— 1984.”
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Necrotizing Enterocolitis: a Chronic Colonic Disease
W hile acute necro tizin g e n te ro co litis is a
com m on n eonatal c o n d itio n , th e chronic ity o f th e p a tho lo g ic process is o fte n
overlooked.
B etw een 1 9 7 9 and 1 9 8 3 at th e
Foothills H ospital in C algary, a diagnosis
o f acute n e cro tizin g e n te ro c o litis w as
made in 2 11 in fa n ts . Seventeen in fa nts
(8% ) required u rg e n t su rgical tre a tm e n t
in a d d ition to standard m edical m anage
m ent. O verall, 2 0 6 (9 8 % ) in fa n ts sur
vived th e acu te episode. Lo n g-te rm sur
viva l w as 9 2 % (1 9 4 children). The 12
late deaths w e re ascribed to chronic
cardiovascular, p u lm o n a ry and cerebral
diseases and " s h o r t g u t s y n d ro m e ".
C olonic s tric tu re s developed in 9 % o f
those tre a te d m edically; s tric tu re s distal
to th e m uco u s fis tu la developed in 5 0 %
o f those requiring u rg e n t rese ctio n and
e xte rio riza tio n . N one o f th e strictu re s,
w h ic h fo rm e d b e tw e en 1 4 days and 18
m on th s a fte r th e diagnosis w a s made,
resolved sp o n ta n e o u sly. T h e y tended to
be m ultip le and to in vo lve longer seg
m ents in in fa n ts w h o required surgery.
Diarrhea p rolonged the m o rb id ity in these
children.
The tim e course and varied presenta
tio n o f s tric tu re s in th is series suggests a
rationale fo r m anagem ent o f in fa n ts w h o
survive a cu te n e cro tizin g en tero co litis.
L 'e n te ro -c o lite n e crosante a ig iie est un
fre q u e n t d ia g n o s tic en periode neonatale
et la c h ro n ic ite du processus pathologique est s o u v e n t negligee.
Entre 1 9 7 9 e t 1 9 8 3 , les a uteurs ont
diag no stiq u e I'e n td ro -c o lite necrosante
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a igiie chez 2 11 e n fan ts. Un traite m e nt
chirurgical d 'u rg e n ce a 6te requis en plus
du tra ite m e n t m edical standard chez 17
(8% ) d 'e n tre eux. La survie a ete de
9 8 % (20 6 ). La survie a long term e a ete
de 9 2 % (1 9 4 e n fa n ts); les causes de
m orta lite d ta n t a ttrib u te s aux maladies
cardiovasculaires, pulm onaires e t cere
brates et le syn d ro m e de " in te s tin
c o u rt" .
Des stric tu re s in te stin a le s se sont
developpees chez 9 % de ceux traites
m edicalem ent bien que 5 0 % de ceux
ayant requis une resection et une exteriorisation de ve lop p e ren t des strictures
distales k la fistu le . Le te m p s de fo rm a 
tio n des stric tu re s varia de 14 jo u rs a 18
m ois. A u cu n e reso lu tio n spontanee des
strictu re s n 'a ete notee. Les strictures
avaient ten da n ce a e tre m ultiples et a
im pliquer de plus longs segm ents intestinaux chez ceux a ya n t requis de la chirurgie. La diarrhee prolongea la m orbidity de
ces e nfants Id.
L 'e vo lu tio n e t la v a rie tt des presenta
tio n s de s tric tu re s dans c e tte serie suggerent une approche rationelle des
e nfants su rviva n ts a I'e n td ro -co lite necro
sante aigiie.

Although necrotizing enterocolitis was
first described as a clinical entity over 90
years ago,1 the etiology and pathology
are still not clear. Advances in neonatal
care have not only resulted in increased
survival o f infants with this condition, but
have altered the natural history o f the dis
ease. This study shows that acute
necrotizing enterocolitis is a chronic proctocolonic disease requiring long-term
medical and surgical management.

intestinalis. Medical management, which
consisted o f total parenteral nutrition,
systemically administered antibiotics,
nasogastric decompression, no oral intake
and correction o f electrolyte, acid-base
and ventilatory abnormalities, was con
tinued for at least 10 days.
The indications for surgery were clini
cal and radiologic signs of frank intesti
nal perforation or failure of medical treat
ment. At operation, each necrotic bowel
loop was resected and the adjacent via
ble ends were exteriorized. In three
infants the whole intestine was involved.
Ileostomy, with or without ileocolic resec
tion, was performed, but had no effect
on the rapid downhill course o f the
infants who all died.
All surviving children have been fol
lowed up for periods extending from 6
months to 5 years. Clinical examination
was supplemented by appropriate labora
tory and roentgenographic studies.
Retrospective analysis of records and tests
of statistical significance were performed.
R esults

Of the 211 infants, 194 (92%) with a
mean gestational age o f 30 weeks and a
mean birth weight o f 1700 g received med
ical treatment only (Fig. 1). In two, the
course o f the disease was fulminant and
death occurred within 6 hours o f admis
sion, without the opportunity for

P a tie n ts a n d M e th o d s

From June 1979 to December 1983, 211
infants with acute necrotizing enteroco
litis were treated in the Intensive Care
Nursery at the Foothills Hospital in
Calgary.
The diagnosis was made using a com
bination o f clinical, laboratory and radi
ologic investigations. The infants had sep
sis associated with an ileus, hematochezia
and radiologic evidence o f pneumatosis

211 infants who had necrotizing enterocolitis.
BPD = bronchopulm onary dysplasia, C H D
= congenital heart disease, IV H = intraven
tricular hemorrhage.
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laparotomy. Seventeen patients (8%)
required surgery in addition to medical
treatment. These infants had a mean
gestational age of 30 weeks and a mean
birth weight of 1510 g. There were three
deaths in this group due to intractable
necrotizing enterocolitis. The overall sur
vival was 206 of 211 infants (98%).
Among the 192 survivors who received
medical treatment alone, 10 died later of
causes unrelated to the necrotizing
enterocolitis (bronchopulmonary dyspla
sia 7, congenital heart disease 2, intraven
tricular hemorrhage 1). Two of the 14 sur
vivors who received medical and surgical
treatment died later of short gut syn
drome. Thus, 182 of 194 infants (94%)
treated medically and 12 of 17 (71%) who
received medical and surgical therapy sur
vived.
Colonic stricture represented the most
important long-term complication. After
medical treatment, only 16 of 182 children
(9%) had colonic strictures, but surgery
was followed by strictures in 6 of the 12
surviving infants. In five of these six
babies the fibrosis was pancolonic,
including the submucosa of the rectum.
All strictures developed within 18 months
of the acute episode of necrotizing
enterocolitis. The m ost frequently
involved sites were the transverse and
descending portions of the colon. Stric
tures were localized, multiple or segmen
tal. No colonic strictures resolved spon
taneously.
Discussion
A number of factors are likely involved
in the etiology of necrotizing enterocoli
tis. It is seen most commonly in the
stressed premature infant. Proposed con
tributory factors relate most directly to
mucosal ischem ia.2 Resultant tissue
edema and damage may predispose to
colonization of the gut wall, especially in
the presence of an immature immune sys
tem unable to resist local invasion.3’4
In this study, once acute necrotizing
enterocolitis was diagnosed the infant
received a standard treatment protocol
for a minimum of 10 days.2’5’6 Survival
was 98%, similar to that reported by

FIG. 2—Treatment algorithm for infants
with acute necrotizing enterocolitis, adapted
from Schwartz and associates.6

Schwartz and associates6 and substan
tially better than the 45% to 75% survival
reported previously.7-9 The successful
outcome of medical treatment is proba
bly related to general improvement in the
medical management of sick neonates,
earlier diagnosis and more stringent indi
cations for surgical intervention.
Surgery is performed in 9% to 50% of
cases of acute necrotizing enterocolitis.6,8
Only 8% of infants in our series under
went surgery. Irrespective of the indica
tion for surgery, infants survived the
operation only if the gross pathologic fea
ture was localized intestinal necrosis and
perforation. The disease in all infants
involved the terminal ileum, cecum and
proximal ascending colon. The necrotic
intestine was resected and the infant was
left with an ileostomy and an ascending
or transverse colostomy (mucous fistula).
Colonic strictures developed in 22
(11%) of 194 children after successful
m anagem ent of acute necrotizing
enterocolitis. The reported incidence of
stricture formation varies from 3% to
44% .2,6,8,i°,ii jn thjs stuciy a significant
difference was noted (9% versus 50%) in
stricture formation between those infants
treated medically and those requiring sur
gery (x2 = 19, p < 0.001). Our
experience confirms that colonic strictures
may develop at variable intervals follow
ing an acute episode o f necrotizing
enterocolitis,2,6,11 in our series from 14
days to 18 months. Most frequently the
stricture was diagnosed within the first 6
months. Thus, a normal roentgenogram
after barium enema 4 to 8 weeks follow
ing the acute episode does not exclude
stricture formation later. In contrast to
others,2,6,11 we failed to observe spon
taneous resolution of such a stricture.
Moreover, the small intestine was never
involved in the chronic pathologic
process.
Strictures that developed in children
whose acute necrotizing enterocolitis
required medical treatment only were
localized and single. These infants
presented with symptoms and signs of a
partial obstruction of the distal bowel.
Roentgenography after a barium enema
indicated the site of the stenosis. Stric
tures were most commonly seen in the
transverse colon.2’9,12’13 Excision of the
involved length of colon with primary or
staged colocolic anastomosis was uni
formly successful.
Whereas one of the six infants who
underwent surgery for acute necrotizing
enterocolitis had multiple strictures local
ized to the transverse and descending
colon, the remaining five had extensive
fibrotic narrowing involving all the colon,
including the rectum as far distal as the
dentate line. The gross morphology of
lengthy strictures frequently resembled
multiple atresias with intraluminal mem

branes seemingly unrelated to colonic ste
nosis elsewhere. However, histologic
examination revealed continuous fibrotic
and chronic inflammatory changes in the
colonic wall without skip areas. The more
extensive involvement in those infants
who required surgery probably reflects
the severity o f the disease. However, the
rectum should be spared by virtue o f its
systemic blood supply. The histologic fea
tures of necrotizing enterocolitis suggest
that the rectal submucosal fibrosis and
chronic inflammation are similar to the
pathologic findings in the more proximal
large intestine. Diffuse and progressive
small-vessel disease of the colon not
associated with variations in m ajor
arterial blood supply14 may account for
the pancolonic involvement and subse
quent stricture formation.
Loss of terminal ileum, ileocecal valve,
colon and rectum with an ileoanal anasto
mosis, while at first associated with gross
diarrhea and a perineal rash, has
responded to dietary manipulation, oral
administration of loperamide hydrochlo
ride (0.25 mg to 1 m g/kg daily) and appli
cation of karaya-zinc oxide-glycerine
paste to the perineum. Long-term follow
up in these children has shown a gradual
return to normal stools with normal nutri
tional status. All bouts of diarrhea should
be energetically treated to prevent
dehydration and the appearance of a
perineal excoriating dermatitis.
Conclusions
Since more neonates survive the acute
episode of necrotizing enterocolitis, stric
ture form ation must be recognized as a
potential long-term complication. Ex
perience dictates that strictures may
present as late as 18 months following the
acute episode, long after the child has
been discharged from the hospital. A nor
mal barium enema before discharge does
not exclude development of a stricture
later.
If a clinical diagnosis of incomplete
large-bowel obstruction is suspected in
children treated medically for acute
necrotizing enterocolitis, then roent
genography after a barium enema is
essential in planning the appropriate oper
ative procedure (Fig. 2). When the infant
has had emergency surgery, a contrast
enema and a stom agram m ust be
obtained before closing the stomas to
ensure that no additional strictures have
formed. Careful operative intra- and
extraluminal examination to ensure that
multiple or atypical strictures are not
present must be performed.
Cooperation between the neonatologist, pediatric surgeon and radiologist in
the long-term management of infants who
have had acute necrotizing enterocolitis
is essential to avoid the added morbidity
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should be employed and it is advisable to
monitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given.
A fte r a lo a d in g d o se , th e fo llo w in g
recommendations for maintenance dosage
may be used as a guide:
RENAL
FUN CTION
M ild
im p a irm e n t
M o d e ra te
im p a irm e n t
S e vere
im p a irm e n t
E s s e n tia lly
n o fu n c tio n

C REATININE
CLEARANCE
m L /m in

DOSE

FREQ UENCY

50-30

1-2 g

e v e ry 8-12 h

29-10

1 -2 g

e v e ry 12-24 h

9-5

0.5-1 g

e v e ry 12-24 h

<5

0.5-1 g

e v e ry 24-48 h

In the patient undergoing hemodialysis, the
loading dose of 1 -2 g should be given after
each hemodialysis, and the maintenance dose
should be given as indicated in the Table
above.
Neonates (Including Premature Infants),
Infants and Children (See WARNINGS for
Neonates under ADMINISTRATION in the
complete monograph.)
Prem ature Infants
w ith Body W eights
Above 1500 g

associated with delay in diagnosis of
colonic obstruction.
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2 0 - 4 0 m g / k g e v e r y 8 h I.V.
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Infants
1 m o n t h t o 2 y e a rs
o f age
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C hildren
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In severe infections, the total daily dosage in
infants and children may be increased to
200 mg/kg, but not to exceed 12 g per day.
MEFOXIN* is not recommended for the ther
apy of meningitis. If meningitis is suspected,
an appropriate antibiotic should be used.
A t present there is in s u ffic ie n t data to
recommend a specific dosage for children
with impaired renal function. However, if the
administration of MEFOXIN* is deemed to be
essential the dosage should be modified
consistent with the recom m endations for
adults (see Table above).
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Cesarean Section
The first dose of 2 g should be administered
intravenously as soon as the umbilical cord
has been clamped. The second and third
2 g doses should be given intravenously or
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after the first dose.
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Std.) is supplied as sterile powder in boxes of
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No. 3357 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored
below 30° C.
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AESTHETIC BREAST SURGERY. Edited by
Nicholas G. Georgiade. 408 pp. Illust. Wil
liams & Wilkins, Baltimore, 1983. $84
(US). ISBN 0-683-93450-2.

Dr. Georgiade has convened a distinguished
group of well-known plastic surgeons to contri
bute to this textbook on aesthetic breast surgery.
Two thirds of the contributors are from the
United States with the remainder representing
Brazil, Canada, Great Britain, France, Spain,
Sweden and Switzerland. They were selected
for their interest in a particular aspect of the
subject. Although the book contains more than
400 pages, it is easily read, since a large propor
tion is devoted to black and white photographs
and line drawings. The quality of the illustra
tions is excellent.
The book begins with the usual introductory
chapters on anatomy, physiology and the psy
chological aspects of aesthetic breast surgery.
Following these are chapters devoted to breast
augmentation, correction of breast asymmetry,
hypertrophy and ptosis. The final chapters deal
with management of gynecomastia, common
congenital anomalies of the nipple and areola,
with the last one covering problem cases.
Multiauthored texts are unavoidably repe
titive, especially when so many give their indi
vidual points of view on a relatively narrow
subject. The editor does succeed, however, in
presenting “ the extensive experience of the
foremost international authorities in the field
of aesthetic surgery” , as stated in his preface.
The format is straightforward, and the text and
illustrations are well synchronized, with the
exception of the final chapter, where it would
have been advantageous to have the photo
graphs on the same page as the case summaries.
Dr. Georgiade’s book is a complete, wellwritten and illustrated overview of the current
status of aesthetic breast surgery and I recom
mend it as a valuable addition to the plastic
surgeon’s library.
G. A
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PLASTIC RECONSTRUCTIVE BREAST
SURGERY. Gaston F. Maillard, Denys
Montandon and Jean-Louis Goin. 317 pp.
Illust. Masson, Paris, 1983. (Price not sta
ted). ISBN 2-225-80076-6.

This bilingual textbook updates reconstructive
breast surgery. It is particularly valuable to the
surgeon with extensive experience in this field.
The authors have deliberately kept their com
ments concise so that they would be read; their
analysis of various techniques is generally based
on their experience and often is lacking in
depth. Their reasons for choosing a technique
are outlined along with their comments.
The discussion on augmentation mammaplasty, listing its advantages and disadvanta
ges, is good. I disagree with the authors’
mastectomy technique for gynecomastia; I
believe that most surgeons would not leave a
1.0 to 1.5-cm platform under the nipple areo
lar complex. The section on subcutaneous
mastectomy is nicely handled. The general sur
gery and pathologic features of malignant
lesions of the breasts are well discussed and I
agree that a 3- to 12-month waiting period
should follow mastectomy before breast recon
struction is begun. The various techniques of
subcutaneous mastectomy are discussed and
analysed. The section on breast implants is well
presented and the complications are mentioned
in sufficient detail. I believe that manual rup
ture of the capsular contracture following
implants is still a questionable procedure.
The pathologic aspects of malignant lesions,
as presented by Dr. Larue Charlus, are brief
but to the point. The alarming figure of 67 000
new cases of breast carcinoma annually in
Europe is noted, as well as 30 000 deaths
annually from this disease.
The authors mention that three out of five
women who undergo mastectomy are interested
in reconstruction, and the indications and con
traindications are reasonably presented. Breast
reconstruction, using direct prosthetic implan
tation, musculocutaneous flaps, such as the
rectus abdominis and the latissimus dorsi, and
local de-epithelialized flaps, is well presented
continued on page 187
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Delay in Diagnosing Gastrointestinal Injury
After Blunt Abdominal Trauma in Children
Intestinal perforation after blunt abdomi
nal trauma in children is rare and thus
the diagnosis may be delayed. For this
reason the authors reviewed their
experience with 12 children to recom
mend a protocol for investigation that
would reduce the delay in diagnosis. Of
the 12 perforations, 2 were gastric, 2
duodenal, 7 jejunal and 1 colonic. The
diagnosis of jejunal perforation, in partic
ular, was usually delayed because free
air was not seen radiologically in the first
few hours after injury. This may be
because of delayed rupture or spasm of
the injured intestine. Serial films were
valuable in aiding the diagnosis and are
recommended, together with assessment
of solid organ injury by radionuclide
scanning. In this series peritoneal lavage
was not used. No child died.

Chez I'enfant, la perforation intestinale
consecutive a une contusion abdominal
est rare, ce qui peut done en retarder le
diagnostic. En consequence, les auteurs
ont analyse leur experience personnels
chez 12 enfants dans le but de degager
un protocole d’examen qui permettrait de
reduire les delais de diagnostic. Des 12
perforations, 2 etaient gastriques, 2 duodenales, 7 jejunales et 1 colique. Le
diagnostic de perforation jejunale a ete
particulierement retarde du fait qu'il etait
impossible de visualiser Fair libre a la
radiographie dans les premieres heures
qui suivaient le traumatisme. Ceci peut
etre le fait d'un delai de rupture ou d'un

spasme de I'intestin. Les radiographies
seriees ont contribud au diagnostic et
sont done recommandees en association
avec revaluation des blessures des organes solides par scintigraphie isotopique.
On n'a pas eu recours au lavage perito
neal dans cette serie. Aucun enfant n'est
decede.

are often neither marked nor characteris
tic.3,4 We have investigated 12 patients
with intestinal perforation seen at the
Children’s Hospital o f Eastern Ontario,
Ottawa, between 1974 and 1984. This
review has led us to recommend a plan
of investigation to reduce the delay in
diagnosis.
Patients and Methods

Blunt abdominal trauma in children
usually results in solid organ injury and
much more rarely in hollow visceral per
foration.1,2 Since trauma to solid organs
is treated nonsurgically, if possible, in
most pediatric centres, the presence of
blood on peritoneal lavage is not itself an
indication for surgery, so lavage is often
not performed except in unconscious
patients. The diagnosis o f hollow visceral
perforation is made by the disclosure of
free or retroperitoneal air on roentgeno
graphy. Often this cannot be seen in the
first few hours after injury and may never
appear. Thus, the diagnosis may be
delayed unduly. Also, abdominal findings

Twelve children, ranging in age from
14 months to 14 years (mean 6.8 years),
with gastric, duodenal, jejunal and
colonic perforations after blunt abdomi
nal trauma, were seen in the study period.
We reviewed their records from the stand
point o f the viscus involved, the type of
trauma suffered and associated injuries
(Table I), delay in diagnosis and its rela
tion to radiologic studies (Table II),
peritoneal lavage and peritoneal soiling at
the time o f surgery, the presence or
absence o f solid organ injury, postoper
ative complications as they relate to delay
in diagnosis and the viscus perforated
(Table III).
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Gastric Perforation
Two children had gastric perforation.
One was secondary to child abuse (case
1); the other child (case 2) was a pedes
trian involved in a motor vehicle accident.
Both perforations were diagnosed within
2 hours of injury. In each, the laceration
was on the greater curvature and there
was gross intraperitoneal soiling. Free air
was seen on the roentgenogram in one.
These cases presented no diagnostic
problem. They had gross abdominal find
ings and were in shock. Postoperatively,
one child had bowel obstruction from
adhesions and remained in hospital for 17
days. The other had a pleural effusion
and atelectasis and remained in hospital
for 27 days.

214 years to 12 years (mean 6.8 years).
Supine and erect abdominal films were
obtained in all cases within 2 to 3 hours
of injury; none showed free air.5 Free air
was seen in four cases (nos. 5, 6, 8 and
11) at 11 to 96 hours after injury (mean
41 hours). In three patients (nos. 7, 9 and
10) free air was never present. In case 7
the diagnosis preoperatively was perito
nitis of unknown cause but laparotomy
revealed a 1-cm long rupture of the jeju
num. In patients 9 and 10, the preopera
tive diagnosis was bowel obstruction; in
case 9, the diagnosis was only made 96
hours after injury although the jejunum
was completely transected and in case 10
the perforation sealed spontaneously, giv
ing rise to a stricture with subacute
obstruction and the condition was finally
diagnosed 40 days after injury.

DuodenaI Perforation

Colonic Perforation

Two cases of duodenal perforation
were seen. Both resulted from motor vehi
cle accidents. One child (case 3) was a pas
senger wearing a seat belt and the other
(case 4) was riding a motorcycle. In
neither case did the initial films show free
air. In case 3, a child who had a perfora
tion of the first part of the duodenum,
free air was apparent 18 hours after
injury. In the second child, who had a
perforation in the second part of the
duodenum, there was only a retro
peritoneal air leak and the diagnosis was
not suspected until the leak was noted 31
hours after injury.
The first child was treated with simple
suture and was discharged from hospital
after 25 days. He returned 6 weeks after
discharge with a chronic duodenal fistula.
This closed spontaneously after jejunal
feeding for 3 weeks through a catheter
passed nasally under radiologic control.
The second child was treated by simple
suture and pyloroplasty.

One child (case 12) had spontaneous
drainage of an abscess around a fistula
in the mid-ascending colon 14 days after
injury. Neither free intraperitoneal air nor
retroperitoneal air was seen at any time.
The diagnosis was complicated by para
plegia due to a fracture-dislocation of the
lumbar spine with consequent loss of sen
sation below the umbilicus.

Findings

Jejunal Perforation
There were seven cases of jejunal per
foration in children ranging in age from

Discussion

Usually gastric perforation is diagnosed
easily, soon after injury. There are gener
ally signs of gross peritoneal irritation
from leakage of gastric content, and early
shock. Immediate laparotomy is indi
cated.
Duodenal perforation may be diag
nosed quite early after injury if the leak
is into the general peritoneal cavity, as in
our case 3, but even so no free air was
seen until 18 hours after injury. In case
4, the rupture was in the second part of
the duodenum and the leakage of fluid
and air remained retroperitoneal. The
diagnosis was delayed for 31 hours.
Jejunal perforation is more difficult to
diagnose early. Free air may not be seen

for several hours or indeed may never be
seen. Clear abdominal findings that
would lead at least to an exploratory
laparotomy are often absent. The perfo
ration may be due to a blow-out of dis
tended or air-filled jejunum. This appears
to be the commonest injury but the jeju
num also has considerable capacity to go
into spasm so that peritoneal soiling is
minimal. In addition, jejunal contents are
not very irritating and are essentially
sterile, at least in the upper part. In one
case (no. 8) complete transection of the
upper jejunum occurred with minimal
soiling of the peritoneal cavity and with
functional closure of the transected ends
of the bowel by spasm and by omentum.
All our jejunal perforations occurred in
the upper half. Less severe trauma may
cause only localized injury to the bowel
wall or its mesenteric blood supply. This
may result in either a very small perfora
tion or delayed perforation. In our patient
10, it may have been responsible for the
jejunal stricture that followed a direct
injury to the abdomen but was diagnosed
only after 40 days.6 It was a factor in
case 5 in which free air was seen, but the
tiny perforation was not clear at opera
tion and was seen only on pathological
examination. In no case was peritoneal
lavage carried out. We do not believe that
it would have helped diagnostically since
there was little or no peritoneal soiling at
operation in any of our children.
In the child with colonic perforation,
the absence of peritoneal signs was, of
course, related to the retroperitoneal posi
tion of the injured colon and to abdomi
nal anesthesia secondary to the spinal
cord injury.
Of interest is that in none of the seven
patients with perforated jejunum was
there solid organ injury involving spleen
or liver. This is probably related to the
level of injury, which was below the costal
margin and directed to the central abdo
men, resulting from direct seat-belt
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trauma. In the second case of gastric per
required lysis. The complication rate is
foration, the patient had a splenic lacer
similar to that in other series, but did not
ation resulting from a motor vehicle acci
seem related to a delay in diagnosis9
dent. This is the only example o f proven
(Table III). In the five cases with compli
splenic laceration associated with gas
cations, the mean delay was 94.5 hours
trointestinal injury in our hospital over
and in the seven uncomplicated cases, the
a 10-year period in which 64 ruptured
mean delay was 167 hours. There were no
spleens and 17 ruptured livers were diag
deaths in the series and no lasting
nosed. While this series o f gastrointesti
problems related to the perforation.
nal perforations is small, it is compara
ble to or larger than others in the
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Catheterization of the Umbilical Artery in Neonates:
Surgical Implications
Catheterization of the umbilical artery is
a common procedure in neonatal inten
sive care units. The authors studied the
records of 100 consecutive newborns
who underwent this procedure to review
the indications for and complications of
umbilical artery catheterization and to
discuss preventive measures and alterna
tive techniques. Only polyvinylchloride
barium-impregnated catheters were used
(nos. 3.5 and 5.0 French). The com
monest indications were respiratory dis
tress syndrome, asphyxia and congenital
heart disease. Of the 100 infants, 75
weighed less than 2500 g.
Ampicillin and calcium were the com
monest medications infused (70 and 65
babies respectively). There were three
major complications, two of which were
gangrene of the lower extremity. Ampu
tation of the foot was necessary in one
and amputation of the toes in the other.
The third complication was the develop
ment of gluteal necrosis. In all three
cases, catheter placement was low and
the infusion was ampicillin. In two of the
babies, calcium was also administered.
Minor complications were seen in 32
cases, with vascular spasm in the lower
limb being the most common.
All catheter tips were cultured; there
was bacterial colonization in 1 3 % ,
Staphylococcus epidermidis being the
commonest organism. Proven necrotizing
enterocolitis was seen in eight infants
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and was suspected in eight others.
Blanching is a serious sign and was
seen in the three infants with major com
plications. The infusion should be
stopped immediately. When necrotizing
enterocolitis is suspected, the catheter
should be removed.
Le catheterisme de I'artere ombilicale est
une intervention courante dans les unites
neo-natales de soins intensifs. A I'etude
des dossiers de 100 nouveau-nes qui ont
subi consecutivement cette intervention,
les auteurs revoient les indications et
complications du catheterisme de I'artbre
ombilicale et commentent les mesures
preventives ainsi que les techniques
alternatives. Seules des sondes de chlorure de polyvinyle marquee au barium
(sonde French no. 3,5 et 5.0) ont ete
utilisee. Les indications les plus frequentes etaient le syndrome de detresse respiratoire, I'asphyxie et les maladies cardiaques congenitales. Des 100 bebes, 75
pesaient moins de 2500 g.
Les medicaments les plus frequemment perfuses par cette voie sont I'ampiciline et le calcium (chez 70 et 65 bebes
respectivement). On a enregistre trois
complications serieuses. dont deux cas
de gangrene des membres inferieurs
necessitant I'amputation d'un pied dans
un cas et celle des orteils dans I’autre.
La troisieme complication fut I'apparition
d'une necrose du muscle fessier. Dans
ces trois cas, le catheter etait place bas
et il s'agissait d'une perfusion d'ampicilline. Du calcium etait aussi administre a
deux de ces enfants. Des complications
benignes ont aussi ete observees dans
32 cas, les spasmes vasculaires des
membres inferieurs etant les plus frequentes.
Toutes les extr6mites de catheters ont
ete cultivees; on a constat^ une coloni
sation bacterienne dans 1 3 % des cas. Le
Staphylococcus epidermidis fut le
microorganisme le plus frequemment
isole. Une enterocolite necrosante fut
diagnostiqube positivement chez huit
enfants et soupgonn£e chez huit autres.
La paleur de la peau est un signe serieux
qui fut observe chez les trois bebes qui
ont souffert de complications graves.

Dans ce cas, la perfusion doit etre arret6e immediatement. Le catheter devrait
etre retire dfes qu'on soupconne une
enterocolite necrosante.

Umbilical artery catheterization has
become a common procedure in neona
tal intensive care units. It is easily per
formed and provides a useful access for
blood sampling, blood-pressure monitor
ing, infusion of fluid and medications,
exchange transfusion, cardiac catheteri
zation and angiography.1-5
Complications of the procedure are
being reported increasingly frequently.
They include death,6 th rom bosis,7’8
infection,3 visceral gangrene and perfo
ra tio n ,6 hem orrhage,9,10 em bolism ,11
hypertension,12,13 necrotizing enterocoli
tis,114 aortic aneurysm,15,16 peritoneal
perforation with bleeding,17 paraplegia,18
foot drop,19 osteomyelitis,20 refractory
hypoglycemia,21 vesicoumbilical fistula,22
visceral herniation through the umbilical
ring,23,24 urinary ascites,25 and gluteal
necrosis and others.26,27 The incidence of
major complications is reported to be
from 1.5% to 30% .1,11,14 Minor compli
cations such as blanching from vascular
spasm are more common.28
We reviewed the records of 100 con
secutive newborns who underwent umbil
ical artery catheterization. Our purpose
is to discuss the indications for the proce
dure and its complications, the warning
signs of major complications and preven
tive measures and alternative techniques.

Methods
At the Children’s Hospital o f Eastern
O ntario in Ottawa, 100 consecutive
infants (41 girls, 59 boys) who had umbil
ical artery catheterization were reviewed.
O f these, 75 infants weighed less than
2500 g. The most common indications for
the procedure were for sampling of blood
and infusion of fluids and medications
(Table I). The most common conditions
requiring catheterization were respiratory
distress syndrome, asphyxia, congenital
heart disease, pneumothorax, sepsis,
hyperbilirubinemia and meconium aspi
ration (Table II).
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In all cases polyvinylchloride bariumimpregnated catheters (Argyle; Sherwood
Medical Industries, Inc., St. Louis, Mo.)
were used. In 81 cases the size of catheter
was not recorded, but in 10 infants no.
3.5 French was used and in 9, no. 5
French.
The position o f the catheter was low
(below L2) in 60 infants, intermediate
(from T12 to L2) in 28 and high (above
T12) in 12.
Cultures of the catheter tip grew organ
isms in 13 cases: Staphylococcus epidermidis in 9, Enterococcus in 2, Staphy
lococcus aureus in 1 and a-hemolytic
streptococcus in 1.
There were 3 major and 32 minor com
plications. Major complications included
gangrene o f the right foot and the right
leg and left gluteal necrosis. Minor com
plications included blanching cyanosis
and discoloration o f foot and toes. All
resolved completely after removal o f the
catheter.
In one case, minor umbilical bleeding
was easily controlled.

Findings
M ajor Complications
Case 1.—A boy born after 40 weeks’ gesta
tion had Down’s syndrome, respiratory distress
syndrome and meconium aspiration. The birth
weight was 3140 g. A no. 5 French umbilical
artery catheter was introduced at 12 hours of
age. It was initially positioned at T il (high
position) but was repositioned at L3-4. A 10%
dextrose solution with calcium and ampicillin
added was infused through the catheter, which
was also used for blood sampling. After 12
hours, blockage and persistent blanching in the
right foot prompted removal of the catheter.
A second catheter was introduced, and the
same medications and solution were infused
when the blanching had subsided. A few hours
later recurrent blanching of the right foot
occurred with increasing cyanosis. Because of
decreased pulses in the right leg with ischemia,
the catheter was removed. Angiography was
not done. Despite removal of the catheter,
there was progressive ischemia. Thrombectomy
was not considered to be indicated. The
catheter tip was sterile on culture. Gangrene
of the right foot (Fig. 1) necessitated belowknee amputation. Heparinization was not con
sidered desirable because of the risk of cerebral
hemorrhage.
Case 2.—This girl was born at 31 weeks’
gestation. She weighed 1680 g and was the
first of twins. She had severe respiratory dis
tress syndrome, congenital heart disease and
bilateral pneumothorax. Umbilical artery
catheterization was performed for blood sam
pling and infusion of fluids at 3 hours of age.
The catheter was initially positioned at T9. It
was later positioned lower, just below the aortic
bifurcation in the left iliac artery. A few hours
later it was again repositioned at L3. All the
while, 10% dextrose solution with calcium and
ampicillin was infused. Sodium bicarbonate,
packed cells and fresh frozen plasma were also
infused. Two days later the catheter became
completely blocked. It was changed and posi
tioned at L3-4. Persistent blanching and cya
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nosis developed in both legs. Twenty-four
hours later, decreased pulses in the right leg
and definite ischemia required removal of the
catheter; gangrene in the right fourth and fifth
toes (Fig. 2) necessitated amputation. Contrac
tures of the calf with foot drop subsequently
improved with physiotherapy.
Angiography was not done. The tip of the
catheter was sterile on culture.
Case 3.—This male infant of 42 weeks’
gestation had a birth weight of 3160 g. Meco
nium aspiration developed with severe
asphyxia, right pneumothorax, seizures and
myotonic dystrophy. An umbilical artery
catheter (no. 5 French) was inserted at 2 hours
of age. Initially the catheter was found to be
in the left side but it had not reached the com
mon iliac artery. It was advanced to L5-6 some
hours later. The next day the catheter became
blocked so a new one (no. 3.5 French) was
inserted. Initially the catheter was at T11 and
was repositioned at L3.
From the beginning there was recurrent
blanching in the left buttock.
The catheter remained in position for 3 days,
during which time 10% dextrose solution,
ampicillin, calcium, sodium bicarbonate,
Lasix, phenobarbital and fresh frozen plasma
were infused through it. When it became obvi
ous there was ischemia of the left buttock, the
catheter was removed.
An ulcer developed in the buttock (Fig. 3)
and subsequently healed slowly. The tip of the
catheter was sterile on culture.

Necrotizing Enterocolitis
O f the 100 cases, 8 had proven
necrotizing enterocolitis with a typical
clinical picture and pneumatosis intestinalis. Eight cases o f necrotizing
enterocolitis were suspected clinically but
not confirmed radiologically. In all 16,
the catheters were in the low position at
L3-4 and were removed promptly.

Discussion
About 300 newborns are admitted to
our neonatal intensive care unit each year.
About one third require intubation and
assisted ventilation. On average, 66
umbilical artery catheters are inserted
each year, mostly by residents and fellows
in neonatology. Careful aseptic technique
is used and care is taken not to damage
the arterial intima. All catheter positions
are checked radiologically.
Som etim es catheters are placed
between T8 and T12 but we prefer to
place them between L3 and L5. Twentyeight o f our catheters lay between T12

Table 1-Medications and Solutions
Infused in Umbilical Artery Catheter
Medicationfsolution
10% dextrose
Ampicillin
Calcium
Fresh frozen plasma
Potassium chloride
Sodium bicarbonate
Packed red cells
Furosemide
Aminophylline
Cloxacillin
Prostaglandin E,
Phenytoin

No. of
cases
100
70
65
24
12
17
16
5
5
2
2
1

Table 11-Diagnoses in 100 Cases of
Umbilical Artery Catheterization
No. of
Diagnosis
cases
Respiratory distress syndrome
81
Asphyxia
25
Congenital heart disease
21
Pneumothorax
15
Sepsis
11
Hyperbilirubinemia
8
Meconium aspiration
6
Hypoglycemia
3
Hypocalcemia
3
Disseminated intravascular
coagulation
2
Hydrocephalus
2
Hemangiomatosis with heart failure
1
Diaphragmatic hernia
1
Di George syndrome
1

FIG. 1—Case 1. Gangrene o f right foot
which required below-knee amputation.

FIG. 2—Case 2. Gangrene o f right fourth
and fifth toes required amputation. Contrac
ture of calf improved with physiotherapy.
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and L2 and their position was classed as
intermediate.
There has been discussion as to the best
position of umbilical artery catheters.4,5
Most reports suggest that while compli
cations are fewer with a high position of
the catheter tip, they are more serious
since thrombosis may affect the celiac,
mesenteric and renal arteries.2,14,28
Low placement results in more compli
cations but they tend to be less serious.
They may be due to differences in blood
flow and velocity in the thoracic and
abdominal aorta. Upward propagation of
a low thrombus has been reported.2,4 It
is of interest that in our three babies with
major complications, the catheter was ini
tially in the high position before being
changed to the low position. Of the 32
infants with minor complications, 5
catheters were in the high position, 6 in
the intermediate and 21 in the low
position.
We did not see any visceral or aortic
thromboses nor have we seen any cases
of renal thrombosis or of hypertension.
We do not use heparin since it has not
been shown to affect the incidence of
thrombosis or embolism.7,14,28 Also, we
do not use antibiotics prophylactically
because they have not been shown to
decrease the frequency of positive blood
culture or of catheter-tip infection.28
They may result in the development of
resistant strains and may delay normal
colonization of the intestine and increase
the risk of fungal infections. In 13
catheter tips, organisms were cultured.
The frequency of positive cultures has
been reported to range from 6% to
55%.3,20 We routinely cultured all the
catheter tips when they were removed or

FIG. 3—Case 3. Gluteal ulcer healed slowly
with conservative management.

changed. Cultures were negative in our
three cases of major complications.
We continue to use the commercially
available polyvinylchloride umbilical
catheters in sizes 3.5 and 5 French. The
throm bogenicity o f these b arium impregnated catheters is well known but
no other practical type of catheter is avail
able for umbilical artery catheteriza
tion2,29 and about 120 000 o f these
catheters are sold each year in the United
States alone.30
The barium impregnation for radiologic identification of the catheter seems
to be the major factor in thrombus for
mation.29 It is surprising that while bet
ter catheters of Silastic are available for
central venous can n u latio n , v en 
triculoperitoneal shunts and nasogastric
tubes, they are not for umbilical artery
catheterization, particularly when this
catheter is placed in a vessel as important
as the aorta.
Nasogastric tubes (infant type) should
never be used for umbilical artery
catheterization because of a higher inci
dence of thrombus formation. An endhole catheter is preferred because there is
no dead space at the d p .2
The size of the catheter is not crucial.
Indeed, higher complication rates have
been reported with the no. 3.5 French
than with the size 5 French catheter.5,17
The infusion of medications and hyper
osmolar solution is an important factor
in producing complications.4,5,8,14,26,28,29
Our three infants with major complica
tions all had several medications infused.
Ampicillin, calcium and sodium bicar
bonate are especially dangerous when
injected intra-arterially.31 In fact, these
medications are the commonest to be
infused through umbilical artery catheters
in neonatal nurseries. All our infants who
had minor complications had ampicillin,
calcium and sodium bicarbonate infused
alone or in combination with other drugs.
In view of the possible complications,
the indications for umbilical catheteriza
tion should be carefully assessed. The
umbilical arteries in a newborn infant are
readily available and because cannulation
is easy, this procedure is often overused
and its dangers are underestimated. It is
true that it provides quick access for
monitoring, sampling arterial blood and
infusing medications. While the benefits
may outweigh the risks,1,28,30 in general
a safer way to sample arterial blood
should be used. New, improved, per
cutaneous catheters (Angiocath, Medicath) are now available in small sizes. It
is possible to cannulate the radial and
posterior tibial arteries, the dorsalis pedis
artery and small branches of the temporal
arteries in even premature babies. Cer
tainly these procedures are not without
complications and are technically more
difficult; nevertheless, they should be

used instead of umbilical artery catheteri
zation if possible.
The infusion of hyperosmolar solutions
and medications should be reserved only
for cases in which a vein cannot be cannulated. This almost never occurs in a
recently born baby with unused veins.
There is no place for infusion of total
parenteral solutions through an umbili
cal artery catheter.2,29,31
Umbilical artery catheterization should
never be maintained for longer than
necessary. When other routes are avail
able, the catheter should be removed.
Manipulation of the catheter should be
avoided. In our three babies with major
complications, the catheter had been
repositioned. The catheter should also be
removed promptly when a complication
is suspected, for example when there is
blanching, if necrotizing enterocolitis is
present or suspected, or if the catheter is
blocked or the flow has decreased.
When thrombosis is suspected, it is use
ful to perform angiography through the
umbilical artery catheter before it is
removed.4,6,14
Pediatric surgical consultation should
be requested early if thrombosis or bleed
ing is suspected. In some cases thrombec
tomy or embolectomy can be performed.
The pediatric surgeon can also help when
vascular access is difficult and is urgently
required. Peripheral venous cutdowns are
safer than umbilical artery catheterization
for infusion of medications or intra
venous solutions. When peripheral hyper
alimentation is not possible, a central
venous line can be inserted and when
arterial blood gases cannot be measured
percutaneously or through a capillary ves
sel, a peripheral arterial cutdown can be
performed.
With the advent of new and more effi
cient percutaneous oxygen and carbon
dioxide monitoring, arterial blood sam
pling for gases in the newborn may
become unnecessary.
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A postmenopausal woman with a pelvic mass will require early opera
tion. Uterine endometrial sampling, barium enema, and the cervical
Pap smear are steps used to determine whether the tumor is arising
primarily in an ovary, or whether the mass could represent metastatic
disease from colon, cervix, or endometrium. Pyelography is used to
identify possible ureteral compression or deformity of the urinary blad
der secondary to the mass. Laparoscopy is not indicated because it will
not add important information. Biopsy through the laparoscope would
not be indicated.
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Single-Layer Large-Bowel Anastomosis:
a Report of 250 Cases
Single-layer mucosa-excluding intestinal
anastomoses involving the large bowel
were evaluated in 249 patients (250
procedures). All patients operated on
electively had mechanical bowel prepara
tion but not all received antibiotics.
Forty-nine anastomoses were performed
as part of emergency procedures in
which antibiotics were given
intravenously. Three leaks were noted in
two patients, a rate of 1.2% . There
were no deaths attributable to anasto
motic dehiscence. These results compare
favourably with both hand-sewn and sta
pled anastomoses described in the liter
ature.
L'anastomose du gros intestin par suture
en monocouche (excluant la muqueuse)
a ete evaluee chez 249 patients (dans
250 interventions). Tous les patients
operes de facon non urgente ont subi
une preparation mecanique de I'intestin
mais tous n'ont pas recu d'antibiotiques.
Quarante-neuf anastomoses ont ete
effectuees en urgence sous la couverture
d'antibiotiques intraveineux. Trois fuites
ont ete notees chez deux patients pour
un taux de 1.2%. Aucun deces attribuable a une desunion des sutures n'a ete
enregistre. Ces resultats se comparent
favorablement avec ceux des anastomo
ses avec suture manuelle ou a I'agraffe
decrits dans la presse medicale.

Anastomotic dehiscence in colorectal sur
gery is a dreaded complication. Morbidity
is increased and approximately one third
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of deaths following colorectal procedures
are the result of leaking anastomoses.1,2
Factors contributing to dehiscence are
both local and systemic. Adequate
mechanical preparation, good blood sup
ply and absence of tension rank as the
most important prerequisites for uncom
plicated healing.3-5 Anemia, jaundice,
advanced age and poor nutritional status
militate against satisfactory healing.1-4A
further factor, having nothing to do with
technical expertise is the method of
anastomosis used.
Multiple-layered serosa-to-serosa appo
sition has remained the standard method
of intestinal anastomosis since it was first
popularized by Lembert in 1825. Halsted6 and others have encouraged use of
single-layer techniques but they have
not been widely accepted in North
America.7 Reported here is our experi
ence with a one-layer mucosa-excluding
anastomosis of the large bowel.
Patients and Methods

The case records of 249 patients (148
male, 101 female) who underwent
colorectal surgical procedures (Table I)
between 1969 and 1982 were analysed.
The patients ranged in age from 1 month
to 94 years with over 50% being more
than 60 years old. Twelve patients were
T a b le 1— P ro c ed u re s P erfo rm e d
P roced ure

N o.

R ig h t h e m ic o le c to m y
T ra n s v e rs e c o le c to m y

67
14

S u b to ta l c o le c to m y
lle o re c ta l a n a s to m o s is
C eco sigm oid a n a s to m o s is
L e ft c o le c to m y

11
5

P rim ary a n a s to m o s is
H a rtm a n n 's closure
C olo tom y

122
29

T o ta l

250

under 1 year of age. Forty-nine proce
dures were performed as emergencies for
bleeding, obstruction or acute inflamma
tory process. Carcinoma was present in
189.
Not all patients operated on electively
received antibiotics before operation.
From 1976 an antibiotic regimen was
instituted in which orally administered
antibiotics were included with mechani
cal preparation. This included a bulk-free
diet for 3 days, cleansing enemas until
return was clear 2 days before operation
and preoperative sigmoidoscopic cleaning
of the rectosigmoid region. When semiobstructing or emergency situations
prevented adequate and thorough
mechanical cleansing, broad-spectrum
antibiotics, covering both aerobic and
anaerobic organisms, were given
intravenously.
Silk and cotton sutures were used for
the first 4 years. Polyglycolic acid deriva
tives have been used exclusively since
then.
The technique is illustrated in Fig. 1.
The mucosal layer is excluded, but
meticulous care is taken to ensure that the
muscularis mucosae is included in each
bite. Sutures are placed 4 to 5 mm apart,
at a depth of 5 to 8 mm from the cut edge.
Sutures are tied only after all in the
posterior row are in place. This ensures
precise alignment, limiting discrepancies.
Anterior sutures are tied as they are

2

FIG. 1—One-layer mucosa-excluding
anastomosis.
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placed. After the occlusion clamps are
removed, the large bowel is filled with air
to evaluate the integrity of the anastomo
sis. Drains have not been used routinely.
Sump drains have been placed in the
pelvis following a low anterior resection,
taking care to avoid direct contact with
the anastomosis. An 84-year-old man,
who underwent a low anterior resection,
had a proximal colostomy for decom
pression.
Anastomotic dehiscence was diagnosed
when there was fecal drainage from the
sump tube or through the incision. A
fever, unexplained by respiratory, urinary
or wound infection was thought to be an
anastomotic dehiscence until proven
otherwise. Contrast studies with either
barium or Gastrografin were not per
formed unless the possibility of an anasto
motic leak had to be excluded.
Results
Clinically, three leaks (1.2%) occurred
in two patients; one patient experienced
two leaks in separate operations. All leaks
involved operation on the left colon or
rectum. Spontaneous closure on two
occasions resulted from nonoperative
measures. Feculant drainage through
sump drains was the initial manifestation
of dehiscence in two instances while in the
third a fecal fistula developed through the
wound. One year after closure of a fistula
a 50-year-old man experienced constipa
tion which was secondary to anastomotic
stenosis as confirmed by roentgenography
after barium enema. Subsequent revision
of the anastomosis by a longitudinal tran
section across the stenosis led to further
breakdown. This was an obvious error in
choice of procedure. A diverting left
transverse colostomy was performed sub
sequently with a smooth recovery and
closure of the colostomy 3 months later.
The two patients who had anastomotic
dehiscence are well 6 and 9 years later
respectively.
No complications attributable to
anastomotic leak occurred in the remain
ing 247 patients. There were eight deaths
within 3 months of operation: two
octogenarians died of myocardial infarc
tion within 1 week of operation. Cardiac
disease was confirmed at autopsy as was
the integrity of intestinal anastomosis. Six
patients died of malignant disease with
extensive liver metastases, inanition and
pneumonia.
The wound infection rate was 10.6%;
two cases were classified as having major
wound infections with abscess formation.
Delayed primary closure has been prac
tised increasingly since 1977, with a result
ing decrease in wound infection. This
coincided with widespread use of paren
teral antibiotics preoperatively. One
patient had a gunshot wound to the abdo
men which necessitated transverse colec

tomy, proximal colostomy and distal
mucosal fistula. Following this, a left subphrenic abscess developed; this was
drained. Continuity of the colon was re
established without complication 6
months later. Of three patients with
splenic injuries one required splenectomy
and the others were controlled by
hemostatic means. Postoperatively acalculous cholecystitis developed in a
78-year-old woman who had done well
following colectomy. A small-bowel
obstruction secondary to adhesions
required operation for lysis. Culture
positive pneumonia developed in 8
patients while significant urinary tract
infection occurred in 10 patients, who all
had indwelling catheters.
Discussion
The long-practised method of inverting
cut edges of bowel in anastomosis presup
poses that the junction of the two serosal
layers provides the most secure healing.
German surgeons in the late 1800s took
Lembert’s concept in stride and the
inverting two-layer anastomosis became
standard surgical practice. It was Flalsted6
who recognized that the submucosa of the
intestine is the only layer of the intesti
nal wall that has sufficient tensile strength
to maintain an anastomosis. Fie suggested
that a single-layer anastomosis, including
all coats except mucosa, was the ideal.
Interest in the one-layer technique was
sporadic for the next 50 years. Gambee
and associates,8 in 1956, reported on 10
years’ experience with the single-layer
through-and-through technique that now
bears his name. Emphasis, however, was
placed on inversion of the cut edges and
on the serosa-to-serosa approximation.
The end-on mucosa-excluding anasto
mosis we describe was first reported by
Jourdan.9 Evidence that this technique
compares favourably, in terms of leakage
rates, with the traditional two-layer
anastomosis is accumulating.7,10'14 Evalua
tion in the laboratory has clearly demon
strated the superiority of the one-layer
technique. Earlier revascularization,
increased collagen concentration and ten
sile strength after postoperative day 5 are
all factors considered conducive to heal
ing.15'21 The single-layer technique results
in less tissue strangulation, and dec
reases in edema and inflammatory re
sp onse.15"17,22 Reduction of lum inal
diameter is less with the single-layer than
with the two-layer anastomosis.15' 18 Fur
thermore, the one-layer anastomosis can
be carried out more expeditiously with
less tissue trauma and vascular interfer
ence.17 Anastomotic edges are approxi
mated more accurately, favouring earlier
secure healing.
Conclusions
The clinical leak rate with single-layer

mucosa-excluding anastomosis in our ser
ies was 1.2%. To our knowledge this is
the lowest rate reported that was of clin
ical importance. We believe that the use
o f this technique should be encouraged.
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Transluminal Angioplasty: Results in High-Risk Patients With
Advanced Peripheral Vascular Disease
The role of percutaneous transluminal
angioplasty in treating advanced
peripheral vascular disease is unknown.
The authors therefore reviewed the
experience of Sunnybrook Medical
Centre in Toronto with 85 consecutive
patients who had rest pain, ulceration,
pregangrene or gangrene as a result of
peripheral vascular disease and who
underwent percutaneous transluminal
angioplasty. Seventy-four percent were
smokers and 91% were at increased risk
due to one or more of the following:
coronary or cerebral ischemic disease,
diabetes mellitus, obesity and hyperten
sion. Thirty-six patients underwent dila
tation of iliac lesions, 46 of superficial
femoral or popliteal and 3 of more distal
lesions. In nine patients angioplasty was
repeated on the same lesion. In 16
patients, the procedure was technically
unsatisfactory. The morbidity and 30-day
mortality were 5% and 2% , respectively.
When the procedure was technically
satisfactory, surgery was avoided and
the limb was salvaged at 1, 2 and 5
years in 69 % , 62% and 54% of cases,
respectively (life-table analysis). The
authors conclude that percutaneous
transluminal angioplasty is acceptable
treatment for patients with advanced
peripheral vascular disease, because the
morbidity and mortality are low and the
long-term results are good.
On ignore quel role exact peut jouer
I'angioplastie transluminale percutanee
dans le traitement des maladies vasculaires peripheriques avancees. En conse
quence, les auteurs ont analyse I'experience accumulee au Sunnybrook Medical
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Centre de Toronto lors du traitement de
85 patients consecutifs qui souffraient
de douleur au repos, d'ulceration, d'un
etat pre-gangreneux ou de gangrene,
consecutivement a une maladie vasculaire peripherique, et qui subirent une
angioplastie transluminale percutanee. II
s'agissait de fumeurs dans 74% des cas
et 91% presentaient un risque accru relie
a une maladie coronarienne ou & une
ischemie cerebrate, au diabete, et a
I'obesite ou I'hypertension, ou les deux.
Trente-six patients ont subi une dilata
tion d'une lesion iliaque, 46 de lesions
superficielles femorales ou poplitees et 3
de lesions plus distales. Chez neuf
patients, une deuxieme intervention fut
necessaire pour la meme lesion, [.'inter
vention fut techniquement insatisfaisante
dans 16 cas. La morbidite et la mortalite
a 30 jours furent de 5% et 2% respectivement. Avec une intervention techni
quement correcte, la chirurgie put etre
evitee et le membre sauvegarde pendant
1, 2 ou 5 ans dans 69% , 62% et 54%
des cas respectivement (analyse par la
methode des tables actuarielles). Les
auteurs concluent que I'angioplastie
transluminale percutanee doit etre envisagee pour tout patient souffrant de
maladie vasculaire peripherique avancee
puisque la morbidite et la mortalite sont
faibles et que les resultats a long-terme
sont bons.

Although the technique of percutaneous
translum inal dilatation of arterial
stenoses, using a series of coaxial
catheters, was introduced by Dotter and
Judkins in 1964,1 it was not until 10
years later, when Griintzig and Hopff2
developed the double-lumen balloon
catheter, that the procedure gained
widespread acceptance. Since then, per
cutaneous transluminal angioplasty has
been shown to reduce symptoms in
patients with peripheral vascular dis
ease.3'5 It compares favourably in the
short-term with surgical bypass.6 It has
also been advocated as an adjunct to sur
gery.7 However, its role in the treatment
of peripheral vascular disease is not yet
clearly defined. Many studies report only
short-term follow-up, results have been
inconsistent and the usefulness of the

procedure for limb salvage in patients
with advanced ischemic changes has not
been specifically studied.
The purpose of this study was to review
the experience at Sunnybrook Medical
Centre, University of Toronto, with per
cutaneous transluminal angioplasty per
formed over 5 years in 85 consecutive
patients with advanced peripheral vascu
lar disease.
Methods
The hospital and office charts of 85
consecutive patients (55 men, 30 women)
who underwent percutaneous translumi
nal angioplasty for advanced peripheral
vascular disease at Sunnybrook Medical
Centre between December 1978 and July
1983 were reviewed. The mean age of the
patients was 67 years (ranging from 43 to
91 years). Advanced disease was defined
by the presence of rest pain, ulceration,
pregangrene or gangrene in the affected
limb. Patients who were living at the time
of follow-up returned to the vascular
clinic for assessment. Follow-up history
for patients who died was obtained from
family members.
Transluminal angioplasty was per
formed by one of two radiologists (E.S.
or S.W.) using a standard no. 7 or 9
French balloon dilatation catheter and
standard technique. Balloon diameter
ranged from 4 mm to 10 mm, depending
on the size of the vessel to be dilated.
H eparin sodium, 5000 units, was
administered intra-arterially after the
catheter was passed through the lesion.
For 2 days before and for 6 months after
the procedure, all patients received acetylsalicylic acid (325 mg twice daily) and
dipyridamole (50 mg twice daily). Acetylsalicylic acid (325 mg twice daily) was
then prescribed indefinitely.
Angioplasty was repeated as required
at the discretion of the attending physi
cian. Every angiogram was reviewed
retrospectively by a radiologist who was
unaware of the clinical findings. Note was
made of the site of the lesion, percent ste
nosis, length of the lesion, pressure gra
dient across the lesion before and after
angioplasty (when measured) and any
complications.
Immediate technical failure occurred
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when the artery could not be cannulated,
the catheter could not be advanced to the
site of the lesion or across it, or when
there was immediate thrombosis.
Clinical failure of the procedure was
accepted when the patient underwent sur
gery (sympathectomy, endarterectomy,
bypass or amputation). Repeat angio
plasty of the lesion(s) originally treated
was not considered to be failure as long
as surgery was avoided.
The difference between the pressure
gradient across the lesion before and after
dilatation was evaluated by Student’s ttest. Discriminant analysis was used to
predict technical success, based on the site
of the lesion, length of the lesion dilated
and degree of stenosis. Life-table curves
were compared for patients with stenoses
versus occlusions, iliac versus femoropopliteal lesions, lesions less than versus
greater than 10 cm long, smokers versus
nonsmokers and diabetics versus nondi
abetics, using the generalized Savage
(Mantel-Cox) test.
Findings

Follow-up data were obtained for all
patients.
Of the 85 patients, 63 (74%) were
smokers; 1 smoked a pipe only. The
cigarette smoking history ranged from 5
to 165 pack-years. Other risk factors
included hypertension in 47%, diabetes
mellitus in 34%, obesity in 33% and
hyperlipidemia in 9% of patients. Gener
alized arteriosclerotic disease was
manifest by previous myocardial infarc
tion in 33%, angina pectoris in 28%,
cerebrovascular accident in 16% and
transient ischemic attack in 9% of
patients.
The most advanced symptom was rest
pain for 47 patients, ulceration for 23,
pregangrene for 3 and gangrene for 12
patients.
The 85 patients underwent translumi
nal angioplasty of 92 lesions over the
study period. At the time of the initial
procedure, one lesion was dilated in 78
patients and two lesions in 7. Nine

patients underwent repeat angioplasty of
the lesion(s) originally treated.
The vessels treated included the aorta
(1 patient), iliac artery (36), superficial
femoral or popliteal artery (46), deep
femoral artery (1) and more distal vessels
(3 patients). One patient underwent dila
tation of a stenotic femoropopliteal
venous bypass graft.
Early Deaths
Two patients (2%) died within 30 days
of the procedure. In a 91-year-old patient
with rest pain, ulceration and gangrene,
common iliac artery angioplasty was
attempted, but the catheter could not be
advanced through the lesion. The patient
required below-knee amputation and died
of a cerebrovascular accident following
surgery. The other early death was secon
dary to myocardial infarction in a
60-year-old patient with a history of
angina and myocardial infarction who
underwent successful dilatation of the
superficial femoral artery for rest pain
and ulceration.
Successful Angioplasty
In 69 patients the procedure was tech
nically successful. Of the 69 patients, 40
(58%) were symptomatically improved,
10 (14%) were symptomatically worse
and 19 (28%) were unchanged. Fortyeight percent of these patients had return
of previously absent pulses. Seventy per
cent experienced either a lessening of
symptoms or return of previously absent
pulses, or both. In the 20 patients whose
pressure gradient across the lesion was
measured before and after dilatation, the
gradient fell from a mean of 53 mm Hg
to 6 mm Hg (p < 0.05).
Failed Angioplasty
The procedure was technically unsuc
cessful in 16 cases because the artery
could not be cannulated (1 case), the
catheter could not be advanced to the site
of the lesion (1 case) or across the lesion
(13 cases), or because immediate thrombosis
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FIG. 1—Life-table analysis of success rate
of percutaneous transluminal angioplasty.

Complications
Complications included slight over
distension of the dilated artery in two
patients, minor dissection at the puncture
site in one patient and distal vessel throm
bosis in one patient. The patient with dis
tal vessel thrombosis required below-knee
amputation but had severe pregangrenous
changes before the procedure and may
have required am putation in any case.
The other complications were of no clin
ical significance. The complication rate
was 5%.
Repeat Angioplasty
Angioplasty was repeated on the same
lesion(s) in nine patients 2 to 51 months
after the first attempt (median 6 months).
The immediate failure rate of repeat
angioplasty was 56% (five of nine patients
underwent bypass surgery or amputation
within 1 month of the repeat procedure).
However, there has been no failure of the
other four repeat angioplasties after 4 to
29 months.
Analysis o f Findings

20

0

occurred (1 case). The technical failure
rate therefore was 19%. The dilatation
failed technically in 6 of 36 iliac lesions,
9 of 46 femoral lesions and 1 of 3 more
distal lesions. These proportions were not
significantly different. Ten of the 13 cases
in which the catheter did not traverse the
lesion were from the group of 37 patients
with occluded arteries while only 3 cases
were in the 48 patients with stenotic
lesions. Again this difference in propor
tions was not statistically significant. Seven
of the 13 cases in which the catheter did
not traverse the lesion were in 70 patients
with a lesion less than 10 cm long and 6
cases were in the 15 patients with a lesion
10 cm long or longer. This difference in
proportions was statistically significant (p
< 0.04). Fourteen of the failures occurred
in the years 1979 to 1981 and only 1 tech
nical failure occurred in each of the years
1982 and 1983.
Nine of 16 patients whose procedures
were technical failures were operated
upon on an urgent basis after failed trans
luminal angioplasty. One died of unre
lated causes 8 months after angioplasty
and 6 have been followed up for from 2
to 47 months without surgery.
The patient who underwent dilatation
of a femoropopliteal venous bypass graft
required below-knee am putation 11
months after the procedure.

FIG. 2— Life-table analysis o f success rate
of percutaneous transluminal angioplasty for
diabetic versus nondiabetic patients.

When life-table analysis was used to
assess those patients whose angioplasty
was technically successful initially, 76%
of procedures were shown to be success
ful at 6 months, 69% at 1 year, 62% at
2 years and 54% at 5 years after
angioplasty (Fig. 1).
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Results were compared for dilatation
of iliac versus femoropopliteal lesions,
stenoses versus occlusions, lesions less
than versus greater than 10 cm long,
lesions in diabetic versus nondiabetic
patients and in smokers versus nonsmokers. A significant difference was
found only for diabetic versus nondia
betic patients (Fig. 2). For diabetics, suc
cess at 1, 2 and 5 years was 55Vo, 45Vo
and 30Vo versus 77Vo, 75Vo and 74Vo
respectively for nondiabetic patients (p <
0.02). There was no failure in the nondi
abetic group after 13 months of follow
up, while in the diabetic group, failures
continued to occur up to 36 months after
the procedure.
Discussion
The role of transluminal angioplasty in
treating patients with peripheral vascular
disease is still evolving.8
If transluminal angioplasty is safe and
effective, its advantages over surgery are
many. The procedure is simple, quick and
cheaper, it preserves the saphenous vein
and creates no soft-tissue distortion to
jeopardize the results of future surgery in
case the procedure fails or the disease
progresses.8 Postponement of bypass
surgery or amputation for a few months
or years may be all that is necessary since
these patients often have a short life
expectancy because of advanced age,
generalized arteriosclerosis, diabetes or
obesity. Angioplasty may obviate the
need for further intervention in some
patients. Flowever, bypass or amputation
can still be performed if necessary.
Our study population comprised
patients with rest pain, ulceration,
pregangrene or gangrene, most of whom
would have required surgical bypass or
amputation had angioplasty not been
available. This assumption is supported
by the urgent surgical bypass and ampu
tation rate of 56Vo in patients whose
angioplasty was technically unsuccessful.
There are several reasons why all patients
whose angioplasty was technically unsuc
cessful did not require immediate surgery.
First, despite failure of the balloon
catheter to cross the lesion, in many cases
a guide wire was successfully passed and
may have afforded some clinical improve
ment. Further, the placebo effect, which
produces clinical improvement in some
patients after any sham treatment, may
have accounted for the avoidance of sur
gery in some cases.
The mortality of 2Vo and the compli
cation rate of 5 Vo in this series illustrate
the relative safety of translum inal
angioplasty and compare favourably with
rates reported by others,3‘7'9'10 particu
larly in view of the high-risk population
we studied. Furthermore, the mortality
and complication rates reported here are
152

lower than those in a report of 20 differ
ent series of bypass operations on patients
at less risk and with less-advanced dis
ease.8 The technical failure rate of 16Vo
in this series is also acceptable.6 Long
lesions (more than 10 cm) were more
likely to produce technical failure, usually
because the catheter could not be
advanced across the lesion. The techni
cal failure rate is expected to be much
lower in future, since, of 16 such failures,
14 occurred before 1982. This reflects the
improved technical skill of the radiolo
gists and better selection of candidates.
Seventy-six percent of our high-risk
patients with advanced disease were
spared vascular surgery and amputation
for more than 6 months. In 62Vo of cases,
vascular surgery and amputation were
avoided for more than 2 years (by lifetable analysis, Fig. 1). These results com
pare favourably with those of other ser
ies, which included few patients with
advanced disease.10
In this study, although the majority of
patients experienced relief of symptoms
or return o f previously absent pulses, or
both, success was denoted by the
avoidance of surgery. This criterion prob
ably overestimates the success rate of the
procedure since some patients might have
refused surgery, despite unchanged sta
tus after angioplasty. However, this
proportion of patients was probably not
large since all patients in the study had
advanced disease, and it would not be
possible in many cases to postpone inter
vention because of severe symptoms or
gangrene. Other objective criteria for suc
cess such as repeat angiography, Doppler
flow studies and exercise testing were
lacking in this study. None of these
criteria, unfortunately, are ideal and the
correlation among them is not perfect.10
Doppler studies before and after
angioplasty became part of the routine
office work-up of all vascular patients in
1983 but there were insufficient data to
assess the results.
Published series of patients who
undergo bypass surgery for limb salvage
have reported patency rates at 2 and 3
years of 18Vo to 68Vo, depending on the
anatomic site of the bypass and the con
duit used (saphenous vein, human umbil
ical vein or polytetrafluoroethylene).11'12
Obviously these series are not strictly
comparable to ours but they do indicate
that angioplasty is a reasonable alterna
tive to surgery.
It has previously been reported that
success rates for transluminal angioplasty
depend on the calibre of the vessel
treated.3-5>1° The results of dilatation for
iliac artery disease have been better than
those for femoral artery or more distal
disease. This difference was not demon
strated in our series. Similarly, no differ
ence in success rates for the procedure

were found for stenoses versus occlusions
or smokers versus nonsmokers. Although
trends were evident, the lack of a signifi
cant difference between groups was most
likely due to the small numbers of patients
compared in subgroups.
Diabetics fared less well than nondia
betics (Fig. 2). The 1-year success rate
for diabetics was 55% versus 77% for
nondiabetics. At 5 years, the success rate
for diabetics was 30% versus 75% for
nondiabetics (p < 0.02).
Our success rate for repeat angio
plasties of 44% at follow-up, ranging
from 4 to 29 months, indicates that repeat
dilatation of the same lesion may further
postpone surgery if angioplasty fails ini
tially.
Conclusions
In a large group of high-risk patients
with advanced peripheral vascular dis
ease, percutaneous transluminal angio
plasty was associated with a low mor
bidity and mortality. The procedure was
successful in avoiding surgery and ampu
tation for more than 5 years in the
majority of patients. For patients who are
at high risk for surgery or who might
otherwise require amputation, percutane
ous transluminal angioplasty should be
considered as treatment for those with
dilatable lesions.
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Effects of Abdominal Aneurysmectomy, Aortoiliac Bypass
Grafting and Angioplasty on Male Sexual Potency:
a Prospective Study
The preoperative frequency and
postoperative status of male sexual
potency was studied prospectively in 46
patients who underwent abdominal aortic
aneurysmectomy, aortoiliac and aortofemoral bypass grafting, or percutaneous
transluminal angioplasty of the iliac
artery. The patients with aortic
aneurysms were older; approximately
half of them were potent. The frequency
of impotence was highest in patients
who underwent aortoiliac bypass, and
correlated well with their low penile to
brachial pressure index. Patients who
had angioplasty had more localized
lesions, a higher penile to brachial pres
sure index and the lowest rate of impo
tence. Postoperatively, 13% of the
patients regained nocturnal erection and
10% became functionally potent (defined
as the ability to achieve penetration).
The improvements were similar in bypass
and angioplasty patients. No patient
experienced deterioration in sexual
potency and all showed a markedly
improved thigh to brachial pressure index
postoperatively. Routine aortoiliofemoral
artery angiograms were of limited value
in predicting the status and outcome of
sexual potency in this series of patients.
On a etudie de fagon prospective la viri
lity pre- et postoperatoire de 46 hommes
qui ont subi soit une anevrismectomie de
I'aorte abdominale, soit un pontage
aorto-iliaque ou aorto-femoral, ou encore
une angioplastie transluminale percutanee de I'artere iliaque. Les patients souf-
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frant d'anevrisme aortique etaient plus
ages; environ la moitiy d'entre-eux possedaient encore leur virility. La frequence
de I'impuissance sexuelle etait la plus
elevye chez les patients qui ont subi un
pontage aorto-iliaque et montrait une
bonne correlation avec I'index tensionnel
penis-bras. Les patients soumis a
I’angioplastie avaient des lesions plus
localisees, un index tensionnel penisbras plus eleve et presentaient le plus
faible taux d'impuissance. Apres I'intervention, 13% des patients ont recouvre
la possibility d'avoir une erection noc
turne et 10% etaient redevenus fonctionnellement virils (cet etat etant defini
d'apres la capacity de reussir la penetra
tion). Le pontage et I'angioplastie ont
procury des amyiiorations identiques.
Aucun patient n'a vu sa puissance
sexuelle se deteriorer des suites de I'operation et tous ont montry une nette ame
lioration de I'index tensionnel cuissebras. L'angiogramme des arteres aortoilio-femorales pratique de fagon systematique a ete de peu d'utilite pour predire
I'etat, puis I'amyiioration de la virilite
chez ces patients.

Since Leriche described male impotence
secondary to aortic occlusive disease in
1940,1 the anatomy and physiology of
male sexual function has been elucidated
in great detail. The effects of aortoiliac
reconstruction on male potency have been
described by many authors.2-8 The prin
ciples of nerve-sparing dissection of the
aortoiliac system and of maintaining the
patency of and flow to the internal iliac
arteries are well established. Nevertheless,
the ability to restore potency to patients
who are impotent because of vascular
inadequacy varies widely with different
series.
The development of percutaneous
transluminal balloon angioplasty to treat
occlusive arterial disease creates an
opportunity to study vasculogenic impo
tence from another viewpoint. There is no
question of operative neural damage with
this technique, and using penile blood
pressure available through the Doppler
technique we can estimate the increase in

pelvic blood flow. This group can then
be compared to the more conventional
group of patients who have undergone
operative vascular reconstruction.
We prospectively studied patients with
either abdominal aortic aneurysm or
occlusive disease of the aortoiliac system.
The patients’ sexual performance was
questioned both before and after inter
vention. We found that both angioplasty
and aortoiliac reconstruction increase pel
vic and penile blood flow. Neither proce
dure causes impotence, if the surgeon is
cognizant of such a possibility. However,
neither procedure does much to alleviate
vasculogenic impotence; clear improve
ment in our series was the exception
rather than the rule. Thus, we can
increase pelvic blood flow to some extent,
we can spare neurologic reflex arc and
sympathetic ganglia, but many patients
had disease that was too diffuse or too
distal to be amenable to our present tech
niques of aortoiliac reconstruction.
Patients and Methods
We studied prospectively 46 patients
with vascular disease, including abdomi
nal aortic aneurysms and aortoiliac and
peripheral vascular disease. There were no
insulin-dependent diabetics or psychotic
patients in the group. All emergency
aneurysmectomies and revascularization
procedures were excluded from this study.
Patients were selected for either oper
ation or for transluminal balloon angio
plasty, depending on the nature of their
occlusive disease and the opinion of the
vascular surgeon in consultation with the
therapeutic angiographer (M.H.). As a
rule, any localized lesions that were
amenable to angioplasty were dilated.
All patients were questioned in a per
sonal, private interview by the same nurse
(D.L.) who performed the vascular
laboratory studies. The study documented
the availability of sexual contact, occur
rence of nocturnal erections and ability
to penetrate the vagina. In addition to
routine Doppler vascular measurements,
thigh, brachial and penile blood pressures
were recorded and the indices calcu-
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who had performed the previous exami
nations.
The results were analysed using the
paired Student’s t-test.

lated.9 The patients then underwent rou
tine peripheral angiography which
documented the exact nature of their dis
ease and the patency of the internal iliac
arteries. Three months after operation,
the Doppler vascular studies were
repeated, the pressure indices recalculated
and the questionnaire on sexual perfor
mance was repeated by the technician

Results
The patients with abdominal aortic
aneurysms were significantly (p < 0.05)

Table I—Preoperative P o t e n c y ____________ ________
Preoperative potency,
no. (%)
Procedure

_

___

Abdominal aortic aneurysmectomy
Aortoiliac or femoral bypass
Iliac angioplasty
__

Age,
yt*

Nocturnal
erection

66.1 ± 1.8
56.5 ± 2.4
56.6 ± 2.2

T I5 4 )-

5l45)

71331
10171)

1 (5)t
6 (43)4

No. of
patients

~TF~
21
14

Penetration

"Mean ± standard error.
tNot attempted in 3 patients.
4Not attempted in 1 patient.

Table II—Correlation of Preoperative Penile to Brachial Pressure Index With Potency
No. of
patients

Potency

Penile to brachial
pressure index*_____________p value
0.68
0.44
0.76
0.46
0.69

23
23
12
30
4

Nocturnal erection present
Nocturnal erection absent
Penetration present
Penetration absent
Penetration not attempted

±
±
±
±
±

0.02
0.02
0.02
0.02
0.03

< 0.001
< 0.0001

____________

’ Mean ± SEM.

Table III -Thigh to Brachial Pressure Indices*
Postoperative

Preoperative

Right

Left

0.90 ± 0.05
0.84 ± 0.03
0.86 ± 0.05

0.80 ± 0.06
0.83 ± 0.40
0.86 ± 0.05

Left

Right

Procedure

Abdominal aortic aneurysmectomy 0.88 ± 0.06
0.63 ± 0.04
Aortoiliac or femoral bypass
0.75 ± 0.04
Iliac angioplasty

0.87 ± 0.07
0.52 ± 0.04
0.76 ± 0.05

"Figures are mean ± SEM.

Table IV-Penile to Brachial Pressure Indices*
P r o c e d u r e ____________________ Preoperative

Postoperative

p value

Abdominal aortic aneurysmectomy
0.63 ± 0.05
Aortoiliac or femoral bypass
0.50 ± 0.03
Iliac angioplasty______________________ 0.59 ± 0.05

0.64 ± 0.05
0.57 ± 0.04
0.68 ± 0.05

NS
< 0.02
< 0.01

"Figures are mean ± SEM.
NS = not significant.

Table V-Surgeon's Accuracy in Predicting Potency from the
Preoperative Angiogram
_______
Accuracy of prediction, %
Prediction
Should be potent preoperatively
Should not be potent preoperatively
Should improve postoperatively
Should not improve postoperatively

Penetration

Nocturnal
erection

33
94
11
100

44
63
17
100

Penile to brachial
pressure index
~ 56
88
61
50

older than those with aortoiliac occlusive
disease (Table I). Eleven aneurysmecto
mies, 21 aortoiliac or aortobifemoral
bypasses and 14 iliac artery angioplasties
were performed.
Using the presence of nocturnal erec
tions as a criterion of potency, we found
that only 33% of the aortoiliac group
were potent, compared with 54% of the
much older patients with aneurysms. In
the angioplasty group, 71% were still
potent. When we used actual vaginal
penetration as a measure o f potency, the
sexual dysfunction of patients in the
bypass group became even more manifest
(Table I).
The preoperative penile to brachial
pressure index correlated well with the
presence or absence of nocturnal erections
and with the capacity for vaginal penetra
tion (Table II).
When we calculated the thigh to
brachial indices for each group to docu
ment the adequacy of blood flow through
the pelvis for assessing the degree of dis
ease preoperatively and the success of the
reconstruction postoperatively, we found
as expected that the patients with the most
diffuse disease, who underwent aortoiliac
or femoral bypass grafting, had the lowest
indices preoperatively. Postoperatively,
the index was markedly improved in these
patients and those who had transluminal
angioplasty. The patients who had aor
tic aneurysms had much better preoper
ative indices, which were essentially
unchanged after operation (Table III).
The penile to brachial pressure index
was used as a measure o f changes in
penile blood flow. All patients served as
their own controls for comparison of
preoperative and postoperative indices.
The patients who underwent aneurysmec
tomy demonstrated no change, but
patients in the other tw o groups
manifested a significantly improved index
(p < 0.02) (Table IV).
Four patients in this series o f 46
improved overall, 3 who had bypass
grafting and 1 who underwent angio
plasty. They all had marked improve
ment in their postoperative penile to
brachial pressure index. Of the 23 incapa
ble of nocturnal erection before opera
tion, 3 (13%) regained that ability and of
the 30 who were known to be incapable
of penetration before, 3 (10%) regained that
capacity after operation. No patients
were made worse by the procedures.
The vascular surgeon (P .E .B .)
involved, reviewed the angiogram s
obtained preoperatively and in a double
blind fashion estimated whether the
patient was or was not potent and what
effect the operation would have on the
patient’s potency. The results (Table V)
show that the surgeon tended to be overly
optimistic in estimating function and in
estimating a good outcome. He was much
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more accurate with respect to negative
predictions.

Discussion
This prospective study of preoperative
and postoperative sexual function of a
group of patients with vascular disease
compared the results of three interven
tions, two o f which were surgical and
potentially could damage the neurologic
structures necessary for ejaculation and,
to some extent, erection. These two
procedures can also threaten pelvic blood
flow if performed without proper con
sideration for morbid anatomy. The third
procedure, percutaneous angioplasty, the
oretically can only improve pelvic blood
flow and poses no threat to the neurologic
structures involved in male sexual func
tion. We were, therefore, able to make
some interesting comparisons.
We believe that a sensitive confidential
interview was sufficiently accurate to
gauge potency. The incidence of potency
in four studies was reported as 25Vo,2
50% ,10 71 % 4 and 88% ." Our study
demonstrated one of the reasons for such
wide variability. When our patients were
questioned as to the presence of noctur
nal erections, nearly 50% of the overall
group were potent. Nocturnal erection,
because it excludes psychological factors,
had been used as the standard of clinical
evidence o f organic potency,10’12'13 but as
recent studies of nocturnal penile tumes
cence have shown, not all nocturnal erec
tions are o f the same quality.14 Thus,
when potency was defined as the ability
to achieve vaginal penetration, the func
tional potency dropped to 26% in our ser
ies. In other words, 50% of our patients
had sufficient blood flow to experience
nocturnal erections, but only 26% could
perform sexually, indicating that the
remaining patients suffered either from
a psychological inhibition or from poorquality penile erection, the latter
presumably due to inadequate blood
flow. In some patients who did not have
nocturnal erections, certain medications
such as antihypertensive drugs might have
played a role, although most of these
patients in our series were found to have
a low penile to brachial pressure index,
suggesting that the impotence was of vas
cular origin.
Because o f the difficulty in obtaining
a sufficiently accurate history, and since
fertility is unimportant in patients of this
age group, we have ignored the question
of retrograde ejaculation3 and concen
trated solely on the relation of pelvic
blood flow to erectile potency.2' 13
Others8 have demonstrated, however,
that should the hypogastric plexus of
nerves be disrupted either at the level of
the inferior mesenteric artery take-off
from the aorta or as the nerves cross
anterior to the left common iliac artery,
156

a significant incidence of retrograde
ejaculation will occur resulting in func
tional potency but, de facto, sterility.
Various techniques for measuring
penile blood flow, including the wave
form analysis,15 penile vascular resist
ance11 and absolute blood pressure, have
been used, with each investigator claim
ing superiority of his methods. We noted
a close correlation between penile blood
pressures and penile to brachial index4’16
in our patients. We calculated these
indices and compared them with the clin
ical information we had gathered. As
others6'11 have found, this index shows
significant discriminatory ability to
predict impotence. It is not foolproof and
there is a grey zone,6’11 but certainly any
patient complaining of impotence who
has a penile to brachial pressure index of
less than 0.6 probably has a vascular com
ponent.47 Our results corroborate these
earlier studies.
Our findings also show the relative
unimportance of age and the clear neces
sity of adequate pelvic blood flow for
male sexual potency. The patients who
had an abdominal aneurysm were 10
years older on average than the patients
who had aortoiliac or femoral artery dis
ease and yet their rate of impotence was
substantially lower. In addition to
attempting to augment pelvic blood flow,
we thought it essential to demonstrate
that we had achieved the principal aim of
the operations, namely, to bypass the
atherosclerotic obstruction in the aor
toiliac system. To this end, we measured
the thigh to brachial pressure indices for
each patient in this study and routinely
found significant increases in the
postoperative period, indicating the ade
quacy of the repair. The preoperative data
also demonstrated that patients with the
worst thigh to brachial and penile to
brachial indices were those selected for
aortoiliac repair.
Our patients with aneurysms demon
strated no change of pelvic blood flow
after aneurysmectomy. Their functional
capacity likewise did not change; this
agrees with several reports4,6-8 in the
literature. It is now quite clearly shown
that if patency of the internal iliac artery
is preserved and not isolated by repair,
no iatrogenic im potence should
result.3'5’7’17
The patients who had the most severely
occlusive disease (those who underwent
aortoiliac or femoral bypass grafting)
showed some improvement in the penile
to brachial pressure index (Table IV), but
only 13% improved sufficiently to have
nocturnal erections and only 10% became
functionally potent again. These results
are in marked contrast to reports that
claim a 73% return of potency.4’11
Others7 have shown a more modest
im provem ent in about 30%. The

improved penile to brachial and thigh to
brachial indices of our patients indicate
that their repairs were anatomically cor
rect. Nevertheless, it appears that the
penile to brachial pressure index would
have to increase to a level better than 0.6
for the patient to experience a notable
improvement.4,7 We suspect, as others
have, that the reason lies in more distal
occlusive disease of small vessels.13
To date, there have been few studies
reporting the results of percutaneous
transluminal angioplasty on sexual func
tion, and there are no comparisons of this
technique with the conventional surgical
approach to aortoiliac disease. Our
patients who had angioplasty certainly
had less diffuse disease. This was reflected
in their higher preoperative penile to
brachial and thigh to brachial indices and
lower incidence of impotence. However,
as with the patients who had aortoiliac or
femoral artery bypass, despite some
improvement in these indices postoperatively, demonstrated by paired analysis,
only one of the four patients with no noc
turnal erections before operation was
improved after operation and only one of
the seven patients who were incapable of
penetration before was sexually func
tional after operation. Our failure to
achieve greater success in this group of
patients reinforces our belief that the
small-vessel changes make an important
contribution to vasculogenic impotence in
many such patients.
Our results, in common with others,4
also illustrate the unreliability of routine
aortoiliofemoral angiography to supply
predictive information. Such predictions
might be improved with more selective
angiography10,11 of the pudendal arteries,
which we are doing now in some cases.
The reported short-term success of
direct pudendal vessel bypassing also sug
gests the role of small-vessel disease in
vasculogenic impotence, but the long
term results of these microvascular tech
niques have not been clearly estab
lished.10,17' 19
In conclusion, our results show that the
incidence of male sexual impotence is high
in patients with aortoiliac disease, and
contemporary vascular surgery does not
interfere with the neural mechanism
associated with erection. We can increase
pelvic blood flow, but usually not enough
to make a functional difference. Per
cutaneous angioplasty, when feasible, is
the procedure of choice because it is less
invasive, but there is no reason to believe
that it causes less iatrogenic impotence
than a careful bypass operation where
efforts are made to preserve the distal
aorta and its overlying neurologic struc
tures.
Fortunately, we rarely cause sexual
deterioration when we improve blood
flow to the lower extremities. Conversely,
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La splenectomie dans le purpura thrombocytopenique
idiopathique. Etude retrospective de 40 cas
Les auteurs ont analyse de facon retros
pective les dossiers de 40 malades soumis a une splenectomie pour purpura
thrombocytopenique idiopathique chez
qui un premier essai therapeutique aux
corticosteroTdes avait prealablement
abouti a un echec total ou partiel
(recidive). La mortalite operatoire
a ete nulle mais la morbidite. sur le
plan respiratoire en particulier, a ete relativement importante soit de 4 0 % des
cas. Un drainage chirurgical de la loge
splenique dans de telles circonstances
devrait systematiquement etre evite
puisqu'il semble clairement etre associe
a une frequence plus grande de compli
cations pulmonaires. Le suivi hematologique moyen de 30.3 mois effectue chez
37 des malades a montre un taux de
remission complete post-splenectomie de
8 9.2% . Ce resultat confirme la valeur
therapeutique de la splenectomie dans le
purpura thrombocytopenique idiopathi
que, en particulier chez les malades
ayant presente une reponse transitoire a
la corticotherapie.
The authors analysed retrospectively the
files of 40 patients who underwent
splenectomy for idiopathic thrombocyto
penic purpura and who were totally or
partially (relapse) resistant to a therapeu
tic trial of corticosteroids. There was no
operative mortality but morbidity, espe
cially respiratory, was substantial, being
4 0 % . Drainage of the splenic bed should
be avoided because this is clearly asso*Chef resident, Service de chirurgie gene
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dated with a greater frequency of pul
monary complications. In 37 patients
with a mean follow-up of 30.3 months,
there was complete remission in 89.2%
after splenectomy. This confirms the
therapeutic value of splenectomy in
idiopathic thrombocytopenic purpura,
especially in those who showed a partial
(transitory) response to corticosteroids.

Le purpura thrombocytopenique idiopa
thique (PTI) est une maladie caracterisee
par la formation d’auto-anticorps antiplaquettaires entraTnant dans le systeme
reticulo-endotheliai et plus particulierement dans la rate, une destruction prematuree des plaquettes sanguines circulantes. La corticotherapie orale constitue le
traitement initial habituel de cette mala
die, tandis que la splenectomie est generalement reservee aux malades qui resistent a un premier traitement medical ou
qui presentent des recidives. La place des
immuno-suppresseurs nonsteroldiens
dans le traitement du PTI demeure controversee; ils sont le plus souvent
employes chez les patients refractaires au
traitement medical et chirurgical.1,2
Nous avons effectue une etude retros
pective de 40 splenectomies consecutives
pratiquees chez des patients atteints de
PTI, au cours d’une periode de 10 ans. Le
but de cette etude etait d ’evaluer dans un
premier temps la morbidite et la morta
lite operatoire et, dans un deuxieme
temps, les resultats therapeutiques de la
splenectomie. Nous avons aussi tente
d’evaluer la valeur de certains elements
dans la prediction du resultat de la sple
nectomie.
Patients et methode

Les dossiers de 40 malades ayant subi
une splenectomie pour PTI entre janvier
1968 et janvier 1978 a l’Hopital du SaintSacrement a Quebec ont ete revus. La
surveillance hematologique a ete effectuee par les membres du service
d ’hematologie.
Le diagnostic de PTI a ete porte suivant quatre criteres essentiels reconnus3
soit, premierement, un decompte plaquettaire de moins de 150 x 109/L , deux-

iemement un myelogramme revelant un
nom bre norm al ou augm ente de
megacaryocytes, troisiemement une
absence d ’histoire medicamenteuse et
quatriemement une absence de splenomegalie palpable.
Un cinquieme critere diagnostique soit
la presence dans le sang circulant d ’anticorps anti-plaquettaires (IgG associees
aux plaquettes) est maintenant suggeree
dans la litterature1 meme s’il n’est pas
essentiel au diagnostic. Cette epreuve
n’etait pas offerte par nos laboratoires
durant la periode couverte par 1’etude.
Les m alades atteints de lupus
erythemateux dissemine ou chez qui une
histoire de prise medicamenteuse aurait
pu etre a 1’origine de la thrombocytopenie
ont ete elimines de l’etude.
La remission apres corticotherapie ou
apres splenectomie est definie a partir des
criteres habituels4 soit, premierement
une remission complete permanente
(numeration plaquettaire a plus de 150 x
109/L pour plus de 14 jours), deuxiemement une remission complete transitoire
(numeration plaquettaire a plus de 150 x
109/L pour moins de 14 jours),
troisiemement une remission partielle
(numerique plaquettaire maintenue entre
50 et 150 x 109/L) et quatriemement
une absence de remission (numeration
plaquettaire a moins de 50 x 109/L).
La splenectomie a ete pratiquee soit par
une incision para-mediane ou une incision
sous-costale gauche. Une recherche atten
tive de rate accessoire a toujours ete notee
aux protocoles operatoires.
Resultats

Les patients ont ete subdivises en deux
groupes, soit ceux de moins de 12 ans (7
patients) et ceux de 12 ans et plus (33
patients). L’age varie de 5 a 66 ans
(moyenne de 28 ans), avec predominance
chez la femme de 2 pour 1.
Le purpura et les ecchymoses ont con
stitue la raison de consultation chez 39
malades. Seule une patiente de 23 ans a
presente des metrorragies comme premier
symptome, sans manifestation cutanee de
sa maladie.
Chez nos 40 malades, 1’echec du traite
ment medical, soit la corticotherapie pen-
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dant une periode de 6 semaines ou plus,
a constitue l’indication de la splenectomie; 19 malades ont presente une remis
sion complete transitoire, 15 malades une
remission partielle et 6 malades n’ont
obtenu aucune remission.
Nous avons retrouve a Pexploration
abdominale, des rates accessoires chez
42.5% de nos malades. La majorite des
rates accessoires etaient uniques et de
diametre inferieur a 2 cm. Elies furent
retrouvees le plus souvent (14 malades) au
hile splenique, au ligament gastrosplenique et au ligament spleno-colique.
Les localisations ectopiques moins frequentes ont ete au niveau de la queue du
pancreas chez un patient et au grand
epiploon chez un autre. Un patient
presentait une rate accessoire au mesentere et un dernier au niveau du ligament
lieno-renal.
L’etude de la morbidite operatoire a
permis de constater la survenue de com
plication chez 16 malades (40%). Dans 11
cas, il s’agissait de complications pulmonaires, dans 3 cas, de thromboses
veineuses des membres inferieurs sans
embolie et dans 2 cas, de complications
locales, soit un hematome et une
ecchymose a la plaie operatoire.
Nous notons une frequence accrue des
complications pulmonaires chez les six
patients chez qui un drainage de la loge
splenique a ete effectue. En effet, 4 des
6 patients ont presente des complications
bronchopulmonaires alors que seulemerit
7 des 34 patients (20%) nondraines, ont
presente ce meme type de complication.
Le taux global des complications pul
monaires a done ete de 27.5%.
La mortalite operatoire, definie comme
etant celle survenant dans le mois qui suit
le geste chirurgical, a ete nulle. Toutefois,
un patient est decede au 38ieme jour postsplenectomie par hemorragie intracranienne suite a une recidive de sa
thrombocytopenie.
Le suivi hematologique a ete realise
chez 37 de nos 40 malades; sa duree varie
entre 1 et 120 mois (moyenne de 30.3
mois). Le resultat de la splenectomie a ete
evalue separement pour chacun des deux
groupes deja definis et pour l’ensemble
des malades. Une remission complete permanente (tableau I) fut obtenue chez
100% des enfants et chez 86.6% des
adultes pour un taux global de remission
de 89.2%.
De tous les facteurs preoperatoires
evalues, seule la reponse prealable aux
corticosteroides semble avoir une valeur
pronostique significative sur le resultat du
traitement chirurgical. Ainsi 100%
(18/18) des patients ayant obtenu une
remission complete transitoire sous cor
ticotherapie ont beneficie d’une remission
complete permanente apres splenectomie
alors que seulement 86.5% (13/15) des
patients chez qui une remission partielle

en preoperatoire avait ete obtenue, ont
vu leur condition amelioree de fa?on per
manente par la splenectomie. La chirurgie n ’a malheureusement pu offrir une
remission complete permanente qu’a 50%
(3/6) des malades chez qui une absence
totale de reponse a la corticotherapie avait
prealablement ete constatee.
Discussion
L’evolution naturelle du PTI chez l’enfant est differente de celle generalement
observee chez l’adulte. En effet, les taux
de remission spontanee ou de remission
a long terme observes apres traitement
aux corticosteroides sont plus eleves que
chez l’adulte. La litterature fait etat d ’une
reponse favorable aux steroides chez 60%
des enfants contrairement a 15% seule
ment chez les adultes. C ’est en raison de
cette difference importante que nous
avons du, pour cette etude, repartir les
malades en deux groupes, soit les malades
de moins de 12 ans et ceux de 12 ans et
plus. Ces observations expliquent egalement la plus grande frequence de splenec
tomies chez l’adulte. L ’age moyen de 28
ans dans notre groupe de malades est
essentiellement celui que Ton retrouve
dans la litterature.5
La presentation clinique caracteristique
sous forme de purpura et d ’ecchymoses
se retrouve chez tous nos patients sauf un.
Les autres manifestations telles les hemorragies intra-craniennes et les hemorragies
des muqueuses sont rares.6
L’indication chirurgicale est habituellement portee d ’apres l’absence d ’une
remission adequate apres traitement med
ical.5,710 Tous nos malades ont done subi
un premier essai therapeutique aux
steroides et la remission complete tran
sitoire, la remission partielle ou l’absence
de remission ont constitue l’indication
chirurgicale.
Dans aucun cas la splenectomie n ’a ete
provoquee en raison d ’une hemorragie
intra-cranienne active ou de complication
de la corticotherapie comme il est rap
porte dans moins de 10% des cas des
series revisees.5,11
Le taux de 42.5% de rates accessoires
observees dans notre propre serie est plus
eleve que le taux moyen de 15% a 30%
cite dans la litterature.12"15 Aucune raison

evidente nous parait pouvoir expliquer
cette difference pourtant importante.
La morbidite operatoire observee dans
notre serie nous semble plutot elevee. Il
nous faut insister sur la constatation que
66% des patients draines suite a la
splenectomie ont presente des complica
tions respiratoires alors que seulement
20% des patients qui ont subi leur
splenectomie sans drainage ont presente
ce meme type de complication. Ces
chiffres evocateurs suggerent qu’un
drainage systematique post-splenectomie
augmenterait la morbidite de fa?on sig
nificative. La frequence globale de nos
complications pleuro-pulmonaires est
beaucoup plus elevee que celle rapportee
dans les series de S chw artz et
collaborateurs11 et de Mintz et collaborateurs5 avec des taux respectifs de
5.8% et de 4.4%.
Quant aux complications thrombotiques veineuses que nous avons observees
(7.5%) leur frequence se compare a peu
pres au taux de 5.8% rapporte par Mintz
et collaborateurs.5 En general, la sur
venue d’accidents thrombo-emboliques
post-splenectomies dans le PTI n ’est pas
plus frequente que celle observee apres
d ’autres interventions comme le soulignent Schwartz et collaborateurs.11
Finalement, le type d ’incision utilisee,
para-mediane ou sous-costale, ne nous
parait pas avoir eu quelque influence que
ce soit sur la frequence des complications,
en particulier celles d ’ordre pleuropulmonaire.
Un dernier point important de cette
etude a trait a la remission obtenue suite
a la splenectomie. Le taux observe de
remissions (89.2%) nous apparait plus
eleve dans notre serie que dans plusieurs
autres et en particulier celle (77.3%) de
M intz et collab o rateu rs.5 Le suivi
hematologique de 4.8 ans de cette derniere
etude explique peut-etre cette difference
de resultat. Par ailleurs, notre taux de
remission est identique a celui de 88%
rapporte par Schwartz et collabora
teurs.11 Le seul facteur pronostique
valable d ’une remission complete du PTI
apres splenectomie semble etre la surve
nue prealable d ’une remission transi
toire aux corticosteroides en preope
ra to ire .5 Dans notre etude, nous
avons effectivement observe une remis-
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sion complete post-splenectomie chez tous
les malades satisfaisant a ce critere, contre 86.5% chez ceux qui n ’avaient obtenu
qu’urie remission partielle et 50% chez
ceux qui n ’avaient obtenu aucune
reponse. Mintz et collaborateurs5 obtient
pour les groupes correspondants des
valeurs de 92.3%, 68% et 50% respectivement (p < 0.001). Notre nombre de
patients etant relativement restreint, il est
difficile d ’en tirer des conclusions statistiques. Toutefois, nos resultats semblent
concorder avec ceux de l’etude citee.
Nous pouvons conclure que les resul
tats de cette etude retrospective de 40 cas
de splenectomie se comparent favorablement a ceux qui ont ete rapportes
jusqu’ici dans la litterature et qu’ils justi-

fient l’usage du traitement chirurgical
dans le PTI cortico-resistant.
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Mononucleose infectieuse et pseudokyste splenique:
presentation d’un cas
Les auteurs rapportent le cas Clinique
d'un patient de 18 ans qui a presente
une masse symptomatique a I'hypochondre gauche, precedee d'une mononu
cleose infectieuse 6 mois auparavant.
L'investigation preoperatoire a comprit
principalement une echographie et une
tomographie axiale de I'abdomen,
demontrant une masse kystique au pole
inferieur de la rate. Une splenectomie fut
pratiquee. L’examen anatomopathologique revela un pseudokyste sple
nique avec coque fibreuse et absence de
revetement epithelial interne. La pathogenese du pseudokyste de la rate secondaire a une mononucleose infectieuse est
discutee, de meme que le traitement.

a fibrous capsule without an epithelial
lining. The treatment and pathogenesis
of pseudocysts of the spleen secondary
to infectious mononucleosis are dis
cussed.

Les pseudokystes spleniques sont des entites cliniques rares. Dans la majorite des
cas, ils surviennent a la suite d ’un traumatisme abdominal.
Les pseudokystes spleniques consecutifs a une mononucleose infectieuse sont
d ’autant plus rares. A l’aide d ’un cas,
nous en revoyons la presentation clinique
et discutons de sa pathogenese et de son
traitement.

Presentation clinique
Un jeune patient de 18 ans, sans antecedent
contributoire, presente en decembre 1981 une
mononucleose infectieuse caracterise par une
asthenie, des adenopathies cervicales bilaterales et une serologie positive.
Quatre mois plus tard le patient souffre d’un
malaise a l’hypochondre gauche avec augmen
tation du volume de I’abdomen. L ’anamnese
ne revele aucune notion de traumatisme,
aucune douleur precise, aucun symptfime
digestif associe. L’examen physique demontre
seulement la presence d’une masse mal delimitee a l’hypochondre gauche, 8 cm sous le
rebord costal, partiellement mobile, non douloureuse.
L’evaluation biologique de base s’avere

The authors report the clinical case of an
18-year-old patient who presented with
a symptomatic mass in the left upper
quadrant 6 months after having infec
tious mononucleosis. The preoperative
investigation consisted principally of
echography and computerized axial
tomography of the abdomen, which
demonstrated a cystic mass of the lower
pole of the spleen. Splenectomy was
carried out. Histologic examination
showed a pseudocyst of the spleen with
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FIG. 1—L’echographie abdominale demontre une masse principalement kystique, d’origine
splenique probable.
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negative. L’investigation radiologique consiste
en une echographie et une tomographie axiale
de l’abdomen.
L ’echographie abdominale demontre une
masse kystique avec loculations au quadrant
superieur gauche en contact intime avec la rate,
sans evidence de calcification (fig. 1).
La tomographie axiale determine une masse
d ’aspect heterogene de 10 x 8 x 7 cm fixee
au pole inferieur de la rate. Par ailleurs, la rate
est legerement augmentee de volume (fig. 2).
Apres [’administration d’un vaccin antipneumococcique (Pneumovax 0.5 mL, 2 semaines
en preoperatoire), une laparotomie est pratiquee par incision sous-costale gauche. Les
constatations peroperatoires sont celles d’une
rate de volume sensiblement normal avec une
masse kystique, de coloration blanchatre, intimement liee a son pole inferieur (figs. 3 et 4).
Devant la presence d’adherences locales, la
masse kystique et la rate sont excisees en bloc.
L ’examen anatomo-pathologique temoigne
a la macroscopie d’une rate de 350 g (15 x 8
x 3.5 cm) et d’une masse kystique de 9 cm de
diametre contenant 450 mL de liquide brunatre . C ette masse kystique est extraparenchymateuse, reliee au pole inferieur de
la rate par une base de 5 cm de diametre.

L’examen microscopique revele une rate
d ’aspect histologique normal et la presence
d ’un kyste dont la paroi est formee de tissue
de granulation avec presence de cellules geantes et d ’exsudat hemorragique. Aucun revetement epithelial interne n ’est mis en evidence
a partir de multiples coupes histologiques (fig.

5).
Discussion
Les pseudokystes spleniques secondaires a une mononucleose infectieuse cons
tituent une entite clinique peu frequente
telle qu’en temoigne la rarete des publi
cations disponibles. Une revue poussee de
la litterature nous permet de retrouver la
publication d ’un cas dans une revue polo
naise, en 1977.1 Cependant, la rupture
splenique spontanee avec hemoperitoine
est une complication bien connue, quoique rare, de la mononucleose infec
tieuse.2’5
La presentation clinique d’un pseu
dokyste splenique est non-specifique et en
relation avec une masse comprimant les
organes avoisinants. La majorite des
patients presente un simple malaise sans
autre symptomatologie. Une minorite
des patients presente des symptomes pre
cis tels que douleurs a I’hypochondre gau
che, douleur irradiant a l’epaule et satiete
precoce. L ’examen physique est de meme
peu precis, revelant une masse mal deliTableau I—Classification
des kystes spleniques acquis

FIG. 2—La tomographie axial de (’abdomen
demontre une masse (10 x 8 X 7 cm) d ’aspect
heterogene, fixee au pole inferieur de la rate.

Kystes parasitaires
Echinococcus
Kystes non-parasitaires
Kystes vrais
Kyste dermoi'de
Kyste epidermoYde
Kyste simple (sereux)
Pseudokyste

mitee, de diametre variable, au quadrant
superieur gauche de l’abdomen.
Toute lesion kystique de la rate implique un diagnostic differentiel; ce dernier
peut etre etabli a l’aide d ’une classifica
tion sommaire des kystes spleniques
(tableau I).
Parmi les kystes spleniques, les kystes
parasitaires sont les plus frequents quoique rares en Amerique du Nord. Par la
suite, les pseudokystes figurent au
deuxieme rang en frequence, constituant
environ 70% a 80% des kystes nonparasitaires. La principale cause de pseu
dokyste est le traumatisme abdominal; la
mononucleose infectieuse et la malaria
sont parmi les causes rares. Derniers en
frequence, les kystes vrais constituent
20% a 30% des kystes non-parasitaires.6
Done le diagnostic differentiel est principalement celui des kystes parasitaires et
des pseudokystes post-traum atiques.
D’ou 1’importance du questionnaire dans
les notions de voyage recent et de trau
matisme abdominal. Des cultures du
liquide doivent etre effectuees lors de la
possibility d ’une etiologie infectieuse.
L’examen anatomo-pathologique devient
sou vent la cle du diagnostic.
La pathogenese d ’un pseudokyste sple
nique apres mononucleose infectieuse
s’explique probablement par une rupture
splenique occulte suivie de la formation
d ’un hematome intra-parenchymateux ou
sous-capsulaire. Par la suite, on assiste a
l’organisation de cet hematome avec for
mation d ’une capsule fibreuse par le tissu
de granulation. De plus, lors d ’une mono
nucleose infectieuse, il existe une augmen
tation de volume et une friabilite de la
rate, rendant celle-ci plus susceptible aux
traumatismes mineurs qui echappent le
plus souvent au questionnaire.
Conclusions
Le traitement du pseudokyste splenique
est chirurgical. Dans la m ajorite des cas,
une splenectomie s’avere necessaire,
devant la presence d ’un pseudokyste
intra-parenchymateux ou d ’adherences
importantes. Une splenectomie partielle
peut s’appliquer dans de rares cas de
pseudokyste extra-parenchymateux et de
conditions locales adequates.

FIG . 3— Specim en post-ch irurgical.
Volumineuse masse kystique fixee au pole
inferieur de la rate.

References

FIG. 4—Examen macroscopique. A la
coupe, la coque du pseudokyste est visualisee.
La partie interne se caracterise par de multi
ples ramifications friables (hematome ancien).

FIG. 5—Examen microscopique. Capsule
fibreuse dense, trabeculaire, sans revetement
epithelial interne. Presence d’un exsudat
fibrino-hemorragique a la partie superieure du
cliche (hematoxyline et eosin, reduit par 52%
de x 160).
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Spinal Cord Injury in the Work Force
Of 144 patients with spinal cord injury
admitted to the Sunnybrook Medical
Centre from 1974 to 1979, 25 (24 men)
(1 7 .4 % ) had sustained their injuries at
work. The 25 patients ranged in age
from 20 to 56 years, with more than
half being in their third decade of life.
Work-related spinal cord injury was more
frequent in the thoracic region than spi
nal injuries from other causes. The inju
ries were generally severe, 2 4 % of them
being complete cord injuries (i.e., no sen
sory or motor function below the level of
injury). The mean neurologic grade of
these patients did not change substan
tially between the time of admission and
discharge. The mortality was 8 % .
The pattern of spinal cord injury in this
series was compared to that in the
period 1948 to 1973, when 105
(2 9 .3 % ) of 358 spinal cord injuries
occurred at work, constituting the
second most frequent cause of acute
spinal cord injury, after traffic accidents.
In the current series, only 1 7 .4 % sus
tained their injuries at work. This was
the third most common cause of spinal
injuries in this period after traffic acci
dents and sports-recreational injuries.
Falls in industry were the most frequent
mode of work injury from 1974 to 1979,
compared with construction accidents in
the earlier period.
The number of work-related spinal
cord injuries is still too high. Further
more, the severe neurologic damage
suffered and the lack of substantial
improvement emphasize the importance
of preventive efforts, especially in indus-
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try. The fact that work injuries now rank
third as a relative cause of spinal injury
may indicate an absolute decline in this
type of injury, especially among con- struction workers.
Sur 144 victimes de blessures de la
moelle epiniere hospitalises au Sunny
brook Medical Centre entre 1974 et
1979, 25 (dont 24 hommes) (1 7 .4 % )
avaient eu un accident de travail. Leur
age allait de 20 a 56 ans et plus de la
moitie etaient dans la trentaine. Les
lesions de la moelle subies au travail touchaient plus souvent la region thoracique
que les blessures attribuables a d'autres
causes. Les blessures etaient generalement graves; dans 2 4 % des cas il y
avait section complete (c. a d., absence de
fonction sensitive ou motrice sous le niveau
de la lesion). Le stade neurologique moyen de ces patients n'a pas
change de facon appreciable entre leur
arrivee a I'hopital et le moment ou ils
obtinrent leur conge. La mortalite fut de

8 %.
Les types de blessures de la moelle
observes dans cette serie ont ete compa
res a ceux enregistres entre 1948 et
1973 alors que 105 lesions de la moelle
(2 9 .3 % ) sur 358 sont survenues au tra
vail, soit la deuxifeme cause de lesions de
la moelle apres les accidents de la circu
lation. Dans la periode la plus recente,
1 7 .4 % des patients ont ete blesses au
travail. En frequence, il s'agit de la troisieme cause de lesion de la moelle apres
les accidents de la route et les blessures
sportives. Les chutes dans I'industrie ont
ete la cause la plus frequente d'accidents de travail entre 1974 et 1979
comparativement aux accidents de la
construction durant la periode ant6rieure.
Le nombre de lesions de la moelle
resultant d'un accident de travail est
encore trop 6leve. De plus, les dommages neurologiques severe qui sont subis
et le manque d'amelioration appreciable
soulignent ('importance de la prevention,
particulierement dans I'industrie. Le fait
que les accidents de travail arrivent
maintenant au troisi&me rang comme
cause des lesions de la moelle indique
possiblement que ce type de blessure

soit en regression, specialement chez les
travailleurs de la construction.

Severe injury to the spinal cord occurring
in the work place produces major disrup
tion to the individual’s life, his family and
to society in general. In most instances,
the patient has to abandon his job, and
his social life is significantly altered. The
cost per injury can amount to hundreds
of thousands of dollars in lost earnings
and medical costs.1,2
Tator and Edmonds1 have analysed
the epidemiologic factors related to acute
spinal cord injury. They studied 358
patients with acute spinal cord injury due
to accidents, mainly in Ontario, between
1948 and 1973, and found that accidents
at work were the second most common
cause of such injuries, accounting for 105
(29.3%) cases; traffic accidents were the
most common cause. Construction wor
kers were the most frequently affected
group (22.9%), followed by logging wor
kers (17.1%), farmers (14.3%) and
miners (9.5%) with the remainder belong
ing to other small groups. In contrast,
Peerless and Schweigel2 found that log
ging accidents accounted for 45% of the
work-related spinal cord injuries in Brit
ish Columbia.
Although in the past decade, major
advances into the pathophysiology of
acute spinal cord injury have resulted in
greater understanding of the acute
changes that occur in the cord after
trauma,3-6 treatment of such injury is
still far from perfect in terms of recov
ery of neurologic function. Thus, preven
tion must be emphasized. We have, there
fore, studied the epidemiology of
work-related accidents occurring in
Ontario between 1974 and 1979 with the
view that it is necessary to identify specific
etiologic factors for systematic prevention
of these devastating injuries.
Patients and M ethods

We reviewed the hospital records of the
first 144 consecutive patients admitted to
the Acute Spinal Cord Injury Unit, Sun
nybrook Medical Centre, University of
Toronto, between 1974, when the unit
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was opened, and Dec. 31, 1979. The over
all management of this group of patients
was recently reported.7 The information
was analysed at the University of Toronto
Computer Centre using the “ Statistical
Package for the Social Sciences” (SPSS).
Patients included in the present study
were restricted to those who sustained
acute spinal cord or cauda equina injury
while at work. Patients with chronic back
or neck pain due to degenerative disc dis
ease and other spinal disorders such as
acute lumbar disc herniation and flexionextension sprains were excluded.

Mechanism o f Injury

Level o f Spinal Injury

It is noteworthy that 14 patients (56%)
in group 1 were injured in falls, 8 (32%)
were struck or crushed and 3 (12%) were
injured in automobile-related accidents
(two farm vehicles and one truck) (Table
IV). The majority of those truck or
crushed were in the age group 20 to 29
years, whereas falls involved all the age
groups. Apart from the two patients in
the logging category who were both
struck by trees, falls were the predomi
nant mechanism of injury in each of the
other categories (Table V).

Eleven (44%) patients in group 1 had
an injury of the cervical spine (Table VI),
compared with almost 60% in group 2,
but a higher proportion of workers
(group 1) had an injury of the thoracic
spine than the nonworkers (36% versus
25.2%).
The Severity o f Injury
On admission, 19 patients had an
incomplete spinal cord injury and 6 had
a complete cord injury (i.e. no motor or
sensory function below the level of

Findings

Causes

__________________________ Table 11-Age of Cord-Injured Patients_______

Work was the third most common
cause of acute spinal cord injury, after
traffic accidents and sports injuries (Table
I). Twenty-five (17.4%) of the 144
patients sustained spinal cord or cauda
equina injury in work-related accidents.
Sex and Age

_________________________ No. of patients
Group 2

V________________ Group 1
<20

1

20-29
30-39
40 -4 9
50-59
Totals
Mean ± SD

12
A
2
7
0
25
35.8 ± 12.7

Age, yr
20 -2 9
30-39
40 -4 9
50-59
Totals

Table Ill-Type of Work Related to Age at Injury
Category of injury
Logging
Construction
Factory
Farm
1
3
1
0
0
0
0
0
0
0
0
1
1
1
1
1
2
4
2
2

>60

Twenty-four (96%) of the 25 patients
with work-related spinal cord injury
(group 1) were men. The only woman was
a 48-year-old farmer who fell off a trac
tor she was driving and was run over by
the hay wagon behind it. Of the other 119
patients who were not injured at work
(group 2), 89 (75%) were men.
The 25 patients in group 1 ranged in
age from 20 to 56 years (Table II), with
two peaks of frequency, one in the 20- to
29-year age group, and the other in the
50- to 59-year age group. In group 2, the
ages of patients ranged from 12 to 83
years.

Industrial
5
3
1
3
12

Totals

30
37
17
9
9
17
U9
33.6 ± 18.3

30
49
21
11
16
17
144
34.0 + 17.4

Other
2
1
0
0
3

Totals
12
4
2
7
25

Type o f Work Injury
Table III shows that industrial acci
dents were the most common type in
group 1 (48%), followed by construction
accidents (16%). Logging, farming and
factory accidents each accounted for 8%,
with 12% due to other causes. The indus
trial accidents tended to occur in all age
groups, the farming accidents involved
older workers and three of the four
patients injured in construction accidents
were in the third decade of life.

Table 1-Causes of Acute Spinal Cord
Injuries in 144 Patients (1 974-1979)
Cause
Traffic
Sports-recreation
Work
Falls at home
Others
Total

166

No. of
patients (%|
59(41.0]
32(22.2)
25(17.4)
15(10.4)
13(9.0)
144(100)

Table IV-Mechanism Related to Age at Injury
Age, yr
20-29
30-39
40 -4 9
50-59
Totals

Category
of injury
Industrial
Logging
Construction
Factory
Farm
Other
Totals

Mechanism
Struck or crushed

Fall
5
3
1
5
14

6
0
1
1
8

Motor vehicle accident
1
1
0
1
3

Totals
12
4
2
7
25

Table V--Type of Work Related to Mechanism of Injury
Mechanism
Fall
8
0
2
1
1
2
14

Struck or crushed
2
2
2
1
1
0
8

Motor vehicle accident
2
0
0
0
0
1
3

Totals
12
2
4
2
2
3
25
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tions, the Workers’ Compensation Board
and governments now put greater empha
sis on worker safety. However, much has
still to be done.
Reviews in other parts of the world
show that the incidence of work-related
injury ranges from 20% to 50% of all spi
nal cord injuries.2,9'12 The pattern of
occupations resulting in such injuries
shows regional and national variation,
depending on the nature of the main
industries. For example, Peerless and
Schweigel2 found that logging was the
cause of spinal cord injury in 45% of
Mortality
work-related spinal cord injuries in Brit
The mortality in group 1 was 8% (2 of
ish Columbia. On the other hand, con
25) compared with 12.6% in group 2 (15
struction accidents produced the highest
of 119). The two patients in group 1 died
number of work-related spinal cord inju
during the initial hospitalization. One was
ries in the earlier study in Ontario.1 It is
a 27-year-old construction worker who
encouraging to note that the relative fre
fell and sustained an odontoid fracture
quencies of construction and logging acci
with severe neurologic injury (grade 4 on
dents as causes of spinal cord injury are
the Sunnybrook scale). He died of
lower in this study than they were in the
respiratory failure 32 days after the fall, earlier one, and that there were no spinal
with other contributing factors being
cord injuries in mining in the recent study,
hypoxic encephalopathy and gastric
perhaps due to safety campaigns in these
hemorrhage. The second patient was a
fields.
37-year-old industrial worker who fell,
Fourteen of our 25 injuries were due
sustaining a third-degree burn to 60% of
his body, a fracture-dislocation at C5-6 to falls and 10 of these occurred in
and a grade 2 spinal cord injury. He died patients in the third and sixth decades.
Job inexperience might be a factor and
of renal failure 48 days after the injury.
in the older group some workers may be
too old for jobs requiring the climbing of
Discussion
scaffolding and ladders. Prevention
Our study identifies work as the third would require more specific instructions
most common cause of acute spinal cord to new employees about climbing safety,
injury in Ontario, after traffic and sports- including guidelines on how to stabilize
recreational injuries, in the period 1974 ladders and scaffolds at work sites.
to 1979. In comparison with an earlier Perhaps workers over 50 years of age
study by Tator and Edmonds,1 covering should be prohibited from climbing.
the period 1948 to 1973, there has been
In many epidemiologic studies of spi
a relative decrease in the frequency of nal cord injury, the cervical spine is the
work-related spinal cord injury (17.4% most frequent site of injury.1,9Although
versus 29.3%). In that period, work- the same was true in our study, there were
related spinal cord injury was the second relatively more thoracic injuries among
most common cause, behind motor vehi the workers, probably because of the
cle accidents (34.4%) and ahead of sports- predominance of falls.
recreational accidents (15.4%). Unfor
This study again shows the poor recov
tunately, no accurate statistics are avail ery of neurologic function after major
able on the total annual number and cord injury. The average neurologic sta
causes of spinal cord injuries in Ontario, tus of the patients did not change substan
but we believe there has been only a tially between admission and discharge.
moderate increase between the two study Although the mortality among the wor
periods. Thus, it is quite likely that the kers was lower than that of the other
incidence of work-related spinal cord group, presumably because of the youn
injury has declined slightly in this ger mean age, an 8% mortality is still too
province. It is true that workers, high. The average duration of hospitali
employers, accident prevention associa zation at Sunnybrook was 65 days fol

injury). At discharge, the distribution was
the same, although one patient with a
complete cord injury improved to in
complete status at the time of discharge
and one patient whose injury was
incomplete initially became complete
after admission. On both admission and
discharge, the mean severity grade of the
neurologic injury was 4.6 based on the
Sunnybrook severity scale,8 indicating
virtually no recovery of neurologic
function.

G r o u p 1,
no . ( % )

G r o u p 2,
no . ( % )

To ta ls,
no . ( % )
8 2 (5 6 .9 )
39 (2 7 .1 )
3 (2 .1 )
2 0 (1 3 .9 )

Cervical
Th ora cic
Th oracolum bar
Lum bar

11 ( 4 4 )

71 ( 5 9 . 7 )

9 (3 6 )
1 (4)
4 (16)

30 (2 5 .2 )
2 (1 .7 )
1 6 (1 3 .4 )

To ta ls

25

119

Conclusions

Work as a cause of spinal cord injury
was found to be the third most common
cause of spinal cord injury in Ontario,
after traffic and sports. There has prob
ably been a decrease in the frequency of
work-related spinal cord injuries over the
years, although the incidence, morbidity
and mortality are still too high. Efforts
to prevent these injuries must therefore
continue.
We thank Miss Virginia Edmonds for her
technical help.
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Recent Research Suggests...
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Surgical Management of Hydatid Disease of the Liver
The authors review 143 consecutive,
surgically treated cases of hydatid dis
ease of the liver seen over the past 10
years. Of the 208 cysts found, 82
(39.4% ) were complicated; the
remainder were simple. The complica
tions included rupture into the biliary
system (16.3% ), suppuration (11.0% ),
partial calcification of the pericyst
(5.8% ), intraperitoneal rupture (4.8% ),
bronchobiliary fistula (0.9% ) and cystocutaneous fistula (0.5% ).
External capitonnage was the most
commonly used surgical technique
(63.0% ), followed by cystectomy
(17.8% ), omentoplasty (10.6% ), tube
drainage (7.7% ) and cystojejunostomy
(0.9% ). Capitonnage was carried out
with or without tube drainage.
The complications of surgery were
higher with drainage than without.
The main complications of surgery
were infection in the residual cavity
and biliary fistula. The patients who
underwent external capitonnage without
drainage or omentoplasty had good
results with minimal complication rates
(3.5% and 4.5% respectively). For the
patients in whom the cystectomy was
established, the complication rate was

La technique chirurgicale la plus courammente utilisee fut le capitonnage
externe (63.0% ). Suivaient, la kystectomie (17.8% ), I'omentoplastie (10.6% ), le
drainage (7.7% ) et la kystojejunostomie
(0.9% ). Le capitonnage fut pratique avec
ou sans drainage. Les complications
chirurgicales ont ete plus frequentes
avec que sans drainage. Les prin
cip als complications furent I'infection de la cavite residuelle et la fistule
biliaire. De bons resultats ont ete obtenus
avec le capitonnage externe sans drai
nage ou I'omentoplastie et les taux de
complications ont ete faibles (3.5% et
4.5 % respectivement). Le taux de com
plications rattache a la kystectomie fut
de 8.1% .

for a benign condition. In this paper we
present our experience with the operations
of capitonnage, omentoplasty and cystec
tomy at Qukurova University in Turkey.
Patients

The records of 143 consecutive patients
(105 women, 38 men) with hydatid cyst
of the liver treated surgically during a
10-year period (1973 to 1983) were
reviewed. They ranged in age from 7 to
66 years. The most frequent complaint
was dull pain in the upper abdomen.
Hepatomegaly and a palpable cystic mass
were the most common findings. Eleva
tion of the right hemidiaphragm in the
plain chest film was seen in 80 (55.9%)
of the patients. A correct preoperative
diagnosis was made in 81.1% of cases.
Two-hundred and eight cysts were
found. Eighty-nine patients (62.2%) had
a single cyst and 54 (37.8%) had multi
ple cysts in the liver. The majority of cysts
were in the right lobe. Daughter cysts
were found in 38.9% of cases (Fig. 2).
Some of the hydatid cysts had degenera
tion of the parasite and calcification of
the pericyst. Twenty-three patients
(16.0%) had secondary bacterial infec
tion. One patient had a cystocutaneous
fistula with suppuration. The most com
mon complication was rupture into the
bile ducts, in 29 patients (20.3%). In addi
tion, communication between cyst and
right hepatic duct was found in five
patients and bronchobiliary fistula in two.
Exploration of the common bile duct and
T-tube drainage were performed in these

Echinococcus granulosus is endemic in
Turkey and the majority of liver masses
presenting for evaluation are echinococcal cysts. One of the most remarkable
clinical features of hydatid cysts of the
liver is the absence of systemic distur
bances. Currently available diagnostic
tests cannot rule out hydatid disease.1
However, Casoni and Weinberg tests
were positive in 81.1% and 68.5% of
cases in our series. Radioisotopic scan
8 1
ning, ultrasonography and computerized
tomography were the most useful diag
nostic investigations (Fig. 1). Ultrasonog
Les auteurs ont etudie 143 cas consecuraphy should be the first diagnostic
tifs d'echinococcose hydatique du foie
method used.2 We do not believe that
traites chirurgicalement au cours des 10
invasive procedures, such as selective
dernieres annees. Des 208 kystes decouangiography or splenoportography, are
verts, 82 (39.4% ) presentaient des com
necessary to diagnose hydatid disease.
plications; les autres etaient simples.
The role of high-dose mebendazole
Parmi les complications, on observa une
and, recently, albendazole in treating
rupture dans le systeme biliaire (16.3% ),
hydatid disease is still undetermined and
une suppuration (11.0% ), une calcifica
awaiting controlled trials. It is recom
tion perikystique partielle (5.8% ), une
mended that mebendazole be given to
rupture intraperitoneale (4.8% ), une fispatients with inoperable hydatid dis
tule broncho-biliaire (0.9% ) et une fistule
ease.3,4 Surgery is still the treatment of
kysto-cutanee (0.5% ).
choice.5 The main steps of surgical
management are killing of the fertile ele
From the Department o f Surgery,
ments of the parasite by scolicidal agents,
Qukurova University, Adana, Turkey
evacuation of the cyst and management
of the residual cavity. Many surgical tech
Accepted for publication Oct. 12, 1984
niques have been proposed for the
Reprint requests to: Dr. A. Akinoglu,
remaining cavity. Some authors6,7 have
Department o f Surgery, Qukurova Univer recommended
liver resection while
FIG. 1—Ultrasonography showing two
sity Medical School, Numune Hastanesi,
others8,9 believe that this is too radical separate univesicular hydatid cysts of liver.
Genet Cerrahi Klinigi, Adana, Turkey
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seven cases. Spontaneous intraperitoneal
rupture o f the liver cyst and secondary
peritoneal echinococcosis had occurred in
six cases, and rupture after blunt trauma
to the abdomen in four. There was one
patient with associated cirrhosis and
another with cavernous hemangioma.

Operative Management
Surgical access was through an upper
right paramedian incision. In a few
patients a right subcostal incision was
used but never a thoracoabdominal inci
sion. The surgical technique varied
according to the features and location o f
each cyst. External capitonnage with tube
drainage was the procedure used most fre
quently, in 102 liver cysts (49.0%). In
external capitonnage, the cyst cavity was
obliterated with external chromic catgut
sutures usually after excision o f the
redundant portion not containing any
hepatic parenchyma. As a result, inver
sion o f the adventitia was achieved (Fig.
3). Early in the series capitonnage with
tube drainage resulted in a high compli
cation rate. For this reason we chose
capitonnage without drainage and omen
toplasty procedures in the last 3 years.
Omentoplasty is more frequently used in
multivesicular cysts and capitonnage
without drainage in univesicular cysts.
Cystectomy, capitonnage without drain
age and omentoplasty were performed in
37, 29 and 22 hydatid cysts, respectively.
Tube drainage was utilized in 16 infected
cysts as a surgical procedure.

FIG , 2— Evacuation
hydatid cyst.

of

multivesicular

Bactrim Roche

Complications of Operation
The most common complications were
infection in the remaining cavity and leak
age o f bile (Table I). Biliary fistula was
seen in 3.5% o f the hydatid cysts that
were treated by capitonnage without
drainage and in 4.5% o f those treated by
omentoplasty. Postoperative infection in
the pericyst cavity was higher in patients
treated with capitonnage with tube
drainage. The other complications were
serious bleeding, anaphylactic shock dur
ing operation, systemic reactions to for
malin, intra-abdominal abscess and
peritonitis, hepatic coma in a patient who
had cirrhosis, pulmonary infection and
wound dehiscence.

Hospitalization
The average hospital stay was 12.3 and
14.1 days in the groups treated by
capitonnage without drainage and omen
toplasty, respectively. For capitonnage
with tube drainage, the average hospital

Indications
The follow ing infections when caused by susceptible
pathogens:
■ upper and lower respiratory tract (particularly chronic
bronchitis and including acute and chronic otitis
media)
■ urinary tract: acute, recurrent and chronic
■ genital tract: uncom plicated gonococcal urethritis
■ gastrointestinal tract
■ skin and soft tissue
■ Pneum ocystis carinii pneumonitis in infants and
children
Not indicated in infections due to Pseudomonas,
M ycoplasm a or viruses
Contraindications
Evidence of marked liver damage or renal impairment
where repeated serum assays cannot be carried out;
blood dyscrasias; known hypersensitivity to trim ethoprim
or sulfonamides.
During pregnancy, and in newborn or premature infants
durin g first few weeks of life
Precautions
Benefit should be critically appraised against risk in
patients with liver damage, renal damage, urinary
obstruction, blood dyscrasias, allergies, or bronchial
asthma. Reduce dosage in patients with renal im pair
ment. Do not adm inister if serum creatinine level is above
2 mg%. Consider possible superinfection with a non
sensitive organism.
Adverse reactions
Most frequent nausea, vomiting, gastric intolerance,
and rash
Less frequent: diarrhea, constipation, flatulence, anore
xia, pyrosis, gastritis, gastroenteritis, urticaria, head
ache, and liver changes (abnorm al elevations in alkaline
phosphatase and serum transaminase)
O ccasionally reported: glossitis, oliguria, hematuria,
trem or, vertigo, alopecia, and elevated BUN, NPN, and
serum creatinine
Hem atological changes: primarily, neutropenia and
throm bocytopenia, and less frequently, leukopenia,
aplastic or hem olytic anemia, purpura, agranulocytosis,
and bone m arrow depression; occur particularly in the
elderly and mostly prove reversible on withdrawal
Dosage
C hildren: 6 mg trim ethoprim kg body weight per day,
plus 30 mg sulfam ethoxazole/ kg body weight per day,
divided into two equal doses
Adults an d children over 12 years o f age
Standard dosage
1 B a ctrim - DS Roche- tablet or 2 adult tablets, twice
daily.
M inim um dosage and dosage for long-term treatm ent
Vi ‘B a ctrim ’ DS Roche- tablet or 1 adult tablet, twice
daily
M axim um dosage (overwhelming infections):
1 Vz B a ctrim - DS Roche- tablets or 3 adult tablets, twice
daily.
In acute infections treat for at least 5 days or until patient
is asym ptom atic for 48 hours; in urinary tract infections,
until urine sterile.
Uncom plicated gonorrhea: 2 adult tablets or
1 B a ctrim - DS -R oche- tablet four times daily for 2 days.
Pneum ocystis c arinii pneum onitis 20 m g /k g /d a y tri
m ethoprim and 100 m g/ kg /d a y sulfam ethoxazole in four
divided doses for 14 days

FIG. 3— External capitonnage. Closure and
inversion of pericyst layer with (A ) or without
(B) drainage.

Table 1 - Postoperative Com plications
Com plications, no. (%)
Infection in
th e remaining
cavity

Hydatid
cysts, no.

Bile
fistula

Capitonnage
W ith tu be drainage
W ith o u t drainage
C ystectom y
O m entoplasty
Tube drainage alone
C ystojejunostom y

102
29
37
22
16
2

1 3 ( 1 2 .7 )
1 (3 .5 )
3 (8 .1 )
1 (4 .5 )
4 (2 5 .0 )
-

3 6 ( 3 5 .3 )

T o tals

208

2 2 (1 0 .6 )

3 8 ( 1 8 .2 )

Procedure

Rx Summary

Totals

Supply
A d ult tablets: White, capsule-shaped, biconvex tablet
with ROCHE C engraved on one face and BACTRIM and
indented score on the other, each containing 80 mg tri
m ethoprim and 400 mg sulfamethoxazole.
Bottles of 100 and 500. Unit dose, boxes of 100
DS tablets White, capsule-shaped, biconvex tablet with
ROCHE engraved on one face and BACTRIM DS and
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200 mg sulfam ethoxazole per 5 ml
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25 ampoules.
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Bactrim™ Roche
t (trimethoprim plus sulfamethoxazole)

the drug of
, first choice in

1the treatment
of pneumocystis
carinii pneumonitis
is a solution for
serious infections

‘Bactrim’ Solution for
Infusion has also produced
dramatic results in
■ severe urinary tract
infections
■ septicemia
■ meningitis
TMP-SMX “ ...has particularly
been useful against organisms
that are resistant to
ampicillin or are resistant
to the first and second
generation cephalosporins,
and it has been very active
against certain organisms
that appear to be resistant
to pretty much everything
we have ...”<1)
An important weapon when
aggressive antibacterial
measures are required.

stay was 18.9 days. In the tube-drainage
group, in which the cavities were already
infected, the average hospital stay was 45
days.

opening the cyst wall are important fac
tors in preventing spillage of viable
scolices into the peritoneal cavity.
A variety of surgical procedures has
been proposed for the treatment of
Mortality
hydatid cysts of the liver.12’13 The surgi
There were nine operative deaths cal methods can be divided into two
types. The conservative surgical proce
(6.3*%) in our 143 patients (Table II).
Three were due to secondary infection in dures include evacuation of the cyst and
the residual cavity with abscess formation management of the pericyst cavity. Rad
or peritonitis. One occurred as a result of ical surgical procedures such as cystec
tomy and hepatic resection involve ensevere hemorrhage postoperatively.
bloc excision of the hydatid cyst.13,14
There
is no risk of cyst contents spilling
Discussion
and no danger of anaphylaxis in radical
In hydatid cysts of the liver, leakage of
operations. Cystectomy can be performed
bile causes rupture of the laminated mem
safely in peripherally located cysts.8 This
method was employed in 37 cysts with a
brane and subsequent formation of
daughter cysts that takes place over some
complication rate of 8.1%. Hepatic resec
time. Such cysts are multivesicular.1 For
tion has been strongly recommended by
the univesicular cysts that contain only
a number of surgeons.6’7’14 We believe
hydatid fluid, the postoperative compli that conservative surgical methods and
cystectomy are adequate; there is no rea
cation rate was lower than for multivesic
ular cysts. This was not dependent on the
son for performing hepatectomy. Excel
difference in surgical technique.
lent surgical results can be achieved in
properly selected patients with cystec
Rupture into the biliary tree is one of
tomy, capitonnage without drainage and
the most common complications of
hydatid cysts of the liver. The other com omentoplasty. The postoperative mor
plications such as suppuration, degener
bidity is under 5% and mortality is close
to zero.13 In the surgical treatment of a
ation and calcification develop secondar
benign condition such as hydatid cysts of
ily to the intrabiliary rupture.10 In all
the liver, hepatectomy seems to be too
forms of complicated hydatid cyst, the
aggressive and has increased the operative
communications with the bile ducts can
mortality in some series.11’14
be seen after the cavity has been opened
and its contents have been evacuated. We
One of the most controversial aspects
advocate closing these openings with fine
of the surgical treatment for hydatid cysts
chromic catgut sutures.
of the liver is management of the
The operative field must be carefully
remaining cavity. If the cyst is secondar
walled off by towels to prevent spillage
ily infected, surgical drainage is almost
of the scolices. Plastic drapes11 and cryo mandatory.1 Tube drainage was carried
genic cones' have been used to prevent
out in our patients who had infected cavi
spillage of the hydatid cyst contents into
ties. In the sterile cavities, drainage may
the adjacent tissue. We have injected into
result in secondary in fectio n .1’5 In
the cavity either formalin, hypertonic
omentoplasty,15 filling the residual cavity
saline or povidone-iodine solution as a
with omentum, we have had a 4.5% inci
scolicidal agem. One of our patients died
dence of biliary fistula.
from a systemic reaction to formalin. This
Capitonnage is ideal for hydatid cysts
agent has not been used in the last 5 years.
of the liver.10 In this operation a series of
As alternative scolicidal agents exist, for internal sutures of heavy chromic catgut
malin should not be used. The most con are used to obliterate the cavity. This
venient scolicidal agents are 20% saline
procedure runs the risk of injuring bile
and povidone-iodine solutions. Applying
ducts and vessels and leaving dead spaces.
effective concentrations of these agents
Considering the disadvantages of internal
and waiting for a specified period before
capitonnage, we recommend the modifi

cation of external capitonnage in the
management of the remaining cavity.
In our series, external capitonnage was
used in 139 cysts. Twenty-nine patients
underwent external capitonnage without
drainage and had a low complication rate.
There was a significant difference in
postoperative complications between
capitonnage with tube drainage and
capitonnage without drainage (p = 0.05,
X2 test).
We advocate external capitonnage
without drainage and omentoplasty in the
surgical management of hydatid cysts of
the liver.
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Prescribing Information
ZANTAC® INJECTION (ranitidine hydrochloride)
PHARMACOLOGICAL CLASSIFICATION
Histamine H 2-receptor antagonist

ACTION
Ranitidine is a selective antagonist of histamine at gastric H 2-receptor sites. Thus
ranitidine inhibits both basal gastric secretions and gastric acid secretion induced
by histamine, pentagastrin and other secretagogues. On a weight basis, ranitidine is
between 4 and 9 times more potent than cimetidine. Inhibition of gastric acid secre
tion has been observed following intravenous, intraduodenal and oral admin
istration of ranitidine and it is dose related, a maximum response being achieved at
an oral dose of 150 mg.
Pepsin secretion is also inhibited but secretion of gastric mucus is not affected.
Ranitidine does not alter the secretion of bicarbonate or enzymes from the pancreas
in response to secretin and pancreozymin.
Ranitidine is rapidly absorbed after oral administration, peak plasma concentra
tions being achieved within 2 to 3 hours. These plasma concentrations are not
significantly influenced by the presence of food in the stomach at the time of the
oral administration nor by regular doses of antacids.
Bioavailability of ranitidine administered orally is approximately 50%. Serum
protein binding of ranitidine in man is in the range of 10% to 19%. The elimina
tion half-life is approximately 3 hours. The principal route of excretion is the urine
(40% recovery of free and metabolised drug in 24 hours).
Intramuscular ranitidine is fully bioavailable in comparison to intravenous
ranitidine. The median elimination half-life of ranitidine injection 50 mg, adminis
tered intravenously or intramuscularly was found to be 140 minutes (range 120 to
160 minutes.) The half-life of ranitidine in patients with renal dysfunction is
prolonged. However, in a study of 27 patients with varying degrees of renal impair
ment therapeutic plasma levels of ranitidine were shown to be achieved without
risk of drug accumulation, using half the normal dose of ranitidine in patients with
plasma creatinine concentration greater than 300 /umols/litre.
There is a significant linear correlation between the dose administered and the
inhibitory effect upon gastric acid secretion for doses up to 150 mg orally.
A plasma ranitidine concentration of 50 ng/mL has an inhibitory effect upon stimu
lated gastric acid secretion of approximately 50%. Estimates of the IC50 range from
36 to 94 ng/mL. Following the administration of 150 mg ranitidine orally, plasma
concentrations in excess of this lasted for more than 8 hours and after 12 hours the
plasma concentrations were sufficiently high to have a significant inhibitory effect
upon gastric acid secretion. In patients with duodenal ulcer, 150 mg ranitidine
given by mouth every 12 hours significantly reduced mean 24 hour hydrogen ion
activity by 69% and nocturnal gastric acid output by 90%.
Following intramuscular injection of 50 mg ranitidine, plasma concentrations
in excess of 100 ng/mL were achieved within five minutes of administration and
remained above this level for 4 to 6 hours.
Intravenous infusion of ranitidine in seriously ill patients at a rate of
0.125 mg/kg/hour produced a rise of intragastric pH between 5.6 and 7.0 after two
hours and maintained this level over the test period. The volume of gastric secre
tion was reduced by more than 55%. Doubling the infusion rate to
0.25 mg/kg/hour produced no further increases in gastric acid inhibition.
A single 50 mg intravenous bolus dose of ranitidine produced significant acid
inhibition 8 to 9 hours after administration. When 13 seriously ill patients with two
or more risk factors (shock, sepsis, respiratory failure, jaundice, renal insufficiency
and peritonitis) were treated with a 50 mg intravenous bolus dose of ranitidine
followed by a continuous infusion of 0.2 mg/kg/hour the number o f ‘at risk’ days
when gastric pH was less than 3.5 on three consecutive four-hourly aliquots, was
approximately half that for placebo treated patients.
Furthermore, in respect of both 24 hour acidity and nocturnal acid output,
ranitidine, 150 mg twice daily was superior to cimetidine 200 mg three times daily
and 400 mg at night (P <0.001 and <0.05, respectively).
Ranitidine injection is well tolerated following intravenous administration at
dose levels of up to 100 mg four times daily for ten days. These levels are in excess
of those recommended for normal clinical use.
Treatment of volunteers with ranitidine 150 mg twice daily for 7 days did not
cause bacterial overgrowth in the stomach.
Volunteers treated with ranitidine have reported no significant gastrointestinal
or central nervous system side effects; moreover, pulse rate, blood pressure, electro
cardiogram and electroencephalogram were not significantly affected in man
following ranitidine administration.
In healthy human volunteers and patients, ranitidine did not influence plasma
levels of the following hormones: cortisol, testosterone, estrogens, growth
hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating
hormone, aldosterone or gastrin - although like cimetidine, ranitidine reduced
vasopressin output. Treatment for up to 6 weeks with ranitidine 150 mg twice
daily by mouth did not affect the human hypothalamic-pituitary-testicular-ovarian
or -adrenal axes.
At 50 mg intravenously, ranitidine had no effect on prolactin levels. Only at
the 300 mg i.v. dose level was an increase in prolactin secretion, equivalent to that
produced by 200 mg of cimetidine i.v., observed.
At the high dose levels used in the tolerance studies, minor, transient increases
in serum alanine transaminase (ALT/SGPT) and aspartate transaminase
(AST/SGOT) levels were observed in some patients. No other liver function tests
were abnormal for these subjects and the cause and clinical significance of these
findings are unknown.
Laboratory studies have shown that ranitidine has negligible affinity for the
cytochrome P4S0-linked hepatic mixed function oxidase system. In man, ranitidine
treatment has been shown not to impair the metabolism of antipyrine,
aminopyrine, warfarin or diazepam.

PRECAUTIONS
Use in pregnancy and nursing mothers - The safety of Zantac in the treatment
of conditions where a controlled reduction of gastric secretion is required during
pregnancy has not been established. Reproduction studies performed in rats and
rabbits have revealed no evidence of impaired fertility or harm to the fetus due to
Zantac. If the administration of Zantac during pregnancy is considered to be neces
sary, its use requires that the potential benefits be weighed against possible hazards
to the patient and to the fetus. However, therapeutic doses of Zantac administered
to obstetric patients in labour or undergoing caesarean section have been without
adverse effect on labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers but the clinical
significance of this has not been fully evaluated.
Use in impaired renal function - Ranitidine is excreted via the kidney and in
the presence of severe renal impairment, plasma levels of ranitidine are increased
and prolonged. Accordingly, in the presence of severe renal impairment, clinicians
may wish to reduce the oral dose to half of the usual dose taken twice daily, simi
larly it is recommended that ranitidine injection be administered in doses o f 25 mg
to patients with renal dysfunction.
Children - Experience with Zantac in children is limited and such use has not been
fully evaluated in clinical studies. It has however been used successfully in children
aged 8-18 years in doses up to 150 mg orally twice daily without adverse effect.

ADVERSE REACTIONS
No serious adverse effects have been reported to date in patients treated with
Zantac. There has been no clinically significant interference with endocrine,
gonadal or liver function, nor has the drug adversely affected the central nervous
system even in elderly patients.
The incidence of adverse events among Zantac-treated patients (8.1%) was very
little greater than that among placebo-treated patients (7.7%). Only five adverse
events, namely, tiredness (0.38%), headache (0.90%), dizziness (0.32%), diarrhea
(0.52%) and skin rashes (0.52%) had a greater incidence in the ranitidine treated
group than in the control group.
A small proportion (1.99%) of patients treated with ranitidine injection experi
enced itching or burning at the injection site. This reaction was mild and usually
subsided within 10-15 minutes.
Headache was experienced by 2.54% of patients receiving ranitidine injection.
The majority of these cases were not thought to be treatment-related. In some in
stances the headache was thought to be due to over-rapid injection of ranitidine,
and did not recur on rechallenge with slow intravenous injection. Similarly, some
patients experienced nausea after rapid injection of the drug, but on subsequent
occasions with slow-intravenous injection, experienced no ill-effects.

OVERDOSAGE
Zantac is very specific in action and accordingly no particular problems are
expected following overdosage with the drug. Symptomatic and supportive therapy
should be given as appropriate. If need be, the drug may be removed from the
plasma by haemodialysis.

DOSAGE AND ADMINISTRATION
Adults: Zantac injection may be given either as a slow (over one minute) intra
venous injection of 50 mg, which may be repeated every six to eight hours; or as an
intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be
repeated at six to eight hour intervals.
In the prophylaxis of haemorrhage from stress ulceration in seriously ill
patients or the prophylaxis of recurrent haemorrhage in patients bleeding from
peptic ulceration, parenteral administration may be continued until oral feeding
commences. Patients considered to be still at risk may then be treated with Zantac
tablets 150 mg twice daily.
In patients considered to be at risk of developing acid aspiration syndrome
Zantac injection 50 mg may be given intramuscularly or by slow intravenous injec
tion (over one minute) 45-60 minutes before induction of general anaesthesia.
Experience with Zantac in children is limited and it has not been fully eval
uated in clinical studies - see PRECAUTIONS.

AVAILABILITY
Zantac Injection is available as 2mL ampoules each containing 50 mg ranitidine
(as hydrochloride) in 2mL solution for intravenous or intramuscular administra
tion. Packages of 10 ampoules.
Zantac Tablets are available as white film-coated engraved ZANTAC 150 on
one face and GLAXO on the other containing 150 mg ranitidine (as the
hydrochloride), in packs of 28 & 56 tablets.
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1. Morison, David H. et al: A Double-Blind Comparison of Cimetidine and
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INDICATIONS AND CLINICAL USE
Zantac injection is indicated for the treatment of duodenal ulcer, benign gastric
ulcer, post-operative ulcer, reflux esophagitis, Zollinger-Ellison syndrome and
other conditions where reduction of gastric secretion and acid output is desirable.
These include the prophylaxis of gastrointestinal haemorrhage from stress ulcera
tion in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients
with bleeding peptic ulcers and before general anaesthesia in patients considered to
be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients
during labour.
For appropriate cases Zantac Tablets are also available.

THE BETTER (pSffi ANTAGONIST.

CONTRAINDICATIONS
There are no known contraindications to the use of Zantac (Ranitidine).

WARNINGS
Gastric ulcer - Treatment with a histamine H 2-antagonist may mask symptoms
associated with carcinoma of the stomach and therefore may delay diagnosis of the
condition. Accordingly, where gastric ulcer is suspected the possibility of malig
nancy should be excluded before therapy with Zantac is instituted.

Glaxo
Glaxo Laboratories
A Glaxo Canada Limited Company
Toronto, Ontario Montreal, Quebec
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The Angelchik Antireflux Prosthesis
A silicone collar containing circumferen
tial tape was tied around the cardioesophageal junction in eight patients
with symptomatic, refractory reflux, who
were not good candidates for a standard
antireflux procedure. A fine polypropy
lene tie or clip secured the knot. In two
patients with large hiatal defects, the
crura were approximated loosely. Mean
operating time, including one
cholecystectomy and one ventral hernia
repair, was 51 minutes. Patients who
underwent this simple operation had a
combination of hypertension, heart dis
ease, obesity and old age, and two had
undergone horizontal gastroplasty previ
ously for morbid obesity. The reflux was
associated with hiatal hernia in seven of
the eight patients. Preoperative studies
included barium swallow roentgenogra
phy in all eight patients, and endoscopy,
manometry and Bernstein test in six. All
the studies were repeated postoperatively. Follow-up ranged from 17 to 48
months (mean 37.8 ± 10.6 months).
Postoperatively, there was a significant
(p < 0.01) improvement in symptoms,
endoscopic findings and lower
esophageal sphincter pressures. No
prosthesis has migrated yet.
Chez huit patients souffrant d'un reflux
symptomatique resistant et ne se pretant
pas a une intervention antireflux stan
dard, un collier de silicone renfermant en
circonference un ruban a ete noue a la
jonction du cardia et de I'oesophage. Un
petit clip de polypropylene a servi a fixer
le noeud solidement. Chez deux patients
souffrant de hernies hiatales importantes
les crura ont ete rapproches de facon
approximative. La duree moyenne de
I'intervention, incluant une cholecystec-

From the Department o f Surgery, Univer
sity o f Toronto and St. Joseph’s Health
Centre, Toronto, Ont.

tomie et la reparation d'un hernie ventrale, fut de 51 minutes. Les patients qui
ont subi cette operation simple souffraient d'une association d'hypertension,
de maladie cardiaque, d'obesite et de
vieillesse. Deux avaient subi dans le
passe une gastroplastie horizontale pour
obesite pathologique. Chez sept des huit
patients le reflux etait relie a la hernie
hiatale. A I'examen preoperatoire, une
radiographie apres repas baryte a ete
pratiquee chez les huit malades, et une
endoscopie avec manometrie et test de
Bernstein chez six. Ces examens furent
repetes apres I'operation. Les examens
de controle s'echelonnent sur de 17 a
48 mois (moyenne de 3 7 .8 ± 10.6 mois).
En postoperatoire, on a note une amelio
ration marquee des symptomes (p < 0 .0 1 ),
des observations d'endoscopie et de la
pression de sphincter du bas oesophage.
Aucune prothese n'a bouge jusqu’a
maintenant.

The conventional operations for sympto
matic, refractory gastroesophageal reflux
during the past 15 years have been the Hill
repair and Belsey and Nissen fundoplications.1'3 These are major operations.
When performed by experienced sur
geons, the reported recurrence rate is 5%
to 15%, which is an improvement over
the 50% recurrence rate o f the Allison
repair.4 Angelchik and Cohen5 reported
their use o f an antireflux prosthesis since
1973, with good results. This prosthesis
has been used widely; more than 20 000
have been implanted to the present (Barrowcliff E: personal communication,
1984). Although our standard antireflux
procedure remains a fundoplication, we
believe that the Angelchik device merits
consideration. Thus, from August 1980
to March 1983 we used the rapid Angel
chik procedure in eight poor-risk patients
with symptomatic reflux that was re
fractory to vigorous medical therapy.

Accepted fo r publication Oct. 22, 1984

The Prosthesis

Reprint requests to: Dr. M. Deitel, Depart
ment o f Surgery, St. Joseph‘s Health
Centre Research Foundation, 30 The
Queensway, Toronto, Ont. M6R IBS

The prosthesis (Fig. 1) consists o f a Cshaped collar, with an outer silicone
elastomer shell containing highly crosslinked silicone gel. A Dacron tie-tape is
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incorporated in the outer casing of the
prosthesis circumferentially. A radio
paque tantulum strip is incorporated with
the circumferential strap for radiologic
identification o f the prosthesis. The inner
diameters of the prosthesis are 3.1 and 2.5
cm and the outer diameters are 6 and 7
cm. The prosthesis weighs 45 g.
Surgical Technique
The abdomen is entered through a
short midline incision, the stomach is
reduced if necessary and the lower
esophagus mobilized with minimal dissec
tion. If the hiatal crura are widely apart,
they are approximated but not tightly
(this was necessary in two patients). The
tape is wound on the right index finger,
and the prosthesis brought through from
left to right and oriented with straps
anteriorly. The straps are tied with a
secure knot, which approximates the ends
o f the C anteriorly, encircling the lower
end o f the esophagus loosely (allowing
room for two fingers between prosthesis
and esophagus). The straps are cut about
2 cm outside the knot, and a clip is
applied or a nonabsorbable suture is tied
(or both) just outside the knot in order
to prevent knot slippage.

FIG- 1—Angelchik antireflux prosthesis.
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Patients and Methods
Indications for this operation were a
com bination of hypertension (five
patients), marked obesity (five), old age
(three), atherosclerotic heart disease with
previous myocardial infarctions (two),
angina pectoris (one) and a previous
horizontal gastric partitioning for morbid
obesity (two). One patient (case 8, Table
I) required drainage of an aspiration lung
abscess in the right lower lobe 1 month
before insertion of an Angelchik prosthe
sis. One cholecystectomy and one ventral
herniorrhaphy were performed under the
same anesthetic as insertion of the
prosthesis. The seven women and one
man ranged in age from 28 to 75 years
(mean 54 years). In all patients the gas
troesophageal reflux had been refractory
to medical management, including elevat

ing the head of bed, taking cimetidine,
metoclopramide and antacids, fasting 2
hours before bedtime and attempting to
lose weight. In all patients the reflux was
associated with a sliding hiatal hernia
except in one who had had a horizontal
gastric partitioning who had free gas
troesophageal reflux alone (patient 6). All
eight patients have been followed up from
17 to 48 months postoperatively (mean
37.8 ± 10.6 months).
All eight patients had barium swallow
and upper gastrointestinal roentgenogra
phy preoperatively; these studies were
repeated 3 to 9 months postoperatively.
Although all have been followed up to the
present, because they have no symptoms,
they have refused to undergo a more long
term repetition of the studies; only in
patient 6 with persisting moderate heart

Table 1-Results Pre- and Postimplantation of Angelchik Antireflu* Prosthesis

Case
no.
i
2
3
4
5
6
7
8
'Mean
tMean
*Mean
§+ LES -

Endoscopic
grade
preop/postopt

Age, Date prosthesis Symptom score,
Implanted
preop/postop*
Vi
—
1.1/0.0
75 Aug. 15, 1980
—
50 Aug. 18, 1980
1.0/0.6
0.9/0.0
0/0
68 Jan. 9, 1981
39
Feb. 13, 1981
1.9/0.0
2/0
1.4/0.0
1/0
28 Mar. 10, 1981
53 Nov. 24, 1981
2.6/0.5
3/1
72 Feb. 28, 1982
1.8/0.0
2/0
47 Mar. 15, 1983
2.8/0.5
2/0
score ± SD, 1.7 ± 0.7/0.2 ± 0.3 (p < 0.01).
grade ± SD, 1.7 ± 1.0/0.2 ± 0.4 (p < 0.01).
pressure ± SD, 7.5 ± 3.9117.8 ± 4.3 Ip < 0.01).
positive result, - = negative result.
lower esophageal sphincter.

Fig. 2a

Mean LES
pressure,
mm Fig,
preop/postop*

Bernstein
test
preop/postop§

—

—

—

—

6/10
2/20
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FIG. 2—Case 1. Roentgenogram after barium swallow (a) before and (b) after operation,
showing prosthesis in position.

burn and in patient 7 (who was admitted
to hospital for a femoropopliteal bypass
graft) were we able to perform studies
again, 24 and 30 months after operation
respectively. Pre- and postoperative
symptoms (regurgitation, heartburn, dys
phagia, food intolerance, choking at
night, chest pain, indigestion and weight
loss in patients other than those who had
had gastric partitioning) were graded 0 to
3 (none, mild, moderate and severe). The
mean values were compared.
On the last six patients, seen since
January 1981, upper gastrointestinal
endoscopy, esophageal manometry and
Bernstein acid infusion test were also per
formed preoperatively and 3 to 9 months
postoperatively, and a second postoper
ative study was done in patients 6 and 7
at 24 and 30 months. The Olympus Q gastroscope (W. Carsen Co., Don Mills,
Ont.) was used. Esophagitis as seen
through the endoscope was graded
according to the criteria of Behar and
Sheahan:6 0 — normal, 1 — erythema,
2 — erythema, friability and exudate, 3
— friability and linear erosions and 4 —
all of the above plus deep ulcerations.
Esophageal biopsies generally were not
taken, as we believe that biopsies of the
esophagus for reflux pathology are
unreliable; we reserve biopsies and brushings to rule out the presence of malignant
strictures and premalignant conditions.
Esophageal manometry utilized the
triple-lumen polyethylene catheter with an
internal diameter of 1.1 mm and three
side-holes 120° from each other and 5 cm
apart. The three ends of the catheter were
connected to an Arndorfer pneumohydraulic low-compliance capillary infu
sion system7 and Beckman four-channel
dynograph recorder (Beckman Instru
ments, Etobicoke, Ont.). The lower
esophageal sphincter pressure was
recorded using the mean of the six values
from two station pull-throughs, with the
mean gastric reading representing the
baseline. A Bernstein test8 was done
upon completion of the motility studies,
using 0.1 N hydrochloric acid (and nor
mal saline for confirmation) at a point 5
cm above the lower esophageal sphincter.
Only patient 6 had 24-hour pH electrode
monitoring performed; this was done
through the Toronto General Hospital,
and showed considerable postoperative
improvement in reflux score. This test has
only recently become available at our
hospital.
Symptoms, endoscopic findings and
lower esophageal sphincter pressures were
compared pre- and postoperatively by the
f-test for paired samples.
Results
Mean operating time was 51 minutes
(ranging from 35 to 68 minutes), includ-
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ing the concomitant cholecystectomy and
ventral herniorrhaphy. Mean postopera
tive hospital stay was 7 days (ranging
from 5 to 12 days). No patient had reflux
or hiatal hernia on postoperative roent
genography after barium swallow (Figs.
2 to 5). No prosthesis has yet migrated.
The score of reflux symptoms was
1.7 before implantation and 0.2 after
(p < 0.01) (Table I). All eight patients
were markedly improved, but two
patients (cases 2 and 8) have persisting
slight dysphagia to hard foods and patient
6 (who had had horizontal gastric parti
tioning) has moderate heartburn but is
much improved. In the six patients
studied, endoscopic grading changed
from a mean of 1.7 before to 0.2 after
implantation (p < 0.01). Patient 6, who
had had horizontal gastric partitioning
with free reflux, still had erythema, some
friability and exudate at 9 months, but at
30 months, endoscopy showed just
erythema above the Z-line.
Resting lower esophageal sphincter
pressure increased from a mean of 7.5
mm Hg to 17.8 mm Hg (p < 0.01) (Table
I). The Bernstein test preoperatively gave
a positive result in four out of six patients,
but a negative one in all postoperatively.
The Bernstein test is not infallible in welldocumented reflux disease; patients 3 and
5 had severe regurgitation of bitter acid
juice with choking at night preopera
tively, without evidence of esophageal
mucosal sensitivity to acid.

ed ,*4,19,20 as originaiiy the straps were
attached to the edges of the collar.
Since February 1982, the polyester
Dacron straps have been circumferential,
and can no longer be pulled off their
moorings. Knot slippage is avoided by
multiple secure knots, with a nonabsorb
able tie or large clip just beyond the tie,
or both. Intraluminal erosion10,21 is
avoided by not using the prosthesis near
a suture line or over a hole in the esopha-

M.B.
M.B.

Discussion
W ith the evolution of operations to
control reflux, good results are now being
reported.1-3 However, there are compli
cations with each repair.9-10 In Polk’s
312 fundoplications, there was a 7% inci
dence of splenectomy,11 and Ferraris and
Sube12 reported an 11% incidence of
incidental splenectomy. Late dehiscence
of the fundoplication has been re
ported .11,12 Other problems associated
with fundoplication are a 6% to 51 % inci
dence of “ gas bloat” and dysphagia,12,13
but these tend to be temporary,14 and the
operation is highly successful in the
majority of cases.
Reports about the Angelchik antireflux
prosthesis indicate that 80% to 100% of
patients become completely asympto
m atic.15 No deaths have been reported.
The main side effect is transient postoper
ative dysphagia which resolves in 1 to 3
m onths.14 Patients initially take soft
foods chewed well or those prepared in
a blender.
The prosthesis has potential compli
cations. Migration into the mediasti
num 14,16,17 can be avoided by approxi
mating the crura if they are wide apart,
but without making the hiatus tight.18
Migration to the pelvis, from knot slip
page or torn straps, has been report
178

gus. Minimal dissection will prevent the
prosthesis from moving down the
stomach.19
Infection is a potential problem with
any foreign material, but has not been
reported with this prosthesis. However,
the device should not be used if bowel dis
tal to the pyloroduodenal area is opened
or if the patient has an infection else
where. The silicone shell should not be
handled more than necessary because

Fig. 3a
Fig. 3b
FIG. 3—Case 4. Barium studies (a) before, (b) after operation.

J.B.

J.B.
Fig. 4a
Fig. 4b
FIG. 4—Case 5. Barium studies (a) before, (b) after operation.
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starch from gloves and lint adhere to it
and could cause fibrosis and stricture, and
it must not be punctured. If the crura
have to be approximated, this should be
done before inserting the prosthesis.22
We applied the prosthesis directly from
its inner package or kept it in saline until
ready for use. The device should proba
bly not be used in patients with motility
disorders. Furthermore, there is danger
of it being used unnecessarily at the end
of other operations, when the patient has
a history o f reflux. There has been nega
tive opinion at some academic centres,
without much basis, regarding use o f the
prosthesis.23-25 However, we must also be
cautious o f marketing overtures by the
manufacturers.
The mechanism of action o f the Angelchik prosthesis is not settled: the weight
of the prosthesis may hold the cardia in
the abdomen, allowing transmission of
positive intra-abdominal and intragastric
pressure to the lower esophageal sphinc
ter;17’26 it may act as a posterior padding
or buttress, displacing the posterior
esophageal wall forward and decreasing
the anterior-posterior diameter o f the
lower esophagus,26'27 or it may interrupt
transmission o f tension in the gastric wall,
thereby preventing distraction o f the
lower esophageal sphincter.28
The prosthesis effectively controlled
reflux in our small series o f eight patients,
who were selected because they were not
good candidates for a standard antireflux
procedure. Randomized studies compar
ing the results obtained with this prosthe
sis to those o f the Nissen fundoplication
are in progress at three separate cen
tres.16,28-30 Presently, use o f the device

should generally be restricted to investiga
tional centres, with long-term surveil
lance.
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Fournier’s Gangrene
F ou rn ie r's disease — gangrene o f th e
penis and scrotu m — is an uncom m on
c o n d itio n . During th e p a st 6 years, fiv e
p a tie n ts, w hose cases are described,
w e re a dm itted to T o ro n to General H ospi
ta l w ith th is diagnosis. Four had preced
ing traum a (ischiorectal abscess, p u n c
tu re w o u n d , surgery) and fo u r had
pre -e xistin g d e b ilita tin g problem s (dia
betes, rectal carcinom a, acute lym p h o 
c y tic leukemia, a lco h o lic cirrhosis).
A p p ro pria te tre a tm e n t m u st include
u rg e n t radical surgery to rem ove all
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FIG. 1—Case 1. Early gangrene of penis and
scrotum.
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necrotic tissu e , and co m b in a tio n a n tib i
o tic th e ra p y d irecte d against th e likely
organism s, w h ich are aerobic gram 
negative rods, g ra m -po sitive cocci and
anaerobes. C lindam ycin in com bination
w ith to b ra m ycin or g e n ta m icin proved to
be e ffe ctive in th is series.

e ffica ce c o n tre les m icroorganism es
soupconnes, s o it les b atonnets gramne g atifs, les c o cci g ra m -po sitifs et les
anaerobies. Une a ssociation clindam ycin e -to b ra m ycin e ou clindam ycine-gentam ycine s 'e s t averde e ffica ce dans les cas
d e crits ici.

La maladie de Fournier, so it la gangrene
du penis e t du s cro tu m , est une a ffe c
tio n rare qui fu t d e crite pour la premiere
fo is en 1 8 8 3 . A u co u rs des 6 dernieres
annees, cin q pa tie nts porteurs de ce dia
gnostic o n t ete hospitalises au Toronto
General H o spital. Q uatre avaient precedem m ent subi un tra u m a tism e (abces
ischiorectal, blessure par p e rfo ra tion , chirurgie) et qua tre s o u ffra ie n t ddja d'une
maladie d e b ilita n te (diabete, cancer du
rectum , leucem ie lym p h o cyta ire aigue,
cirrhose alcoolique).
Le tra ite m e n t approprie necessite un
traite m e n t ch irurg ica l radical d 'urgence
afin d 'e lim in e r to u t tissu necrotique et
I'a d m in istra tio n d 'u n e antibiotherapie

Fournier’s gangrene — a necrotizing, sub
cutaneous infection o f the penis and scro
tum — was first described by the French
venerologist, Fournier, in 1883.1 He
reported five previously healthy patients
in whom the condition was o f abrupt
onset and progressed rapidly. In that
preantibiotic era, he stated that the con
dition was idiopathic.
Today, much more is known about
Fournier’ s gangrene. Most cases proba
bly develop by one o f three mechanisms:
local trauma, extension from a urinary
tract infection, or extension from the peri
anal or ischiorectal area.24 M any
patients have diabetes mellitus or some
other debilitating condition. Fournier’ s

FIG. 2—Case 1. Appearance after second
debridement of necrotic tissue.

FIG. 3—Case 1. Penis and abdominal wall
were resurfaced with split-thickness skin grafts,
testes were buried into subcutaneous pockets
in medial thighs.
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gangrene may affect patients of all ages
— from newborns to the elderly.2’4 The
typical bacteriologic flora usually includes
aerobic gram-negative rods, gram
positive cocci and anaerobes, especially
Bacteroides fragilis.2'5-6 The condition is
usually accompanied by fever and toxe
mia and is often life-threatening.2
During the past 6 years, five patients
have been referred to the Toronto
General Hospital for treatment of Four
nier’s gangrene. This study analyses these
patients.

drainage of an ischiorectal abscess at another
hospital. There was massive swelling and cel
lulitis of the penis, scrotum and lower abdomi
nal wall (Fig. 1), and a fecal, anaerobic odour.
Clindamycin (250 mg), penicillin G (2 million
units) and gentamicin (80 mg) were given
intravenously, and the patient was prepared
directly for surgery.
At operation, much of the skin of the penis,
scrotum and lower abdominal wall was found
to be devitalized and this was excised. He was
then treated with hyperbaric oxygen and was
returned to the operating room for further exci
sion the following day, at which time the
remainder of the necrotic skin and soft tissue
was excised from the involved areas (Fig. 2).
The exposed areas were treated with wet to dry
dressings for 10 days, and the penis and
abdominal wall were resurfaced with split-

Case Reports

Case 1
A 45-year-old man was seen 48 hours after

thickness skin grafts. The exposed testes were
buried into pockets in the medial portion of
the thighs (Fig. 3). These wounds healed
smoothly and the patient was discharged on the
24th hospital day. He had recurrent bouts of
lymphangitis of the penis which responded to
antibiotic therapy but has not had any lym
phangitis for the past 6 months. He remains
sexually active and has no other specific
problems.

Case 2
A 68-year-old man was admitted with
impending gangrene of the penis, scrotum and
lower abdominal wall, 2 weeks after he sus
tained traum a to the perineal region. He had
accidentally fallen on his lawn-mower and the
wheel-adjustment lever had pierced his
perineum! He had swelling and pain in the
penis and scrotum within 2 days but did not
seek medical help for a full week. He was then
given antibiotics to be taken orally. He
returned several days later with a fully deve
loped Fournier’s gangrene.
On admission, he was given clindamycin
(250 mg intravenously) and ampicillin (1 g) and
operated on immediately. The procedure
involved radical debridement of the involved
skin and soft tissue of his penis, scrotum and
lower abdominal wall (Fig. 4). A large part of
the abdominal wall was involved. The open
areas were treated with dressings for about 10
days and then were covered with split-thickness
meshed skin grafts. The exposed left testicle
was placed into a pocket in the left thigh (Fig.
5). His wounds healed well. He was discharged
from hospital on the 29th day and has had no
further problems.

Case 3

FIG. 5—Case 2. Penis and abdominal wall
have been resurfaced with skin grafts and left
testicle has been buried into subcutaneous thigh
pocket.

FIG. 4—Case 2. Appearance after extensive
debridement of necrotic tissue from penis, scro
tum and abdominal wall.

A 61-year-old man originally underwent an
anterior resection of the rectosigmoid colon for
rectal carcinoma. Subsequently, a colonic
fistula developed, causing dehiscence of the
abdominal wound. This was followed by gan
grene of the scrotum and penis which was
treated with radical surgery. The exposed areas
were treated with local skin grafting. He was
subsequently discharged from hospital and
made a complete recovery.
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Case 4
In this 71-year-old man, who was a dietregulated diabetic, an ischiorectal abscess deve
loped which was drained at another hospital.
Gangrene of the scrotum and penis developed
and he was admitted through our emergency
department. Tobramycin, cloxacillin and clin
damycin were started intravenously. Radical
debridement and skin grafting were done. He
had several complications, including tobramy
cin nephrotoxicity and a fistula-in-ano, but he
eventually made a full recovery.

Case 5
A 44-year-old man, with a known diagno
sis of acute lymphocytic leukemia, was admit
ted with an incarcerated inguinal hernia, alco
holic hepatitis and Fournier’s gangrene of the
scrotum, abdominal wall and left upper thigh.
Unfortunately, he died within hours of admis
sion. Death was attributed to sepsis.

Discussion
Our five patients with Fournier’s gan
grene ranged in age from 44 to 71 years.
All had definite predisposing factors: four
had a history of local ischial or perineal
trauma, and four had debilitating condi
tions (diabetes, rectal carcinoma, leuke
mia, alcoholic cirrhosis) (Table I).

All five patients were referred to us
after the diagnosis of Fournier’s gangrene
had been made. Several had been started
on antibiotics before they were admitted
to our hospital. Positive wound cultures
demonstrated multiple aerobic and
anaerobic organisms, suggesting the pos
sibility of a synergistic interaction among
different bacterial species.2,7 Antibiotic
therapy was directed against the antici
pated flora: gram-negative bacilli, gram
positive cocci and anaerobic bacteria,
including Bacteroides fragilis (Table I). A
reasonable choice of antibiotics appeared
to be clindamycin (for gram-positive and
anaerobic bacteria) and tobramycin or
gentamicin (for gram-negative rods).
All patients underwent urgent radical
surgery with excision of the involved
necrotic areas. Antibiotics were only an
adjunct to this more important definitive
treatment. Three patients had further
debridement after 24 hours. One patient
underwent hyperbaric oxygen therapy.
This may be useful but only in addition
to surgery and appropriate antibiotic
therapy.
Each of our surviving patients under
went a single uncomplicated skin-grafting
procedure 10 to 14 days after the initial

operation. In two, exposed testes were
placed into subcutaneous pockets in the
medial part of the thigh. Secondary scro
tal reconstruction8 was considered in two
others, but was declined.
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OUR SURGICAL HERITAGE
A. Campbell Derby,

md , frcsc

The Military Surgeon — Not Least in the Crusade
*
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The h is to ry o f th e surgeon in w a rfa re is
brie fly review ed. The ste a d y im pro ve 
m en t in m o rta lity and m o rb id ity in the
m ajor w a rs o f th e 2 0 th c e n tu ry has been
based on a m elding o f sound surgical
and m edical m ilita ry principles.
A num ber o f p oints are emphasized.
Care in the fo rw a rd area is directed
to w a rd s those m easures th a t w ill
preserve life and fa c ilita te early and com 
fo rta b le evacuation to fo rw a rd surgical
hospitals. Triage is v ita l a t th is level w ith
criteria fo r adm ission to h o sp ita l depend
ing at any one tim e on ca su a lty loads
and surgical po ten tia l, th e rem aining
patien ts being sent to large and relatively
fixe d hospitals in the rear. A ll selected
patien ts are ad m itte d to a resuscitation
w ard w here, a fte r th o ro u g h evaluation,
life-saving measures are in s titu te d and
blood-volum e d e fic its rapidly replaced
before operation. The aim is to debride
th o ro u g h ly all w o u n d s w ith in 8 hours o f
injury. The w o u n d s are le ft open and
dressed to be fo llo w e d by delayed
prim ary closure in 7 to 10 days. Repara
tiv e surgery, exce p t to save lim b or life,
is undertaken o nly w h e n th e w ou n d has
healed.
The au tho r rem inisces a b o ut some
Canadian m ilita ry surgeons he has
k n o w n and relates som e surgical vig
ne ttes from th e tw o w a rs in w h ic h he
p articipated.
On exam ine b rie ve m e nt I'h is to ire du chirurgien dans la guerre. Le declin co n ti
nue! dans la m o rta lite e t la m orbidite
d u ra n t les guerres m ajeures du XXeme
siecle a ete base sur une com binaison de
principes solides ch iru rg ica ux e t militaires.
On accentue les p o in ts qui suivent.
Les soins dans la zone avancee sont
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bases sur les m esures qui sauveront la
vie e t fa c ilite ro n t l'6 va cu a tio n rapide et
co n fo rta b le vers les h o p ita u x c h iru rg i
caux avances. Le tria g e des patients est
v ita l a ce tte etape, e t les e n tire s p o u r
adm ission a I'h o p ita l dependent en to u t
te m p s du nom bre de blesses et le p o te n 
tia l chirurgical. Les autres blesses s o n t
envoy6s aux h o p ita u x plus spacieux et
plus perm anents a I'arriere. Tous les
blesses adm is a I'h o p ita l dans la zone
avancee so n t places dans une salle de
resu scita tio n et evalues a fond. Les
m esures de resu scita tio n so n t e ntreprises
e t les d e ficits de volum e sanguin so n t
rem places rapidem ent a va n t la ch iru rg ie .
Ensuite, le b u t e st de debrider a fo n d
to u te s les blessures d u ra n t les prem ieres
8 heures. Les blessures dem eurent
o uvertes et pansees e t puis sont ferm ees
en seconde in te n tio n 7 a 10 jours plus
ta rd . On n 'e n tre p re n d la chirurgie reparatrice que quand une blessure est guerie,
sa u f quand il y a necessity de sa u ve r le
m em bre ou la vie.
En te rm in a n t, I'a u te u r raconte ses so u 
venirs de quelques chirurgiens m ilita ire s
canadiens q u 'il a connu e t fa it le re c it de
quelques v ig n e tte s chirurgicales qu i o n t
eu lieu pendant les guerres dans lesquelles il a participe.

Civilian surgery is an ongoing process
with a constant improvement in diagno
sis, treatment and technique. But the prin
ciples of military surgery, so dearly
learned during a war, are quickly forgot
ten in peacetime only to be expensively
relearned by a new generation forced to
participate in another conflict.
Most members of the present Canadian
medical profession have had no more
than a fleeting contact with military sur
gery. Furthermore, no medical student,
intern or resident in Canada has had any
exposure to the principles of military
surgery.
As this is the 25th anniversary of the
Canadian Forces Medical Service, and 40
years since “ D Day” , it is appropriate to
review briefly the role of the military sur
geon in warfare and to discuss some of
the reasons for the improvements in sur

gical results made in each new war.
Finally, I would like to reminisce for a
moment about some Canadian military
surgeons I have known.

Historical Background
One would think that in the long his
tory of military conflict the treatment of
the battle casualty should have been of
prime importance to the military com
manders, for the saving of life or limb fre
quently meant that the soldier could fight
another day.1 Another equally important
consideration was not only humanitarian
but one of morale.2 A soldier who could
face sudden death from enemy action
with equanimity might well give way
when confronted with the prospect of
dying on the battlefield in agony from a
mutilating wound without receiving med
ical attention.
Unfortunately, these considerations
were ignored in most wars for many cen
turies.
Early Wars
The battle of Waterloo was fought on
June 15, 1815.3 Nine hours of fighting
left more than 40 000 men lying dead and
wounded in an area little more than
5 km2. Evacuation of the casualties was
haphazard. Some of the wounded were
transported the 32 km to Brussels in
rough army wagons or were carried on
stretchers by regimental bandsmen. Many
were left to make their own way either on
horseback or on foot and many more
were left on the battlefield to die. Some
of the available medical officers carried
out first aid on the battlefield, but most
remained in Brussels.
Some 10 000 soldiers died under hor
rible circumstances in the Crimea in
1854,3 many of them in the mud of the
battlefield as, once again, no organized
evacuation was available. Of those able
to make their way to hospital, many died
in the filthy, pest-ridden barracks hospi
tal at Scutari.
Fewer than 100 years ago, Rudyard
Kipling gave this grim advice in the poem
“ The Young British Soldier” :
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When you’re wounded and lie on
Afghanistan’s Plains,
And the women come out to cut up
what remains,
Jest roll to your musket and blow
out your brains
An’ go to your Gawd like a Soldier.

Indeed, it was not until the turn of the
20th century, with the formation of the
British4 and Canadian5 medical corps,
that military commanders reluctantly
accepted medical units with fixed estab
lishments in the battle plan.
Military surgeons quickly discovered
that war wounds had dire consequences
for the soldier and the more sophisticated
the weapon, the more complicated was
the injury. Serious wounds in most cases
led to death. However, if the soldier did
survive the initial wound he could then
look forward, all too frequently, to infec
tion, gangrene, secondary hemorrhage,
amputation and eventually death or per
manent deformity or disability.
Many bizarre methods of treatment
were used.6 In the 16th century it was
common practice to cauterize gunshot
wounds with boiling water mixed with
treacle and to use boiling pitch to control
secondary hemorrhage. These forms of
treatment proved so unsatisfactory and
the mortality from gangrene was so high
in the hospitals that wholesale amputa
tion became the treatment of choice.7 It
was thought better to remove the limb
and have a live patient. Unfortunately,
amputation did little to prevent infection
and death.
World War I
At the outbreak of World War I on
Aug. 4, 1914, the answers to the myster
ies of the wounds of war seemed to have
been solved. Pasteur had discovered bac
teria and, as a result, Lister advocated
antisepsis. It is little wonder then that the
surgeons set out for France with high
hopes and gallons of antiseptics. Further
more, new mobile forward medical units,
the field ambulance and the casualty
clearing station were to assure adequate
first aid and early evacuation of casual
ties.
Unfortunately, this is not how it
worked out. Because of overwhelming
numbers of wounded, surgery was often
delayed up to 48 hours. Moreover, the
increased destructive power of the new
types of missile inflicted severe and com
plicated injuries. The mortality, although
improved, was anything but satisfactory.
Infection and gas gangrene remained a
problem. Amputation rates were unac
ceptably high, soldiers continued to die
of shock in spite of a very limited use of
blood, and the head, abdominal and chest
wounds were fatal in more than half the
cases.
There was one bright spot — with the
184

introduction of antitoxin, tetanus was
almost eliminated.
At the end of this terrible war, there
were 2 000 000 battle casualties, 700 000
deaths and a hospital mortality of over
120/o.6

Unfortunately, the answer to the treat
ment of war wounds did not lie with
antiseptic irrigations — the solution
would have to await another conflict.
World War II
World War II saw the introduction of
the advanced surgical centre (ASC).8
These units were located as far forward
as possible to facilitate early surgery.
They consisted of a casualty clearing sta
tion or field dressing station as the par
ent unit, with a field surgical unit and
field transfusion unit attached. The field
surgical and field transfusion units were
small and self-contained, with complete
facilities in personnel and equipment
(including canvas and transportation) for
forward surgery or resuscitation. The
great advantage was that they could be
quickly attached to or detached from a
parent unit as tactics demanded.
The ASC screened all cases coming
from the front, the sorting being carried
out in a large unobstructed admission
area by skilled triage surgeons and staff.
Triage was vital at this level, for mistakes
were frequently fatal.
Approximately 15% of patients were
admitted to the ASC. The remaining 85%
were evacuated to larger and relatively
fixed hospitals in the rear. The wounded
who were admitted included all patients
in shock, those with penetrating abdomi
nal and chest wounds, amputations,
femoral fractures and major vascular
injuries. Soldiers with head and maxil
lofacial injuries were transferred to spe
cial centres located close behind the
ASCs.
All patients were admitted to the resus
citation ward. This was also a large unob
structed area where their condition was
thoroughly evaluated. Wounds of en
trance and exit were noted and resulting
organ and limb damage was assessed.
Life-saving measures were instituted and
blood-volume deficits rapidly restored
with whole blood and electrolyte solutions
before operation.
It became evident in 1940, as shown by
the excellent results of Trueta9 in the
Spanish Civil War and by a very limited
number of surgeons in World War I,10
that the terrible infection rate of previ
ous wars could be prevented by early
debridem ent o f all w ounds.11 By
debridement was meant the enlargement
of the wounds of entrance and exit and
the removal of all dead and devitalized
skin, subcutaneous tissue, fat, muscle and
detached bone fragments with muscle
debridement being continued until only

pink bleeding and contracting muscle
remained. Fasciotomies were done, as
indicated, to relieve tension and ensure
drainage of subfascial hematomas.
Minimal reparative surgery was under
taken deep to the skin except for those
structures that needed restored function
to maintain life or limb, such as a rup
tured small bowel or severed femoral
artery. Following debridement, the
wounds were drained and, most impor
tantly, left open. Pressure dressings were
applied and splinting was used as indi
cated. In approximately 7 days the previ
ously debrided wounds were closed by
direct suture, rotation flap or skin graft.
These principles were enthusiastically
incorporated in the battle plan of the sur
geons in the desert and in Europe.
The results were indeed rewarding. The
answer to gas gangrene and the infected
wound had arrived. The hospital mortal
ity in World War II was reduced to
4.5% .12
Morbidity was also reduced; the frac
tured femur was an excellent example.13
After initial debridement and immobili
zation in a Tobruk splint in the forward
area, these patients were evacuated to the
base hospital where delayed primary
closure was done. They were then placed
in balanced traction with a tibial tuber
cle pin, and knee-joint movement was
begun early. When the fracture was con
sidered to be stable, they were immobi
lized in a spica cast and sent home.

Recent Wars
Advances in the Korean War included
repair of major arterial injuries, the treat
ment of post-traumatic renal insufficiency
and the introduction of helicopter evacu
ation.
Before the Korean War, ligation was
the accepted treatment of major arterial
injuries, resulting in an amputation rate
of 50% in World War II. In the Korean
conflict, direct arterial repair was
attempted in 304 cases of major arterial
injury with an overall amputation rate of
16.5%.14 End-to-end anastomosis with
out tension was possible in 40%. In the
remaining 60% an autogenous vein graft
was inserted between the divided ends.
Post-traumatic renal insufficiency in
battle casualties was first described in
World War II in crush victims and later
was recognized as a delayed cause of
death in many who had sustained a pro
longed period of shock. No satisfactory
treatment was available and most estab
lished cases proved fatal. In Korea a
renal centre was established behind the
mobile army surgical hospital (MASH)
units where soldiers in whom oliguria
developed were evacuated by helicop
ter.15’16 Of these patients, 50% were
treated successfully by conservative meas-
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ures. Of the remaining 50% who were
treated by dialysis, 50% survived.
A limited number of helicopters were
made available as airborne ambulances.
They could transport two patients in
pods. This resulted in rapid and comfort
able evacuation of certain severely
wounded patients, with the saving of
lives. The overall hospital mortality in the
Korean War was 2.5% .12
In Vietnam, helicopter evacuation of
all wounded was introduced.17 These
large machines carried up to nine patients,
who received resuscitation en route.
Casualties were in hospital 1 to 2 hours
after wounding.
Resuscitation became more sophisti
cated, with much improved monitoring of
patients pre- and postoperatively. An
interesting beneficial effect of early resus
citation was that post-traumatic renal
insufficiency as seen in Korea was almost
nonexistent,18 the marked reduction in
the incidence of severe and prolonged
hypotension being a major factor.
In contrast to what happened in the
Korean War, all major arterial injuries
were repaired, surgeons with vascular
training being available in each forward
surgical centre. A thousand cases were
reported by Rich and associates19 with
an amputation rate of 13.1%.
It was learned the hard way in previ
ous wars that thoracotomy should be
reserved for the patients with chest
wounds who continue to bleed in spite of
chest-tube drainage and adequate resus
citation.20 These principles were accepted
in Vietnam. With better resuscitation and
more successful repair of heart, lung and
great-vessel injuries, an overall mortality
of 2.9% was reported.20,21
Wounds of the abdomen have always
been an enigma to the military surgeon.
Laparotomy was first used in World War
I with disastrous results — more than half
the patients died. In World War II and
the Korean War earlier evacuation, avail
ability of blood-electrolyte solutions and
penicillin, the use of nasogastric suction
and the standardization of treatment such
as exteriorization of all colonic injuries
and the direct suture of small-bowel
wounds, reduced the mortality to 20%.22
In two series from Vietnam, mortali
ties of 10% in 135 cases and 2.4% in 358
cases of penetrating abdominal wounds
were reported.23,24 Four factors seem to
be largely responsible for this improve
ment in mortality:
• Rapid evacuation and effective resus
citation made early surgery possible with
a decrease in the incidence of peritonitis
and other sequelae.
• Substantial improvements in opera
tive technique made possible better con
trol of hemorrhage from the liver,25,26
the exploration of all retroperitoneal
hematomas with the recognition and

repair of duodenal, kidney and pancreatic
wounds, and major vascular injuries and
improvement in handling wounds of the
rectum27 and right colon.28
• Improved anesthesia.
• Improved postoperative care.
In Vietnam the hospital mortality was
2.6% , approximately the same as in
Korea. However, helicopter evacuation
brought into the hospital many seriously
wounded patients who would have died
en route in other wars. A better index is
the ratio of soldiers killed in action to
those wounded in action. In Korea it was
1:4.1. In Vietnam 1:5.6.12

Dr. John Hillsman was born in Vir
ginia but married a Winnipeg girl and set
up practice there before the war. He
looked and talked exactly like General
George Patton. He always wore his steel
helmet, even in the operating room, and
his pistol was also worn at the ready, for
he disdained the Red Cross arm band. He
was a superb and fearless surgical tech
nician. He diagnosed and operated on
four patients with wounds o f the heart,
two of whom survived. He was the author
of the book entitled “ Eleven Men and a
Scalpel” ,31 in which he accurately
describes the battle conditions confront
ing the new military surgeon, who had no
comparable experience in civilian life.

Reminiscences
To reminisce about the two wars in
which I did surgery will bring back
memories to some, but most will have had
no firsthand knowledge of these conflicts.
I hope that these reminiscences will tell
the story of the Canadian military sur
geon in action — his heartaches, frustra
tions, failures and successes.
Dr. Angus McLaughlin, Professor of
Surgery at the University of Western
Ontario, recently made two interesting
points concerning forward surgery in
World War II: first, that his approach to
many surgical problems had been greatly
influenced by his experience as a military
surgeon; he quoted his pioneer work in
delayed primary skin closure29 of con
taminated abdominal wounds and in the
surgical management of diabetic gan
grene,30 and second, that the lasting
friendships he made during the war with
surgeons across Canada facilitated the
setting up of residency systems and new
departments and divisions of surgery. As
a result, the value of the Canadian fellow
ship in surgery, a hallmark of surgical
competence, was established.
During World War II, Dr. Ross Tilley
served with distinction as chief of surgery
in the Royal Canadian Air Force plastic
surgical wing of the Queen Victoria
Hospital at East Grinstead, England. He
was one of the pioneers in the saline treat
ment of burns and performed the plastic
surgery on most of the Canadian airmen
who were burned in action — an extraor
dinary experience. Many of his grateful
patients, who call themselves the “ Guinea
Pigs” , are still alive and meet regularly,
at which time they honour their surgeon.
Dr. D.L.C. Bingham, Professor Emeri
tus of Surgery at Queen’s University, did
forward surgery in North Africa on the
wounded of the famous Eighth Army.
This surgery was often done under appall
ing conditions, with limited supplies and
frequently when in retreat. A distin
guished gentleman and always a friend of
the armed forces, he is now retired and
lives on the west coast.

We operated in Secqueville for ten days and
covered the attack that took the City of Caen.
During those ten days we changed from mere
soldiers to war-wise veterans. We saw the tragic
sights from which we were never to be free for
ten long months. Men with heads shattered and
grey, dirty brains oozing out from the jagged
margins of skull bones. Youngsters with holes
in their chests fighting for air and breathing
with a ghastly sucking noise. Soldiers with
intestines draining feces onto their belly walls
and with their guts churned into a bloody mess
by high explosives. Legs that were dead and
stinking — but still wore a muddy boot. Oper
ating floors that had to be scrubbed with lysol
to rid the Theatre of the stench of dead flesh.
Red blood that flowed and spilled over while
life held on by the slender thread of time. Boys
who came to you with a smile and died on the
operating table. Boys who lived long enough
for you to learn their names and then were car
ried away in trucks piled high with the dead.
We became the possessors of bitter knowledge
that no man had ever been able to describe.
Only by going through it do you possess it.

No. 3 Canadian casualty clearing sta
tion was set up in Nijmegen, Holland, in
December 1944. When I came on duty to
work the evening shift in resuscitation, a
patient was admitted in profound shock
with a German bomb, 75 x 4.5 cm, pro
truding from his left lower quadrant.
Roentgenograms showed the head firmly
imbedded in the left sacroiliac joint.
Would dislodging the bomb from the
bone be sufficient to detonate it? The
officer in charge of surgery was the late
Dr. Lawrence Rabson from Winnipeg.
After the patient was resuscitated and
anesthetized, Dr. Rabson made everyone,
including the anesthetist, leave the oper
ating room. With great difficulty he
extracted the bomb. It didn’t explode. We
then returned to the operating room
and completed the operation. U nfor
tunately, the patient died. Rabson was
nominated for the Distinguished Service
Order but he was turned down.
The Canadian field surgical team in
Korea was attached to 8055 MASH. Dr.
Richard Hooker was a surgical staff
member and author o f the book
“ MASH” . Those of us who knew the
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M ASH could probably identify the
characters in the television series. Dr.
Gerry Lippart was the first commanding
officer o f the team. He is now practising
in Kitchener-Waterloo. He was followed
by the late Dr. Alan Davidson, a perma
nent service officer.
Summary

I have attempted to outline the princi
ples o f military surgery that have evolved
in the major wars of the 20th century.
With the advent of each new war, the
young civilian surgeon must learn these
principles and at the same time bring to
the field new surgical skills acquired
between the wars. When the war is finally
over and he makes the long journey
home, he brings with him a unique
experience that will be a stimulus to him
in civilian surgery.
A quotation from Brigadier Price’s
“ The Hymn to the Fallen” o f the Royal
Army Medical Corps seems also to be a
fitting tribute to my comrades-in-arms —
the military surgeons.
Unarmed they bore an equal burden
Shared each adventure undismayed
N ot less they earned the victors
guerdon
N ot least were they in the Crusade.
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BOOK REVIEW S

the personal libraries of surgeons particularly
interested in breast reconstruction.

continued from page 137

H. Bruce W illiams, md , frcsc
and discussed. However, no mention is made
of skin expansion techniques which surely must
be included for completeness if future editions
are planned.
The chapters on reconstruction o f the nip
ple areolar complex and the management of
congenital malformations of the thoracic area
are concise and include a detailed discussion
of Poland’s syndrome. The chapter on the tho
rax as a donor site for various flaps is also of
interest. The authors conclude with a chapter
on the management of lymphedema; the sub
ject is presented briefly, but the main points
of controversy are mentioned.
In summary, this new textbook represents
the combined experience of three surgeons with
extensive clinical knowledge. The various
procedures are presented in a logical manner
and the diagrams are excellent. 1 recommend
it for medical libraries and as an addition to

Director, Division o f Plastic and
Reconstructive Surgery,
Montreal General Hospital,
Montreal, PQ
H3G 1A4
SURGERY OF THE SKULL BASE. Edited
by Clarence T. Sasaki, Brian F. McCabe
and John A. Kirchner. 254 pp. Illust. J.P.
Lippincott Company , Philadelphia, 1984.
$72.50 (US). ISBN 0-397-50513-2.

This book is an outline to surgery of the skull
base. The text is edited by three otolaryngolo
gists but emphasizes the combined approach
to this region, involving the expertise of the
neurologic surgeon, the otolaryngologist and
the plastic surgeon.
Each chapter, written in a similar format by

authors from various disciplines, lists an out
line of the relevant surgical anatomy of the
skull base, as well as the indications for each
surgical approach. The surgical technique is
described and well illustrated by black and
white photographs and drawings. Instruments
and equipment required, as well as a diagram
of the arrangement of the operating room, are
included. Postoperative complications are
briefly discussed. Each chapter contains a limi
ted but adequate reference section.
I found the text easy to read despite the
multiple-author format. This text would be of
use to residents in training with an interest in
surgery of the skull base, and to the
experienced surgeon as a simple guideline and
concise reference.

Martin J. Black , md , frcsc
Chief, Department of Otolaryngology,
The Sir Mortimer B. DavisJewish General Hospital,
Montreal, PQ
H3T 1E2

CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The
deadline is 1 month before issue date. Regular classified rates (for each insertion): $37.00 for the first 40 words or less, addi
tional words 40C each (additional $14.00 for frame). Special Display under 75 words, 2 1/4" x 2" $90.00. $5.00 charge (first
insertion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.

DIRECTOR OF MEDICAL/SURGICAL
INTENSIVE CARE UNIT
The Moncton Hospital, a teaching 540-bed regional
hospital is looking for an intensivist to direct a
Medical/Surgical Intensive Care Unit of 18 beds.
The hospital serves as a tertiary centre to a population
base of over 200 000 people and has five intensive care
units.
The candidate is expected to provide leadership, advice
and guidance to all staff in the Medical/Surgical Unit and
for all staff involved in the care of seriously ill or injured
patients.
Candidates should be qualified in Intensive Care, i.e.,
FRCPC in Surgery, Anesthesia or Internal Medicine with
Fellowship in Intensive Care or at least 1 year's formal
training in Intensive Care.

Applications may be submitted in confidence to:
Dr. Ginette Gagne-Koch
M edical Director
The M oncton Hospital
135 M acB eath Avenue
M oncton, NB
E1C 6Z8

-S85-10

ORTHOPAEDIC SURGEON TO BE CHIEF
OF SURGERY
ORTHOPAEDIC AND ARTHRITIC HOSPITAL
43 Wellesley Street East
Toronto, Ontario
The Orthopaedic and Arthritic Hospital, a 140-bed fully ac
credited facility in downtown Toronto, is actively recruiting an
academic orthopaedic surgeon to be its Chief of Surgery.
The hospital offers opportunities for patient care, research and
teaching in the midst of a vibrant setting.
The hospital's orthopaedic service is affiliated with the Faculty
of Medicine, University of Toronto, and consists of 100 beds, a
new 8-bed day surgery unit and busy outpatient clinics. There
are currently five full-time orthopaedic surgeons on staff as well
as six part-time staff.
Our rheumatology service consists of 27 beds and busy outpa
tient clinics; expansion of the rheumatology service is also in
progress. We have three full-time rheumatologists on staff and
plans to increase this number to five in the near future. There are
also four internists on staff.
Income on a fee-for-service basis. Remuneration and support
of administrative and academic functions to be negotiated.
This is a challenging position and applicants are requested to
send their resume, in confidence, by April 30, 1985, to:
C h airm an , Search C o m m ittee
C h ief o f Surgery
c /o M r. B .J. M on agh an
A d m in is tra to r
O rth op aed ic and A rth ritic Hospital
43 W ellesley S tre e t East
T o ro n to , O ntario
M 4 Y 1H1
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CHIEF, DIVISION OF CARDIAC SURGERY:
NF — Health Sciences Centre, St. John's,
Newfoundland. The successful candidate will
be responsible to the Chairman of Surgery for
clinical, administrative and academic leadership
to the Division of Cardiac Surgery at the major
teaching institution of Memorial University
Medical School. Approximately 300 adult pump
cases are undertaken per year in the hospital. In
addition the Division of Cardiac Surgery plays a
role in the undergraduate teaching and in the
General Surgical Residency Training Program.
There are active clinical and basic research pro
grams. Applicants should submit an up-to-date
curriculum vitae together with the names of two
referees to: Dr. C. Heughan, Chairman of
Cardiac Surgery Search Committee, De
partment of Surgery, Health Sciences Cen
tre, St. John's, NF A1B 3V6 by April 15, 1985
S85-09

GENERAL SURGEON: ON — required for clean,
congenial, northern community of 3000. Total
population 18 000 served by two hospitals in town.
Thirteen GPs including four GP/anesthetists.
Ob/gyn/ortho an asset. Underserviced area grant
available. Dr. R. Minty, PO Box 489, Sioux
Lookout, ON P0V 2T0, (807) 737-3803.
- S85-06

ORTHOPEDIC SURGEON: ON - Busy modern
350-bed Toronto suburban hospital requires an or
thopedic surgeon with fellowship. Reply in con
fidence to: Box S107, CJS.
S85-11

GENERAL SURGEON
ONTARIO
Required to replace a general surgeon retiring 1985 03
31 in the community of Arnprior, situated on the Ottawa
River approximately 70 km from Ottawa.
Fully accredited 50 acute and 20 chronic care bed
hospital with two ORs. Practice draws from a communi
ty population of 6000 and a catchment area of approx
imately 14 000. Current medical staff includes nine
general practitioners and tw o general surgeons.
Excellent schools and recreational area including golf
courses, curling club, ski hills nearby and a community
centre.
Apply to:
Lt. Col. J.A. Gaumond (Ret.), Chairman
Arnprior & District M emorial Hospital Board
350 John St. N., Arnprior, ON K7S 3H4
-S85-08

SURGICAL RESEARCH FELLOW
INTESTINAL TRANSPLANTATION
A 1-2 year research fellowship at the Toronto
General Hospital, University of Toronto. Techni
ques of canine and rat intestinal transplantation
and transplant immunology will be learned.
Surgical experience necessary, Computer
knowledge helpful.
For more information contact:

Dr. Zane Cohen
Toronto General Hospital
101 College St., 9E-211
Toronto, ON M5G 1L7
(416) 595-3846
-S85-05

GENERAL SURGEON: — with training and ex
perience in fracture surgery. The opening is
available immediately with staff privileges at St.
Mary's General Hospital, an 184-bed active treat
ment facility. This is an excellent opportunity to take
over an established practice in a district referral cen
tre, with private office space available in a
downtown professional building. The call schedule
is shared in cooperation w ith three other certified
general surgeons. Canadian certification is required.
For further information contact: Mrs. Irene Krys,
Acting Executive Director, St. Mary's General
Hospital, 41 Pine St. N., Timmins, ON P4N 6K7.
Tel: (705) 267-2131, or Dr. Peter Richardson,
Chief of Staff, St. Mary's General Hospital.
Tel: (705) 264-2368 or 235-2834.
S85-13

CHIEF OF SURGERY
Victoria Hospital Corporation
London, Ontario
This 835-bed university affiliated active treatment
teaching and research hospital requires a Chief of
Surgery to direct a department w ith large outpatient
and inpatient facilities in the existing and developing
new hospital complex. The successful candidate will
assume a dm in istrative du tie s and coordinate
undergraduate and postgraduate teaching. He/She
must be licensed in the Province of Ontario and hold a
Certificate of the Royal College of Physicians and
Surgeons of Canada. A teaching appointment at the
University of Western Ontario, at an appropriate
academic rank, usually accompanies this position.
Applications with a curriculum vitae and the names of
three references should be sent to: The Chairman,
Joint Selection Comm ittee for Chief of Surgery,
c/o Executive Offices, Victoria Hospital Corpora
tion, 375 South St., London, ON N6A 4G5.
S85-14
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